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CHAPTER I 
 
INTRODUCTION 
 
Bacterial pathogens: a scourge to human health 
 From the dawn of recorded history, human beings have had an intimate 
association with a wide range of bacterial pathogens.  Ancient accounts contain detailed 
descriptions of and instructions for the treatment of lepers and those exhibiting signs of 
skin and soft tissue infections (1, 2): 
Or if there be any flesh, in the skin whereof there is a hot burning, and the 
quick flesh that burneth have a white bright spot, somewhat reddish, or 
white; then the priest shall look upon it: and, behold, if the hair in the 
bright spot be turned white, and it be in sight deeper than the skin; it is a 
leprosy broken out of the burning: wherefore the priest shall pronounce 
him unclean: it is the plague of leprosy (3). 
In 430 BC, war with Sparta precipitated an unprecedented influx of refugees into Athens, 
leading to an outbreak of plague (likely caused by a bacterial pathogen of the genus 
Rickettsia).  This was one contributing factor to the downfall of the great Greek State (4).  
In 125 AD, an anthrax outbreak killed tens of thousands of Romans, one of many 
plagues to affect the Roman Empire (4).  Numerous plague outbreaks (at least in part 
attributable to Yersinia subspecies) devastated what later became Europe throughout 
the following two millennia, killing the great Emperor and Stoic philosopher Marcus 
Aurelius in 166 AD, literally decimating Europe in 1104-10 AD, and killing a third of 
Europeans from 1345-51 AD (4).   
Following the advent of modernity, a devastating blow was struck to the march of 
the prokaryotic contagion when, in 1927, Scottish bacteriologist G. Alexander Fleming 
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serendipitously discovered a contaminating mold that inhibited the growth of 
Staphylococcus aureus on agar plates (14).  This mold was found to produce a highly 
effective antibacterial agent, later named penicillin (14).  Following the development of 
penicillin into an effective drug, penicillin was quickly implemented in the treatment of 
Allied soldiers wounded in the line of combat in the second World War (4).  Penicillin 
quickly became mass produced, yet its discovery and production merely foreshadowed 
the implementation of a wide range of antibacterial agents that many thought would 
close the book on infectious disease. 
 In spite of much optimism surrounding the discovery of safe, effective 
antibacterial pharmacologic agents, it quickly became apparent that the infamous 
reputation of bacterial pathogens as a scourge to human health would not remain in 
question for long.  In the early 1960s, strains of Staphylococcus aureus resistant to the 
β-lactam antibiotic methicillin were first isolated; these strains, known as methicillin-
resistant S. aureus (MRSA) quickly became prevalent in hospital settings as the cause 
of invasive infections (51, 67).  Though drug resistance was initially confined to clinical 
settings, the spread of MRSA merely foreshadowed the emergence of community-
acquired infections caused by multiple drug resistant bacterial pathogens (59, 93).  By 
the beginning of the 21st century, it has become apparent that the rate of discovery of 
new antibacterial agents is in many cases easily rivaled by the rate of acquisition of 
resistance mechanisms on the part of the targeted pathogens.  Because of resistance in 
pathogens targeted by antibacterial agents as well as other limitations to antibiotic 
therapy, it is now clear that bacterial infections are not a phenomenon of the distant past, 
conquered by the ingenuity of man.   
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Staphylococcus aureus antibiotic resistance and pathogenesis 
The quintessential example of a bacterial pathogen that continues to match the 
pace of drug discovery with drug resistance mechanisms is the Gram-positive human 
pathogen Staphylococcus aureus.  The first bacterial pathogen found to have acquired 
penicillin resistance mechanisms was S. aureus (92).  Currently, staphylococcal strains 
that are resistant to most commonly available antibiotics are prevalent (71, 103).  
Furthermore, strains have emerged that are resistant to one of the few remaining 
antibiotics that inhibits the growth of MRSA strains, namely vancomycin (167).    
S. aureus is a commensal of the skin and anterior nares, colonizing 
approximately 25% of humans (178).   In this context, S. aureus is relatively harmless; 
however, serious diseases can occur when S. aureus breaches host epithelial barriers.  
Following invasion of the host, S. aureus is capable of infecting virtually any tissue of the 
human body, leading to diseases including skin and soft tissue infection, endocarditis, 
pneumonia, and osteomyelitis.  In addition, S. aureus toxins are capable of inducing 
several severe intoxications including toxic shock syndrome and other sepses that can 
rapidly lead to death.  The inherent capacity of S. aureus to cause severe infections is 
compounded by widespread antibiotic resistance on the part of this species.  For these 
reasons, S. aureus can be regarded as one of the most significant threats to human 
health worldwide (71).   
 
Host defenses against S. aureus: the role of iron 
 Any bacterial pathogen that invades host tissues must overcome or circumvent 
mechanisms of innate and adaptive immunity.  One strategy utilized by the mammalian 
innate immune system to prevent bacterial proliferation is known as nutritional immunity.  
Nutritional immunity refers to the host-mediated sequestration of nutrients essential for 
the growth or fitness of a pathogen (19).  Metal ions are an example of a class of 
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nutrients that is maintained within host tissues at concentrations too low to support the 
growth of most bacteria (30, 38).  Specifically, mammalian tissues contain very low 
concentrations of bio-available iron, a nutrient required by almost all bacterial pathogens 
(30).  Free iron is maintained at low levels through host iron-binding proteins (including 
transferrin and lactoferrin) and through maintenance of physiologic pH, in which iron is 
sparingly soluble (30, 40).   
S. aureus is unable to proliferate in normal, physiologic iron concentrations 
typical of mammalian tissues, and iron therefore has an influence on staphylococcal 
virulence (65).  This is because numerous biochemical processes of prokaryotes 
(including DNA synthesis, avoidance of reactive oxygen species, and aerobic 
respiration) critically depend on iron (30, 85).  Consequently, growth in low iron is a 
stressful state for S. aureus as well as other bacteria that require iron, and thus 
elaborate iron acquisition systems are expressed under conditions of iron deprivation 
(40).   
The canonical strategy for iron acquisition employed by bacteria involves the 
secretion of iron-chelating small molecules known as siderophores.  Siderophores bind 
free iron ions with remarkably high affinities, removing iron atoms from bacterial 
surroundings.  Siderophore-iron complexes then bind siderophore receptors on the 
bacterial surface; from here, chelated iron is imported into the bacterial cytoplasm for 
release and incorporation into iron-binding proteins.   S. aureus is able to produce 
siderophores upon iron starvation; furthermore, siderophore-mediated iron acquisition 
may influence the outcome of the host-pathogen interaction (41).   
Although S. aureus is capable of acquiring iron though siderophore-mediated 
uptake pathways, which are also capable of targeting transferrin and lactoferrin, free iron 
and transferrin/lactoferrin-bound iron represents only a fraction of the total iron within the 
human body.  Most host iron is found in the form of the heme molecule (44).  This is due 
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to the fact that heme is the cofactor of hemoglobin and myoglobin, the oxygen-shuttling 
and oxygen-storing proteins of human blood and muscle tissue, respectively.  Although 
abundant in the human body, iron in the form of heme is subject to more layers of 
sequestration than any other iron source: in heme, iron cannot by itself dissociate from 
the porphyrin ring.  Furthermore, heme is stably associated with hemoglobin or 
myoglobin, and hemoglobin and myoglobin are both sequestered within mammalian 
cells. 
 
Heme capture by S. aureus 
S. aureus is able to access heme-iron from the host through the concerted 
actions of a set of cell wall-anchored, membrane-bound, and cytoplasmic proteins 
known collectively as the iron-regulated surface determinants (Isd).  An emerging 
paradigm is beginning to explain how the S. aureus Isd machinery functions to acquire 
heme during the association between staphylococci and host tissues rich in heme (112, 
134, 151).  S. aureus is capable of lysing erythrocytes by secreting pore-forming toxins 
including alpha toxin, causing the release of hemoglobin (18, 87).  Upon hemoglobin 
release, cell wall-anchored IsdB and IsdH are able to bind hemoglobin (168), allowing 
IsdA (which is also anchored to the cell wall) to remove heme from hemoglobin (187).  
IsdA passes heme to IsdC, an Isd protein embedded deeply within the cell wall (187).  
Heme is then passed from IsdC to the membrane-localized transport system IsdDEF, 
which shuttles heme into the cytoplasm. Here, the heme monooxygenases IsdG and IsdI 
degrade heme to release free iron, which is capable of satisfying the nutrient needs of S. 
aureus (133, 149).  The importance of heme acquisition to pathogenesis is highlighted 
by virulence defects observed in strains inactivated for members of the Isd family (133, 
150, 168).  It appears that S. aureus can circumvent nutritional immunity by tapping into 
an abundant source of host iron inaccessible to all but a few microorganisms.  
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Furthermore, it is possible that interfering with the ability of S. aureus to acquire iron 
from heme during infection represents a potentially fruitful avenue for the development of 
effective anti-staphylococcal therapeutic agents. 
 
Control of iron acquisition by the ferric uptake regulator 
Through siderophore-mediated iron uptake and Isd-dependent heme capture, S. 
aureus is able to satisfy its nutrient iron requirement.  However, it is possible that S. 
aureus may encounter environments (such as the skin) that are not iron-restricted; in 
such environments, it would be metabolically wasteful to elaborate systems devoted to 
iron acquisition.  Furthermore, if iron acquisition systems are expressed in conditions of 
iron abundance, too much iron may be imported into bacterial cells.  This would be 
disadvantageous to a bacterium, as iron by itself is toxic to biological systems at high 
concentrations due to its capacity to catalyze the formation of reactive oxygen species 
(7).  Therefore, most bacteria tightly regulate the expression of iron acquisition systems, 
only allowing their expression under conditions of iron starvation (40). 
In most bacteria (including S. aureus) genes encoding iron acquisition systems 
are tightly controlled by a repressor called the ferric uptake regulator (Fur).  A 
ferroprotein, Fur chelates iron under conditions of iron abundance and binds to well-
defined sequences upstream of genes for iron acquisition systems, repressing their 
expression (52).  Under conditions of iron paucity, Fur dissociates from iron, decreasing 
its affinity for operator regions within the genes it represses, and allowing expression of 
iron uptake machinery (52).  This prevents the cellular stress that would accompany iron 
overload, and avoids the equally stressful condition of iron starvation through the 
regulated expression of iron uptake systems.  In S. aureus, the importance of Fur to the 
fitness of S. aureus is highlighted by virulence defects observed for S. aureus lacking a 
functional fur gene (80, 183).  Furthermore, Fur-mediated control of gene expression 
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overlaps with heme acquisition in S. aureus, as the Isd system is directly regulated by 
Fur (112, 133).   
 
Metalloporphyrin toxicity: the heme paradox 
Just as iron levels must be tightly regulated within a bacterial cell to avoid the 
twin problems of iron overload and iron starvation, heme homeostasis must be 
monitored closely to achieve a balance between paucity and toxicity.  This is because 
heme is a powerful catalyst that can induce the formation of reactive oxygen species 
(53).  Furthermore, heme is lipophilic, and tends to insert into membranes, interrupting 
membrane fluidity and leading to lipid damage.  For this reason, biological systems that 
synthesize heme or associate with high amounts of exogenous heme must take steps to 
avoid heme toxicity (9, 134, 188).  Furthermore, a few bacterial pathogens express 
systems that are required for the avoidance of heme toxicity (20, 21, 127).  Such 
systems are likely to be of particular importance for bacteria that acquire heme 
exogenously from their host during infection (162).  More specifically, S. aureus and 
other pathogens that acquire heme have been shown to be rapidly killed by heme-like 
molecules brought into the bacterial cell due to the elaboration of heme uptake systems 
(20, 21, 162).  
Although mechanisms of iron uptake by siderophores and heme uptake by the 
Isd system have been extensively investigated in S. aureus, comparatively little attention 
has been devoted to understanding the mechanisms of iron homeostasis on a global 
level in this bacterium.  Genes under Fur-mediated control in S. aureus can be predicted 
in silico; however, no studies have addressed the response of S. aureus to either iron 
starvation or deregulation of the Fur regulon.  Furthermore, no studies have addressed 
the “other side of the coin” of heme capture by S. aureus: the problem of heme toxicity.   
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Herein, we report the cytoplasmic Fur, iron and heme regulons of S. aureus.  
These studies reveal an iron starvation-induced metabolic shift leading to the release of 
iron from host iron-sequestering proteins.  This may represent a strategy for increasing 
the amount of iron available to staphylococci.  In addition, we demonstrate a mechanism 
whereby S. aureus and related Gram-positive pathogens avoid heme toxicity by sensing 
heme through a novel two-component system, which controls expression of a transport 
system responsible for heme detoxification.  This scheme of heme detoxification is 
conserved in Bacillus anthracis, the causative agent of anthrax and an evolutionary 
relative of S. aureus.  We show that perturbation of heme detoxification alters 
staphylococcal virulence, and that heme is sensed during the association of B. anthracis 
with vertebrate tissues.  Last, we begin to elucidate the mechanism of activation of a 
novel heme-sensing histidine kinase utilizing a small molecule library screen.  These 
findings reveal that Gram-positive organisms exquisitely balance heme acquisition with 
the avoidance of heme toxicity by sensing and responding to heme.  
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CHAPTER II 
 
EFFECTS OF IRON STARVATION AND DISRUPTION OF THE FERRIC UPTAKE 
REGULATOR ON THE STAPHYLOCOCCUS AUREUS CYTOPLASMIC PROTEOME  
 
Introduction 
Low iron is a stressful condition to Staphylococcus aureus.  Accordingly, S. 
aureus requires iron to successfully colonize the host (30).  However, elevated levels of 
iron or iron-containing compounds actively acquired by S. aureus (such as heme) are 
also toxic (162).  To ensure efficient uptake and metabolism of host iron sources, S. 
aureus uses Fur to control expression of a variety of genes in response to the level of 
available iron (183).  Importantly, a global analysis of Fur and iron-regulated proteins in 
this important human pathogen has not been reported.  In addition, although numerous 
studies have focused on the mechanism of heme capture by S. aureus, no studies have 
addressed the response of S. aureus to growth in levels of heme that are stressful to 
staphylococci. 
 Based on the demonstrated role for iron, Fur, and heme in staphylococcal 
pathogenesis, we sought to evaluate changes in global protein regulation in response to 
alterations in bacterial iron status (chelation of iron, disruption of fur, and addition of 
heme) using two-dimensional difference gel electrophoresis (2D-DIGE).  2D-DIGE 
enables quantitative differential display analysis with statistical confidence, and is based 
on 2D gel separations whereby thousands of protein features can be resolved based on 
isoelectric point and by apparent molecular mass.  It uses spectrally resolvable 
fluorescent dyes to pre-label samples that are then multiplexed onto the same gel, 
allowing for direct quantification of each resolved protein feature between the three dye 
channels without analytical (gel-to-gel) variation.  Multiple samples from a complex 
experiment can be analyzed across several 2D-DIGE gels through the inclusion of an 
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internal standard comprised of every sample present in the experiment, which is 
included in each multiplexed gel (5, 60, 63).  Within each gel, quantitative measurements 
are made for each resolved protein feature relative to the cognate signal from the 
internal standard, which is then used to normalize the intra-gel ratios between gels in a 
coordinated experiment.  Thus, 2D-DIGE enables multiple conditions with repetition to 
be quantitatively analyzed with statistical confidence.   Proteins of interest are then 
identified using mass spectrometry (MS) and database interrogation. Algorithms such as 
unsupervised hierarchical clustering can be applied to 2D-DIGE datasets to enable 
analysis of global expression patterns. Combining multivariable 2D-DIGE/MS with 
multivariate statistical analyses clusters cellular protein responses across distinct 
environmental conditions based on total expression profiles.   These technologies can 
be combined to identify expression changes in coordinated biochemical pathways.  Such 
data can be used to predict phenotypic changes predicted to be the outcome of shifting 
from one metabolic pathway to another.   
 Here, we utilize 2D-DIGE to reveal the subset of cytoplasmic proteins regulated 
by iron, Fur, and heme in S. aureus.  We show that S. aureus alters the abundance of a 
set of proteins upon conditions of heme exposure, possibly leading to heme 
detoxification.  We also show that S. aureus undergoes a dramatically different response 
to growth in low iron or to disruption of Fur, both of which perturb staphylococcal iron 
homeostasis.  This latter response alters the abundance of key enzymes involved in 
staphylococcal central metabolism, leading to the production of acidic metabolic end 
products.  The commensurate decrease in pH accompanying iron status perturbation 
and release of acidic metabolic products triggers the release of iron from the host iron-
sequestering protein transferrin.  This represents a potential strategy for iron acquisition 
whereby S. aureus senses low iron, alters the pH of its surroundings, and acquires iron 
released from host proteins.  Results obtained from this study identify a novel strategy 
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used by S. aureus to increase iron availability, and begin to define the iron-, Fur-, and 
heme-dependent regulons of S. aureus. 
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Methods 
Bacterial strains and growth conditions - S. aureus clinical isolate Newman was used in 
all experiments.  Prior to preparation of cytoplasmic extracts, bacteria were grown in 
tryptic soy broth (TSB) for 15 hours at 37o C with shaking at 180 RPM.  Iron starvation 
was achieved by addition of 1 mM 2,2’ dipyridyl (DIP) to the growth cultures prior to 
inoculation.  Heme treatment was achieved by addition of 10 µM heme to the growth 
cultures prior to inoculation.  All cultures were harvested at comparable optical densities 
during early stationary phase. Newman ∆fur was created through transduction of the 
previously created ∆fur allele from RN4220 (113) to strain Newman with the transducing 
phage Φ-85 as previously described (149).  
 Preparation of cytoplasmic fractions - Cytoplasmic extracts were prepared upon 
completion of 15 hours of bacterial growth.  Cells were pelleted by centrifugation at 6000 
g for 15 minutes.  Pellets were re-suspended in TSM (100 mM Tris, pH 7.0, 500 mM 
sucrose, 100 mM MgCl2) and incubated at 37o for 45 minutes in the presence of 1 mg of 
lysostaphin.  Following cell wall digestion, protoplasts were isolated by centrifugation at 
13,700 g and washed once and re-suspended in 20 ml of buffer (50 mM Tris, pH 7.5, 
150 mM NaCl, 100 µM phenylmethylsulfonylfluoride).  To lyse the protoplasts, samples 
were subjected to two rounds of French Press mediated lysis at 20,000 psi.  Insoluble 
material was removed by ultracentrifugation at 100,000 g for 45 minutes.  The collected 
supernatant, representing the cytoplasmic fraction, was used in subsequent analyses.  
2D-DIGE/MS - Quadruplicate samples from the four conditions were independently 
prepared as described below.  For each sample, 0.25 mg protein was separately 
precipitated with methanol and chloroform (179) and re-suspended in 30 µl lysis buffer 
(7M urea, 2M thiourea, 4% CHAPS, 30 mM Tris, 5 mM magnesium acetate).  The NHS-
ester dyes Cy2/3/5 were used for the minimal labeling protocol using an internal 
standard (5, 60, 63). Briefly, one-third of each sample (10 µl, 83 µg) was removed and 
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combined into a single tube to comprise the pooled-sample internal standard (1330 µg 
total).  The remaining two-thirds of each individual sample (20 µl, 167 µg) was 
individually labeled with 200 pmol of either Cy3 or Cy5, while the pooled-sample was 
labeled en masse with 1600 pmol Cy2.  The samples were quenched with 10 mM lysine 
(2 µl for each 200 pmol) for 10 minutes on ice, followed by the addition of equal volume 
2x rehydration buffer (7M urea, 2M thiourea, 4% CHAPS, 4 mg/ml DTT).  Pairs of 
Cy3/Cy5-labeled samples were mixed with an equal aliquot of the Cy2-labeled internal 
standard according to the schema in Figure 1B.  Tripartite samples were brought up to 
450 µl with 1x rehydration buffer (same as 2x buffer but with 2 mg/ml DTT) and passively 
rehydrated into 24 cm 4-7 immobilized pH gradient (IPG) strips for 24 hrs (total of 500 µg 
per gel). 
All 2D-DIGE-associated instrumentation was manufactured by GE 
Healthcare/Amersham Biosciences (Piscataway, New Jersey).  First-dimensional 
separations were performed on a manifold-equipped IPGphor first-dimension isoelectric 
focusing unit, and second-dimensional 12% SDS-PAGE was carried out using hand-cast 
gels that had one plate pre-silanized (to ensure subsequent accurate robotic protein 
excision) using an Ettan DALT 12 unit, both according to the manufacturer’s protocols. 
Cy2/3/5-specific 16-bit data files were acquired at 100 µm resolution separately by dye-
specific excitation and emission wavelengths using a Typhoon 9400 Variable Mode 
Imager, and the gels were stained for total protein content with SyproRuby (Molecular 
Probes/Invitrogen) per the manufacturer’s instructions.  
The DeCyder v6.5 suite of software tools (Amersham Biosciences/GE 
Healthcare) was used for 2D-DIGE analysis.  The normalized volume ratio of each 
individual protein spot-feature from a Cy3- or Cy5-labeled sample was directly quantified 
relative to the Cy2-signal from the pooled-sample internal standard corresponding to the 
same spot-feature.  This is performed for all resolved features in a single gel where no 
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gel-to-gel variation exists between the three co-resolved signals.  The individual signals 
from the Cy2-standard were then used to normalize and compare Cy3:Cy2 and Cy5:Cy2 
abundance ratios across the 8-gel set, enabling statistical confidence to be associated 
with each change in abundance or charge-altering post-translational modification using 
Student's t-test and ANOVA analyses. Hierarchical clustering was performed using the 
DeCyder Extended Data Analysis (EDA) module.   
 Proteins of interest were robotically excised, digested into peptides in-gel with 
modified porcine trypsin protease (Trypsin Gold, Promega) and peptides applied to a 
stainless steel target using an integrated Spot Handling Workstation per the 
manufacturer’s recommendations. Matrix assisted laser desorption/ionization, time-of-
flight mass spectrometry (MALDI-TOF MS) and data-dependant TOF/TOF tandem 
MS/MS was performed on a Voyager 4700 (Applied Biosystems, Framingham MA).  The 
resulting peptide mass maps and the associated fragmentation spectra were collectively 
used to interrogate S. aureus Mu50 sequences to generate statistically significant 
candidate identifications using GPS Explorer software (Applied Biosystems) running the 
MASCOT search algorithm (www.matrixscience.com).  Searches were performed 
allowing for complete carbamidomethylation of cysteine, partial oxidation of methionine 
residues, and 1 missed cleavage. Molecular Weight Search (MOWSE) scores, number 
of matched ions, number of matching ions with independent MS/MS matches, percent 
protein sequence coverage, and correlation of gel region with predicted MW and pI were 
collectively considered for each protein identification. 
Measuring medium/culture pH - Bacteria were grown in 10 ml of TSB in a 50 ml flask for 
15 hours at 37oC with 180 rpm shaking. Iron was chelated from the media by adding DIP 
to a final concentration of 1 mM. After 15 hours the cultures were centrifuged and the 
supernatants were collected. All pH values were measured using a S20 SevenEasy pH 
meter (Mettler Toledo).  
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Iron release from transferrin - Measuring the release of iron from transferrin (TF) was 
performed as previously described (72).  Iron-bound TF exhibits an absorption peak at 
470 nm. As iron dissociates from TF the intensity of the peak at 470 nm absorption 
decreases.  Absorption at 470 nm was measured every 30 seconds for 15 minutes upon 
introduction of the samples.  TF stock solutions of 400 µM were prepared by suspending 
human TF (Sigma) in distilled water.  TF stock solutions were added at a final 
concentration of 40 µM to all samples.  All absorption readings were measured using a 
Cary 100 UV-Vis spectrophotometer from Varian. 
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Results 
2D-DIGE/MS analyses of the S. aureus cytoplasmic proteome upon alterations in 
iron status.  To identify proteins that respond to alterations in iron availability or 
exposure to host iron sources, we performed differential expression analyses on S. 
aureus cultures grown under various conditions of iron exposure.  Cytoplasmic proteins 
were prepared from S. aureus ∆fur grown under iron-replete conditions and from wild 
type grown under either iron-replete conditions, after iron starvation through treatment 
with DIP, or after exposure to heme.  Protein extracts from each of the four conditions 
were independently isolated in quadruplicate to control for non-biological variation, and 
the resulting 16 extracts were simultaneously co-resolved across 8 2D-DIGE gels that 
were coordinated by a 16-mix pooled-sample internal standard as described in Methods 
(Figure1A).   
 2D-DIGE analysis combined with subsequent hierarchical clustering (Figure 1B) 
allowed for protein expression changes between these four conditions to be grouped into 
the following five classes:  (I) proteins that are negatively regulated by iron and Fur 
(Table 1), (II) proteins that are positively regulated by iron and Fur (Table 2), (III) 
proteins that are regulated by iron independent of Fur (Table 3), (IV) proteins that are 
regulated by Fur independent of iron (Table 4), and (V) proteins that are regulated by 
heme independent of Fur or iron (Table 5).   We identified 29 resolved protein features 
(representing 20 distinct proteins including isoforms) under iron-dependent negative 
regulation by Fur, 30 distinct features (25 proteins including isoforms) under iron-
dependent positive Fur-mediated regulation, and 21 distinct proteins that respond 
exclusively to heme.  This analysis revealed that exposure of S. aureus to heme results 
in a vastly different, and less severe, change in cellular protein expression as compared 
to altering the iron status of the bacterium (Figure 1B).  Importantly, a novel, 
uncharacterized transport system with a potentially important role in staphylococcal  
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Figure 1. 2D-DIGE-based proteome analysis of Staphylococcus aureus following 
perturbation of iron status.  A. False-colored representative gel from the 8-gel set 
containing three differentially labeled samples as described in Chapter II Methods.  Cy2-
labeled internal standard (blue), Cy3-labeled control #1 (green), and Cy5-labeled iron-
starved #1 (red) are overlayed for illustrative purposes.  B. Unsupervised hierarchical 
clustering of the 16 individual DIGE expression maps (groups, shown along top) and of 
individual proteins (shown on the left), with relative expression values for each protein 
displayed as a heat map using a relative scale ranging from -0.5 (green) to +0.5 (red). 
The gel number (1-8) and Cy3/5 dye labeling for each sample is listed below.  Adapted 
from Friedman et al., 2006 (Ref. 61).  Experiments were performed in collaboration with 
DBF and CW. 
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heme metabolism was dramatically increased in abundance under conditions of heme 
exposure.  However, because iron- and Fur-dependent changes differ greatly from 
heme-dependent changes (Figure 1B), the remainder of this Chapter will address the 
affects of iron perturbation on the S. aureus proteome.  Heme-dependent changes and 
the critical role of the heme-regulated transport system in staphylococcal heme 
metabolism will be discussed in the subsequent Chapters of this manuscript. 
 
S. aureus proteins negatively regulated by iron and Fur.  Proteins that are up-
regulated upon iron starvation or inactivation of fur (via release from repression) 
represent proteins negatively regulated by Fur in an iron-dependent manner, and hence 
comprise the canonical Fur regulon of the bacterium.  We identified 29 distinct protein 
features comprising 20 unique cytoplasmic proteins that are up-regulated from 1.3-fold 
to over 14-fold in the absence of iron or Fur (Table 1).  These results demonstrate a 
strong correlation between expression changes upon iron chelation vs. the absence of 
fur.  As expected, iron acquisition systems previously shown to be iron-regulated via Fur 
are up-regulated under these conditions including proteins involved in siderophore 
synthesis (SbnE isoforms exhibiting over 3-fold increases in low iron or ∆fur,) (41) and 
transport (FhuA, over 8-fold increases) (145).   
Five of 21 proteins that were negatively regulated by iron and Fur with mostly 
moderate changes in abundance (ca. 1.5-fold) are enzymes of the glycolytic pathway 
including fructose 1-P kinase (FruB), fructose bisphosphate aldolase (FbaA), 
triosephosphate isomerase (Tpi), glyceraldehyde 3-phosphate dehydrogenase (Gap), 
and transketolase (Tkt) (Table 1).  This observation is consistent with a systemic up-
regulation of glycolysis upon iron starvation, which would lead to a commensurate 
increase in pyruvate for subsequent use in either the TCA cycle, or as a substrate for 
fermentative metabolism.   
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S. aureus proteins positively regulated by iron and Fur.  Fur is traditionally 
considered a repressor of iron-regulated gene transcription.  However, recent work has 
highlighted a role for Fur in the direct and/or indirect activation of a small subset of 
genes in Helicobacter pylori (97), Vibrio cholerae (115), Neisseria meningitidis (45), 
Escherichia coli (49, 111), and Bacillus subtilis (13).  We identified 30 distinct protein 
features representing 25 unique proteins that were positively regulated by Fur in an iron-
dependent manner as measured by decreased expression in the absence of Fur or upon 
iron starvation (Table 2).   
 Numerous regulatory factors were activated by Fur in an iron-dependent manner 
including RbsU.  RbsU, down-regulated in ∆fur and iron-replete conditions, controls the 
expression of a variety of virulence genes and regulatory systems. Based on this 
pleotropy, small changes in RbsU expression may have profound effects on cellular 
metabolism.  In particular, RbsU activates acetate catabolism; therefore, the Fur-
dependent activation of RbsU is consistent with a down-regulation of the TCA cycle 
upon iron starvation or fur inactivation (154). 
 The value of iron to S. aureus is underscored by the Fur-mediated, iron-
dependent activation of four separate proteins that are predicted to contain iron-sulfur 
clusters. Three of these proteins are the TCA cycle enzymes succinate dehydrogenase 
(SdhA), aconitate hydratase (CitB), and fumarate hydratase (CitG).  A fourth TCA cycle 
enzyme, phosphoenolpyruvate carboxykinase (PckA), which coverts oxaloacetate to 
phosphoenolpyruvate during gluconeogenesis, was also down-regulated upon 
inactivation of fur or iron depletion.  Two additional proteins associated with central 
metabolism and demonstrating this expression pattern are D-fructose-6-phosphate 
amidotransferase (GlmS) and glyceraldehyde 3-P dehydrogenase (GapB).  GlmS 
converts fructose 6-P to glucosamine-6-P, and hence depletes substrate for 
phosphofructokinase in effect antagonizing glycolysis.  GapB is a second glyceraldehyde 
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3-P dehydrogenase of S. aureus and based on its function in Bacillus subtilis, is 
predicted to possess GAPDH activity involved in gluconeogenesis (55). These results 
support the Fur-mediated up-regulation of glycolysis upon iron starvation, and suggest a 
commensurate systemic and regulated inhibition of the TCA cycle.  Together, these 
findings support a model whereby in iron-starved S. aureus, excess pyruvate produced 
as a result of an up-regulation of the glycolytic pathway is shuttled into fermentative 
pathways as opposed to the TCA cycle. These results suggest that excess pyruvate 
produced as a result of increased glycolysis is converted to predicted products of 
staphylococcal fermentative metabolism.    
  
S. aureus proteins regulated by iron independent of Fur.  In addition to Fur, S. 
aureus possesses the metal-dependent regulators Zur (102), PerR (79), and MntR (81), 
raising the possibility that factors other than Fur respond to changes in cellular iron 
content.  We identified 22 unique proteins with changes in abundance upon iron 
starvation, but without detectable changes in response to inactivation of fur (Table 3).  
Three of these proteins are associated with cellular respiration including formate 
dehydrogenase (Fdh), Hpr Kinase (HprK), and NAD synthase (NadE). Thus, we have 
identified a significant pool of proteins that respond to iron independent of Fur, raising 
the possibility that an additional transcriptional regulator exists in S. aureus to monitor 
intracellular iron status. It should be pointed out that DIP binds divalent cations other 
than iron; this may in part explain for some of the expression changes that were 
observed.   
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S. aureus proteins regulated by Fur independent of iron.  We also identified 24 
unique proteins that changed expression upon inactivation of fur without any significant 
changes in iron availability status (Table 4).  One such protein, GapR, is an activator of 
Gap expression and is up-regulated in the absence of Fur.  This moderate increase in 
expression may contribute to the increase in Gap expression observed upon inactivation 
of fur (Table 1).  Inactivation of fur leads to down-regulation of PckA and isocitrate 
dehydrogenase (CitC), consistent with our previous observation of Fur-mediated 
activation of the TCA cycle.   Furthermore, acetoin reductase (ButA) is down-regulated 
by inactivation of fur implying a commensurate decrease in the production of 2,3-
butanediol upon iron starvation.  Taken together with results described above, this 
suggests that the major metabolic end-products of carbohydrate metabolism produced 
by iron-starved S. aureus are pyruvate, lactate and/or formate (Figure 2).    
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Figure 2. S. aureus shifts to fermentative pathways upon iron starvation.   A subset 
of the predicted central metabolic reactions of S. aureus is shown. Proteins shown in red 
are up-regulated in the absence of iron or upon inactivation of fur.  Proteins shown in 
blue are down-regulated in the absence of iron or upon inactivation of fur.  Proteins 
shown in green are down-regulated in the absence of Fur independent of iron status.  
The red arrows predict the direction of reactions upon iron starvation, while the blue 
arrows predict reactions that are inhibited upon iron starvation. The red circle signifies 
one of the primary predicted metabolic end-products of iron-starved S. aureus, lactate.  
Adapted from Friedman et al., 2006 (Ref. 61). 
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Iron-starved S. aureus produce acidic metabolic end products leading to a 
decrease in local pH.  Iron starved S. aureus are known to restrict oxidative capacity by 
oxidizing glucose with the accumulation of lactate, pyruvate, acetate, formate, and 
acetoin (165). The coordinated expression changes of the staphylococcal central 
metabolic pathways identified using 2D-DIGE/MS are summarized in Figure 2, and 
provide a mechanistic explanation for this observation.  Our results suggest that iron 
starved S. aureus undergo a Fur-mediated redirection of central metabolic pathways 
leading to the production of acidic end products of fermentative metabolism.   
 To test this hypothesis, we measured the pH of medium from iron-replete, iron-
deplete, and ∆fur cultures.  These experiments demonstrated a drop in culture pH from 
7.2 to 5.2 upon either iron starvation or fur inactivation.  In contrast, iron-replete cultures 
increased pH to close to 8.0 in identical incubation conditions (Figure 3A).  From these 
data, we conclude that S. aureus elaborates a Fur-mediated redirection of central 
metabolism under iron starvation leading to decreased pH of culture medium.  
TF-iron represents a viable iron source to invading bacterial pathogens.  In order 
to utilize TF-iron as a nutrient iron source, the iron must be dissociated from TF and 
transported into the bacterium.  Free Fe3+ is more readily utilized as a nutrient source 
than TF bound iron, and iron is known to dissociate from TF upon changes in pH (126).  
We hypothesized that the Fur-dependent production of acidic metabolic end products by 
iron starved S. aureus facilitates the release of iron from TF through a decrease in local 
pH.  To test this hypothesis, we measured iron release from TF mediated by spent 
medium from either iron-replete, iron-deplete, or ∆fur staphylococcal cultures.  We found 
that medium from iron starved or ∆fur staphylococcal cultures significantly increased the 
rate of iron release from TF (Figure 3B).  Taken together, these results demonstrate that 
the Fur-mediated production of acidic metabolic end products by iron starved S. aureus 
facilitates the release of iron from host iron-sequestering proteins.     
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Figure 3. S. aureus produces acidic metabolic end products upon iron starvation 
or inactivation of fur.  A. pH of media or culture supernatants following perturbation of 
iron status.  pH readings were taken on triplicate flasks containing fresh TSB (TSB 1), 
TSB incubated at 37°C for 15 hours (TSB 2), TSB + 1 mM 2,2’ dipyridyl (DIP) incubated 
at 37 °C for 15 hours, and 15-hour culture supernatants from S. aureus wild type grown 
in TSB (iron replete), TSB + 1mM DIP (iron deplete), and from S. aureus ∆fur grown in 
TSB (∆fur).  Averages are plotted; error bars correspond to one standard deviation from 
the mean.  B. Iron release from transferrin in media (solid lines) or culture supernatants 
(dashed lines) following perturbation of iron status.  Transferrin (40 µM) was added to 
media or culture supernatants described in A.  Iron release was measured as a 
decrease in absorbance at 470 nm.  Adapted from Friedman et al., 2006 (Ref. 61). 
Experiments were performed in collaboration with GP. 
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Discussion 
 We have analyzed changes in the cytoplasmic protein profile of S. aureus upon 
genetic (∆fur) and biochemical (iron chelation, heme treatment) alterations in iron 
exposure. Using 2D-DIGE, we simultaneously surveyed the S. aureus proteome in 
response to these manipulations.  Overall, 156 protein features of interest, specifying 
approximately 120 individual proteins (including changes in post-translational 
modification) were identified by mass spectrometry and placed into functional groups 
defining Fur-dependent and independent iron regulation as well as heme-responsive 
proteins.  These studies begin to reveal regulatory mechanisms used by S. aureus to 
alleviate stress induced by changes in iron availability (genetic or biochemical) and 
exposure to elevated levels of host iron sources (heme). 
 Analysis of our 2D-DIGE data reveals a number of regulation patterns of potential 
importance to S. aureus physiology and pathogenesis.  One noteworthy class of proteins 
identified in our study was down-regulated upon inactivation of fur in an iron-dependent 
manner, suggesting Fur-mediated positive regulation of these proteins. In Gram-
negative bacteria, investigations have identified the small regulatory RNA (sRNA) Ryhb 
as being responsible for Fur-dependent protein activation in E. coli (110), Pseudomonas 
aeruginosa (180), V. cholera (42) and Shigella flexneri (125).  The targets of Ryhb 
include some of the same genes identified in our study as being positively regulated by 
Fur, including the TCA cycle enzymes aconitase (acnA), fumarase (fumA), and 
succinate dehydrogenase (sdhCDAB) (111).  This observation suggests that a similar 
mechanism of iron-dependent gene regulation is occurring in S. aureus; however, we 
were unable to identify any potential homologues to Ryhb in any Gram-positive bacterial 
genome using traditional BLAST analyses (data not shown).  S. aureus has been 
reported to express at least 12 sRNAs with predicted roles in translational regulation 
through message stability (128).  It is likely that an as-yet-undiscovered sRNA-mediated 
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regulatory system exists in S. aureus responsible for iron homeostasis through targeted 
mRNA degradation. 
 Our data indicate that iron starvation leads to the reversible inactivation (or down-
regulation) of TCA cycle enzymes including aconitase, the down-regulation of which has 
been implicated as a survival response to oxidative stress induced during the host-
pathogen interaction (152).  In S. aureus, down-regulation of the TCA cycle through 
aconitase inactivation prevents maximal expression of the virulence factors lipase, 
staphylococcal enterotoxin C, and α and β hemolytic toxins, and therefore alters the 
interaction between S. aureus and the host (152).  Additionally, inactivation of the TCA 
cycle or growth in iron deplete conditions leads to a decrease in production of formylated 
delta-toxin, a potent neutrophil attractant (153).  Combined, these two factors have led to 
the suggestion that down-regulation of the TCA cycle may protect against host immune-
mediated recognition of infecting S. aureus (153).   
 We propose a model whereby upon iron starvation, such as would be 
encountered inside the host, S. aureus up-regulates glycolysis through the release of 
Fur-mediated repression of glycolytic enzymes.  Based on the simultaneous fur-
mediated down-regulation of TCA cycle enzymes, pyruvate does not enter the TCA 
cycle, but instead is acted on by fermentative pathways.  This is likely to funnel excess 
pyruvate primarily into acidic fermentative end products (Figure 2).   
 This shift to production of acidic metabolic end products is predicted to decrease 
the pH in the microenvironment surrounding infecting staphylococci, a hypothesis 
supported by the observation that the pH of the spent medium from iron starved or ∆fur 
staphylococci is significantly more acidic than that of spent medium from iron-replete 
cultures (Figure 3A).  This overproduction of acidic end products and subsequent 
decrease in pH dissociates iron from host iron-sequestering molecules (Figure 3B).  An 
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increase in local iron concentrations would significantly relieve the iron stress placed on 
the bacterium, and provide a growth advantage to invading staphylococci. 
 Our hypothesis is supported by published results showing that the uptake of iron 
(presented as 59FeSO4) by S. aureus is twice as great at pH of 4.7 as it is at a pH of 7.4 
(37)   If correct, this model implies that under conditions of iron starvation, S. aureus 
alters its central metabolic pathways through Fur-mediated regulation of enzyme activity 
resulting in an increase in the local concentration of bio-available host iron.  These 
fundamental changes in metabolic function potentially provide a survival advantage to S. 
aureus by preventing maximal activation of the immune system while bacteria struggle to 
alter their microenvironment to access host iron.   
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CHAPTER III 
 
ROLE OF THE STAPHYLOCOCCUS AUREUS HEME-REGULATED TRANSPORTER 
IN OVERCOMING HEME TOXICITY 
 
 
 
Introduction 
 Staphylococcus aureus is profoundly affected by conditions of iron scarcity.  This 
is highlighted by the alterations seen in the cytoplasmic protein profile of staphylococci 
biochemically or generically perturbed in iron status (Chapter II).   To combat iron 
starvation during infection, S. aureus utilizes heme as a source of scarce nutrient iron 
(112, 134, 150, 151).  Furthermore, heme is the preferred source of iron for 
staphylococci (150).  In S. aureus and related pathogens (including Listeria 
monocytogenes and Bacillus anthracis), heme acquisition is mediated by the iron-
regulated surface determinants (Isd), which bind host hemoglobin released from lysed 
erythrocytes and remove, import, and degrade heme to release free iron.  Isd family 
members are required for S. aureus to maintain full virulence, highlighting the 
importance of heme-iron acquisition to the outcome of the host-pathogen interaction 
(133, 168).   
 Although heme is a valuable source of nutrient iron for invading staphylococci, 
heme acquisition is a dangerous process.  Heme, hemin (the oxidized, Fe3+ form of 
heme), and non-iron metalloporphyrins are toxic to biological systems due to their 
tendency to catalyze the formation of reactive oxygen species, which damage proteins, 
nucleic acids, and membrane lipids (53, 134, 161, 162, 169).  It is therefore possible that 
during the invasion of host tissues rich in heme, S. aureus may encounter heme toxicity.   
We have previously elucidated a subset of cytoplasmic proteins that undergo 
alterations in abundance upon exposure of staphylococci to heme (Chapter II).  Although 
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a number of these proteins have known or probable roles in staphylococcal stress 
responses, a single protein feature corresponding to an uncharacterized transport 
system exhibited a dramatic change in abundance under conditions of heme exposure.  
This observation formed the basis of our foray into the response of S. aureus to heme, 
as we sought to (I) determine whether S. aureus succumbs to heme toxicity and (II) 
characterize the response of S. aureus to growth in high levels of heme. 
Here, we show that while S. aureus is sensitive to heme toxicity, staphylococci 
are able to sense and adapt to exogenous heme by inducing the expression of a heme-
detoxifying transport system, the heme-regulated transporter HrtAB.  We show that 
HrtAB consists of a permease and ATPase component, the latter of which exhibits 
ATPase activity in vitro dependent on physicochemical conditions and conserved 
residues that are hallmarks of ABC transporter ATPases.  Furthermore, HrtA catalytic 
activity is likely required for the resistance of S. aureus to heme toxicity.  In the absence 
of HrtAB function, S. aureus exhibits perturbed virulence properties, pointing to a 
possible role for heme sensing in pathogenesis.  These studies begin to shed light on a 
mechanism that allows S. aureus to avoid the lethal consequences of actively acquiring 
a toxic host molecule, and form the basis for the elucidation of a novel gene regulatory 
system conserved among Gram-positive bacteria (Chapters IV through VI).   
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Methods 
Strains, mutants, and growth conditions - S. aureus strain Newman (50) and its 
derivatives were used in all experiments.  For mutagenesis of S. aureus, a previously 
published protocol was followed (12).  Briefly, sequences flanking hrtA were PCR 
amplified, assembled into pCR2.1 (Invitrogen) and recombined into pKOR1 (12).  
Inactivation of hrtA was achieved by allelic replacement with pKOR1∆hrtA as described 
previously (12).  TSB was used for the growth of S. aureus; for plasmid selection in S. 
aureus, chloramphenicol was used at a concentration of 10 µg/ml.  Luria broth (LB, 
genetic manipulations) and terrific broth (TB, protein expression) were used for the 
growth of Escherichia coli; for plasmid selection in E. coli, ampicillin was used at a 
concentration of 100 µg/ml (138). 
Genetic manipulations in S. aureus – All plasmids were first electroporated into the 
restriction deficient primary recipient RN4220 (124), after which they were electroporated 
into appropriate electrocompetent secondary recipients (139).   
Complementation of S. aureus ∆hrtA - In the first PCR reaction, PCR-sequence overlap 
extension (PCR-SOE) primers were used to amplify the hrtAB promoter from S. aureus 
strain Newman genomic DNA.  In the second PCR reaction, PCR-SOE primers were 
used to amplify the hrtA gene from Newman genomic DNA.  The PCR products were 
purified (Qiagen gel extraction kit) and 1:300 dilutions of purified reaction 1 and reaction 
2 PCR products were mixed and amplified using distal PCR primers.  This yielded an 
amplicon in which the hrtAB promoter was fused to the hrtA gene.  The hrtAB promoter-
hrtA fusion was subcloned into pCR2.1 (Invitrogen).  The insert was excised using 
restriction endonucleases EcoRI and BamHI and then ligated into pOS1 (143) cut with 
the same enzymes, generating phrtA. 
Growth curve assays and heme adaptation analysis – For adaptation assays, 15 hour 
cultures of S. aureus grown in the presence of 1 or 2 µM heme were diluted 1:75 into 
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150 µl of fresh medium containing 10 µM heme (Fluka BioChemika) in triplicate on a 96-
well round-bottom cell culture plate.  Cells were grown at 37 °C with shaking at 180 rpm 
and absorbance values were determined at the indicated times after inoculation.  All 
spectrophotometry was performed using a Cary 50 MPR microplate reader coupled to a 
Cary 50 Bio UV-visible spectrophotometer (Varian, Inc.). 
Purification of HrtA and HrtA mutants – The full-length hrtA open reading frame was 
inserted between the NdeI and BamHI sites of pET15b, creating pET15b.hrtA for the 
expression of an N-terminal hexahistidine-tagged HrtA.  Pfu mutagenesis (176) was 
used to create expression constructs for the mutants HrtA:K45A, HrtA:R76A, 
HrtA:G145A, HrtA:G145T, and HrtA:E167Q.  All mutants were verified by sequencing.  
For all protein expression, E. coli BL-21 (DE3) harboring each plasmid was subcultured 
1:100 from 15 hour cultures into TB at 37 °C with shaking at 225 rpm until the 600 nm 
absorbance of the culture reached 0.4.  Growth temperature was then switched to 16 °C 
for 1 hour and expression was induced by adding IPTG (0.25 mM).  After an additional 
20 hours of growth at 16 ˚C, bacteria were harvested and recombinant proteins were 
purified by nickel affinity chromatography using Ni-NTA Superflow (Qiagen) following the 
manufacturer’s recommendations.  Purified proteins were dialyzed against dialysis buffer 
(10 mM Tris, pH 7.5, 200 mM KCl, 0.5 mM EDTA, 1 mM DTT, 50% glycerol) overnight 
and stored at -20 °C.  Protein concentration was determined by Bio-Rad Protein Assay 
(Bio-Rad).  For removal of the N-terminal hexahistidine tag from HrtA, restriction grade 
Thrombin Protease (Novagen) was utilized according to the manufacturer’s instructions 
and cleaved HrtA was stored at -20 °C. 
ATPase activity assays – ATPase activities were determined using an Innova 
Biosciences colorimetric ATPase assay system according to the manufacturer’s 
recommendations.  Briefly, recombinant HrtA was diluted to a final concentration of 0.5 
µM in 80 µl of 50 mM Tris (pH 7.5, or other pH as indicated), 2.5 mM MgCl2 (or other 
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divalent cation if indicated), 0.5 mM ATP (or other concentration as indicated).  All 
assays except the temperature-dependence assay were carried out at 20 °C for maximal 
ATPase activity.  At 3, 10, and 20 minutes after the addition of ATP (or other time points 
as indicated), 20 µl of Innova Biosciences Gold Mix (1:100 dilution of Accelerator into 
PiColorLockTM Gold) was added to the HrtA reaction mixture.  Quenched reactions were 
incubated for 2 minutes, after which 10 µl of Stabilizer reagent was added.  650 nm 
absorbance readings were taken on a Cary 50 MPR microplate reader coupled to a Cary 
50 Bio UV-visible spectrophotometer (Varian, Inc.).   
Complementation constructs – A C-terminal c-myc tagged hrtA under the control of its 
native promoter was created by PCR amplifying hrtA from phrtA using a 5’ primer within 
the hrtA promoter and a 3’ primer matching the 3’ end of hrtA and including the coding 
sequence for the c-Myc epitope (EQKLISEEDL).  Amplified DNA was inserted into the E. 
coli/S. aureus shuttle vector pOS1 (143), creating phrtA-myc.  The hrtA-myc K45A, 
R76A, G145A, G145T, and E167Q mutations were introduced as described above for 
the generation of E. coli HrtA mutant expression constructs, generating phrtA-myc:K45A, 
phrtA-myc:R76A, phrtA-myc:G145A, phrtA-myc:G145T, and phrtA-myc:E167Q.  
Mutations were confirmed and secondary mutations were ruled out by sequencing.  
Expression of tagged HrtA and HrtA mutants in S. aureus was tested by preparing 
bacterial extracts and immunoblotting as follows.  Fifteen ml cultures of bacteria grown in 
TSB + 5 µM heme for 15 hours were centrifuged and pellets were washed with wash 
buffer (50 mM Tris, pH 7.5, 150 mM NaCl). Bacteria were centrifuged again and re-
suspended in TSM (100 mM Tris, pH 7.0, 500 mM sucrose, 10 mM MgCl2) with 20 µg/ml 
lysostaphin, incubated at 37 °C for 30 minutes, and protoplasts were harvested by 
centrifugation.  Protoplasts were re-suspended in 800 µl of lysis buffer (wash buffer 
containing 1 tablet complete EDTA-free protease inhibitor (Roche) per 10 ml) and were 
sonicated.  Insoluble material was removed by centrifugation at 16000 x g for 20 
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minutes, and supernatant was analyzed.  Thirty µg of supernatant material was 
subjected to SDS-PAGE, transferred to nitrocellulose, and blotted with sc-789 polyclonal 
rabbit anti-c-Myc primary (Santa Cruz Biotechnology, Santa Cruz, CA) and AlexaFluor-
680-conjugated anti-rabbit secondary (Invitrogen) antibodies.  Membranes were dried 
and scanned using an Odyssey Infrared Imaging System (LI-COR Biosciences, Lincoln, 
NE). 
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Results 
S. aureus adapts to heme toxicity.  We first sought to test whether S. aureus, like 
other bacterial species, is sensitive to the toxicity of heme.  We found that S. aureus 
inoculated into medium containing 10 µM heme fails to proliferate (Figure 4) due to a 
bactericidal activity that heme exerts on S. aureus cells.  These data demonstrate that S. 
aureus succumbs to heme toxicity.  During these experiments, we noticed that S. aureus 
is able to replicate in 10 µM heme at late time points following subculture (>12 hours), 
indicating that staphylococci are eventually able to overcome the toxicity of heme.  We 
reasoned that S. aureus may be able to sense exogenous heme and adapt accordingly.  
We therefore tested whether S. aureus is able to adapt to heme toxicity by growing S. 
aureus in a low, sub-toxic heme concentration (2 µM), sub-culturing into 10 µM heme, 
and following S. aureus growth (Figure 4).  We found that pre-exposure of S. aureus to 2 
µM heme allows staphylococci to resist heme toxicity, an indication that staphylococci 
sense and respond to low levels of heme in a way that prepares bacterial cells for heme 
concentrations that would otherwise be lethal. 
 
S. aureus expresses a potential heme detoxification system upon exposure to 
heme.  Adaptation to heme toxicity indicates that S. aureus may express a heme 
detoxification system in response to heme exposure.  To identify potential heme-
responsive proteins in S. aureus, we analyzed changes in the cytoplasmic proteome of 
S. aureus upon heme exposure by 2D-DIGE (experiment described in Chapter II).  This 
experiment revealed a set of 21 proteins that undergo alterations in abundance upon 
heme exposure (Table 5).  Importantly, not one of these proteins is altered upon iron 
starvation or inactivation of fur, an indication that perturbation of iron metabolism or 
availability induces a significantly different response than heme exposure (Figure 1B). 
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Figure 4. S. aureus adapts to heme toxicity.  S. aureus wild type was grown overnight 
in medium without heme (solid squares) or medium containing 2 µM heme (empty 
squares).  Overnight cultures were then subcultured into medium without heme (solid 
lines) or medium containing 10 µM heme (dashed lines).  In all assays, 600 nm 
absorbance readings were taken on triplicate cultures at the indicated times after 
inoculation and averages +/- one standard deviation are shown (in most cases, error 
bars are too small to be seen). 
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  Proteins with changes upon heme exposure include potential stress-responsive 
factors (superoxide dismutase [SodM] and two stress-responsive chaperones [ClpL and 
HchA]) and enzymes involved in metabolism of the S. aureus low molecular weight 
oxidation/reduction buffer coenzyme A (coenzyme A disulfide reductase [Cdr], acyl 
carrier protein phosphodiesterase [AcpD]).  Most proteins exhibited modest changes in 
abundance (1.2 – 5.3-fold); however, a single protein feature increased in abundance 
dramatically upon heme exposure (45.14-fold, p<0.05).  Mass spectrometry-based 
protein identification followed by database interrogation was used to determine the gene 
encoding this heme-regulated protein.  Known as SAV2359 (according to the S. aureus 
Mu50 genome annotation), this protein is predicted to be the ATPase component of a 
two-member ATP binding cassette (ABC) transport system.  Ubiquitous amongst 
bacteria, ABC transporters couple the cleavage of ATP to the translocation of small 
molecules, ions, and other solutes across the bacterial membrane (24, 130, 186).  In S. 
aureus, SAV2359 is predicted to be co-transcribed with SAV2360, the integral 
membrane permease component of this transport system (Figure 5A).  BLAST-based 
searches reveal that SAV2359/60 is most closely related to ABC transporters with 
known roles in the export of small molecules from the bacterial cytoplasm.  Importantly, 
no function has been ascribed to SAV2359/60; the genes remain hypothetical and their 
functions are predictions.  We hypothesized that this protein may constitute a component 
of a S. aureus heme detoxification system. To reflect the heme-induced expression 
pattern of SAV2359, we named these genes the heme-regulated ABC transporter 
(hrtAB; hrtA, ATPase; hrtB, permease, Figure 5A).   
 
The heme-regulated transporter is required for protection of S. aureus from heme 
toxicity.  To test whether HrtAB protects S. aureus from heme toxicity, we generated a 
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mutant that lacks the hrtA gene and assessed the ability of the resulting strain to resist 
the inhibitory effects of high levels of heme.  We found that S. aureus ∆hrtA is acutely 
sensitive to heme toxicity (Figure 5B), and intact hrtAB genes are required for the 
adaptation of S. aureus to heme (Figure 5C).  Plate-based heme killing assays revealed 
that heme preferentially kills S. aureus ∆hrtA (Figure 5D).  Furthermore, the heme 
sensitivity of this strain can be reversed by providing a full-length copy of hrtA under the 
control of its native promoter in trans to S. aureus ∆hrtA (Figure 5E).  These data 
demonstrate that the heme-regulated transporter HrtAB is required for the resistance of 
S. aureus to heme toxicity. 
 
HrtA exhibits in vitro ATPase activity.  HrtA is predicted to be the ATPase component 
of HrtAB; however, no function for this protein has been demonstrated experimentally.  
To begin elucidating the function of HrtAB, we expressed and purified HrtA as a 
hexahistidine-tagged recombinant protein in E. coli (Figure 6A).  To eliminate potential 
interference of the his(6) tag with HrtA enzymatic activity, we removed the tag by 
thrombin cleavage (Figure 6B).  Next, we analyzed whether HrtA exhibits ATPase 
activity in vitro by testing whether it is capable of liberating inorganic phosphate from 
ATP.  We found that HrtA, but not heat-inactivated HrtA, exhibits ATPase activity in vitro 
consistent with its predicted role as an ABC transporter ATPase (Figure 6C). 
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Figure 5. S. aureus requires HrtAB for resistance to heme toxicity.  A. Genome 
locus of the S. aureus heme-regulated transporter hrtAB.  Boxes represent open reading 
frames; arrow points in direction of transcription.  B.  Hrt is required for growth in heme.  
S. aureus wild type (wt, black lines) and ∆hrtA (grey lines) were cultured in no heme, 5 
µM, or 10 µM heme and growth was tracked.  C.  Hrt is required for adaptation to heme 
toxicity.  The experiment described in Figure 4 was repeated using S. aureus wild type 
and ∆hrtA.  D. Hrt protects S. aureus from the bactericidal activity of heme.  S. aureus 
wild type and ∆hrtA were exposed to the indicated heme concentration.  Immediately 
after heme exposure and following 2.5 hours in heme, 10 µl of cells were plated on TSA.   
Shown are images of plates following 24 hours of growth.  E.  Complementation of 
∆hrtA.  S. aureus wild type harboring plasmid pOS1 (p.), ∆hrtA harboring pOS1, and 
∆hrtA harboring pOS1 containing hrtA under the control of its native promoter (phrtA) 
were cultured in medium containing no heme or 10 µM heme.  Culture density 15 hours 
following subculture is shown.  Data in panels B, C, and E represent averages of 
triplicate samples within the same experiment; error bars correspond to one standard 
deviation from the mean.   Adapted from Torres et al., 2007 (Ref. 169).  Experiments 
were carried out by VJT and DLS; GP constructed S. aureus ∆hrtA. 
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Figure 6. HrtA purification and ATPase activity. A. Coomassie blue-stained SDS-
PAGE gel showing purification of S. aureus his6-HrtA expressed in E. coli. Lanes: M, 
molecular weight ladder; 1, E. coli before IPTG induction; 2, E. coli after IPTG induction; 
3, total cell lysate; 4, insoluble pellet obtained after French press and centrifugation; 5, 
soluble extract used for purification; 6-9, fractions obtained by elution of material bound 
to Ni-NTA with imidazole (10mM, 50mM, 100mM, and 500mM).  B. SDS-PAGE showing 
removal of the hexahistidine tag from his6-HrtA by thrombin protease.  Lanes: M, 
molecular weight ladder; 1, 1 µg purified his6-HrtA; 2, 1 µg HrtA with hexahistidine tag 
removed by thrombin cleavage.  C. Time course analysis of ATP hydrolysis by HrtA.  
HrtA or heat inactivated HrtA (HrtA (h.i.)) were incubated at 20oC in the presence of ATP 
and release of inorganic phosphate was measured at the indicated time points.  Adapted 
from Stauff et al., 2008 (Ref. 156).  Experiments were performed in collaboration with 
DB. 
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HrtA enzymatic activity is influenced by ATP concentration, temperature, pH, and 
metal cofactor.  ABC transporter ATPases have enzymatic activities that are influenced 
by multiple physicochemical conditions (78, 144).  To assess the conditions under which 
HrtA displays maximum enzymatic activity and as a means of testing whether the activity 
of our HrtA preparations is sensitive to perturbations which would be expected to alter 
the activity of an ABC transporter ATPase, we tested the effects of ATP concentration, 
temperature, pH, and metal cofactor on the activity of HrtA.   
 We found that HrtA ATPase activity reaches a plateau at 0.25 mM ATP in vitro 
(Figure 7A).    Interestingly and unexpectedly, the enzymatic activity of HrtA reaches a 
peak at 10-20°C and not 37°C (Figure 7B).  This observation is not likely a result of 
enzyme instability at this temperature, as pre-incubation of HrtA at 37 °C for 20 minutes 
fails to alter the activity of this ATPase at 20 °C (Figure 7C).  Therefore it is possible that 
HrtA displays an unusual temperature dependence in vitro that is not common to ABC 
transporter ATPases.  HrtA reaches maximal catalytic activity within the range of pH 7.0-
8.0 (Figure 7D), a range consistent with the near-neutral pH of the Gram-positive 
bacterial cytoplasm (39).  Divalent metal cations are usually critical for the catalytic 
activity of ATPases.  We found that magnesium (Mg2+) and manganese (Mn2+) both 
support the catalytic activity of HrtA at a number of tested concentrations, with Mn2+ 
supporting slightly elevated HrtA activity over Mg2+ at low concentrations (Figure 7E).  In 
contrast, calcium (Ca2+) does not support ATPase activity at any concentration tested 
(Figure 7E).  These results demonstrate that HrtA is a Mn2+/Mg2+-dependent ATPase 
that functions at an optimal pH of 7.5-8.0 and displays unusual in vitro temperature 
sensitivity uncommon to ABC transporter ATPases. 
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Figure 7. ATPase activity of HrtA is influenced by various physicochemical 
conditions. A. Concentration of ATP required for saturation of enzymatic activity.  HrtA 
(0.5 µM) was incubated with increasing concentrations of ATP at 20°C and ATPase 
activity was measured.  B. ATPase activity determination at different temperatures. C. 
Effect of temperature pre-treatment on HrtA activity.  HrtA was incubated at the indicated 
temperature for 20 minutes and ATPase activity was determined at 20 °C.  D. Influence 
of pH on HrtA ATPase activity. E. Effect of divalent metal cations on HrtA activity.  HrtA 
ATPase activity was determined in the indicated concentration of MnCl2, MgCl2, or 
CaCl2. For all experiments, the average of triplicate ATPase activities is indicated; error 
bars represent one standard deviation from the mean.  Adapted from Stauff et al., 2008 
(Ref. 156). 
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 Predicted ATP binding and cleavage residues are required for in vitro HrtA 
ATPase activity.  ABC transporter ATPases encode highly conserved sequence motifs 
involved in ATP binding and hydrolysis (78, 144).  These include the Walker A motif 
(GxxGxGKS/T), the Walker B motif (DEP/AxxxLD), and the ABC signature sequence 
(LSGGxxQRV) (174).  The signature motif is specific to nucleotide-binding domains of 
ABC-type transporter ATPases, while the Walker A and B Motifs are common to most 
ATPases and are involved in the binding and hydrolysis of nucleotides (104).  Walker A 
Motifs bind ATP through a conserved lysine residue, while Walker B Motifs employ a 
conserved glutamic acid residue to hydrolyze ATP.  In addition, the signature motif 
contains an absolutely conserved LSGGQ motif required for ATPase activity (104). In 
HrtA, all three sequence motifs can be detected (Figure 8A).  To determine whether 
these sequences are critical for the ability of HrtA to bind and cleave ATP, highly 
conserved residues within each motif (K45 of Walker A, G145 of ABC signature, E167 of 
Walker B) as well as a residue outside of these motifs (R76) were individually mutated 
and HrtA mutants were purified and tested for ATPase activity (Figures 8B, 8C).  
Importantly, mutation of R76 reduces the rate of ATP cleavage by HrtA to about 50% of 
that observed for wild type HrtA, while mutation of residues K45, G145, or E167 
eliminates the ability of HrtA to cleave ATP (Figure 8C).  These data indicate that 
conserved residues within nucleotide-binding and hydrolysis motifs of HrtA are essential 
for ATP cleavage.  The fact that mutation of a residue outside of the conserved 
nucleotide binding motif also alters the rate of ATP hydrolysis by HrtA suggests that non-
conserved regions of HrtA are involved in catalysis in vitro. 
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Figure 8. Residues essential for HrtA ATPase activity. A. Representation of a 
prototypical ABC transporter ATPase subunit and sequence alignment of conserved 
domains.  Walker A, ABC signature, and Walker B motifs can be detected within HrtA 
orthologues and other characterized bacterial ABC transporter ATPases. Conserved 
residues selected for mutagenesis (Lys 45, Gly 145, and Glu 167 of S. aureus HrtA) are 
shown in black.  B. Coomassie blue-stained SDS-PAGE gel showing recombinant 
purified wild type HrtA (wt) and HrtA mutants in residues within motifs predicted to be 
involved in nucleotide binding or hydrolysis (G145A, G145T, K45A, E167Q) or a residue 
outside of such motifs (R76A).  C. Relative ATPase activity of HrtA mutants compared to 
wild type (wt).  ATPase activities of recombinant HrtA and HrtA site mutants described in 
B were determined and are expressed as the percent of ATPase activity exhibited by 
wild type HrtA.  The average percentage of triplicate ATPase activities is indicated; error 
bars represent one standard deviation from the mean.  Adapted from Stauff et al., 2008 
(Ref. 156).  Experiments were performed in collaboration with DB. 
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Residues required by HrtA for in vitro ATPase activity are required for the 
resistance of S. aureus to heme toxicity.  We next tested whether HrtA residues that 
are required for ATPase activity in vitro are required for the functionality of HrtAB in vivo.  
Full-length hrtA under the control of the hrtAB promoter was tagged with a C-terminal c-
myc epitope tag, inserted into an S. aureus complementation vector, and independently 
mutated at the four residues analyzed for in vitro ATPase activity (Figure 9C).  S. aureus 
∆hrtA was then transformed with these plasmids and the resulting strains were analyzed 
for their ability to adapt to heme toxicity by growth curve analysis following subculture 
into 10 µM heme.   
While S. aureus ∆hrtA cannot proliferate in 10 µM heme, S. aureus ∆hrtA 
expressing wild type HrtA-Myc can grow in 10 µM heme (Figure 9A, 9B).  Significantly, 
none of the strains expressing HrtA-Myc point mutants that are unable to cleave ATP in 
vitro are able to rescue the heme-sensitive phenotype of S. aureus ∆hrtA (Figure 9B).  
Furthermore, hrtA-myc:R76A, which contains a mutation outside of the conserved 
nucleotide binding and hydrolysis motifs, is able to complement S. aureus ∆hrtA (Figure 
9B).  Notably, this mutant is also able to cleave ATP in vitro (Figure 9C). Importantly, all 
of the analyzed HrtA-Myc point mutants are expressed by S. aureus to a similar extent 
as wild type HrtA-Myc (Figure 9D).   
 Next, we analyzed the ability of catalytically inactive HrtA-Myc point mutants to 
interfere with the normal functioning of HrtAB in vivo.  We transformed wild type S. 
aureus with the plasmids described above and analyzed the ability of these strains to 
adapt to heme toxicity.  While HrtA-Myc and HrtA-Myc:R76A have minimal impact on the 
ability of wild type S. aureus to adapt to heme toxicity, all of the HrtA-Myc mutants that 
are unable to catalyze the cleavage of ATP in vitro display dominant negative activity in 
vivo (Figure 9C).  This indicates that HrtA mutants that are unable to cleave ATP 
interfere with the functioning of HrtAB in vivo.   
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Figure 9. HrtA residues essential for resistance of S. aureus to heme toxicity.  A. 
Legend of plasmids used to transform strains in B and C.  Plasmids include an empty 
vector (black line), a plasmid encoding wild type hrtA-myc (grey line with no symbol) or 
plasmids encoding hrtA-myc mutants (grey lines with symbols).   B. S. aureus ∆hrtA 
harboring the plasmids described in A were grown overnight in medium containing 2 µM 
heme and were subcultured into medium containing 10 µM heme.  Bacterial growth was 
tracked by measuring the A600 of triplicate cultures.  Data points represent averages of 
triplicate measurements; error bars represent one standard deviation from the mean.  C. 
S. aureus wild type harboring the plasmids shown in A were grown and analyzed as in 
B.  D. Immunoblot against cytoplasmic extracts of S. aureus ∆hrtA expressing C-terminal 
c-Myc-tagged wild type HrtA-Myc or HrtA-Myc mutants (I.B.: anti-c-Myc).  Results are 
representative of triplicate independent experiments.  Adapted from Stauff et al., 2008 
(Ref. 156).  Experiments were performed in collaboration with RJ. 
 
 
 50
S. aureus ∆hrtA exhibits perturbed virulence leading to increased hepatic abscess 
formation.  It is possible that S. aureus, which is capable of amassing heme during 
infection (134, 150, 151, 168) and overcoming heme toxicity through expression of 
HrtAB (Figure 4-5), may exhibit decreased fitness during infection if the ability to 
overcome heme toxicity is perturbed.  We therefore tested the role of HrtA expression in 
S. aureus pathogenesis by infecting mice intravenously with S. aureus wild type and 
∆hrtA.  Animals infected with wild type S. aureus exhibited overt signs of disease 
characteristic of staphylococcal infection.  Surprisingly, all animals infected with S. 
aureus ∆hrtA appeared more moribund than those infected with wild type, as evidenced 
by an absence of mobility, a pronounced hunched posture, and extensive tremors. 
Autopsies conducted 96 hr post-infection revealed abscess formation in the kidneys of 
mice infected with both of the staphylococcal strains (data not shown).  In contrast, only 
mice infected with S. aureus ∆hrtA developed abscesses in the liver (Figure 10A).  
Enumeration of bacterial loads in the livers of infected animals revealed a 2 to 3 log 
increase in the number of mutant staphylococci as compared with wild type (Figure 
10B).  This perturbation of virulence was liver specific, as no difference was detected in 
the ability of the mutant strain to colonize the spleen or kidney compared to wild type 
(Figure 10B).  The liver-specific virulence phenotype of S. aureus ∆hrtA is not due to 
intrinsically faster growth rates, because ∆hrtA exhibits similar growth kinetics to wild 
type in laboratory growth conditions (Figure 5).  Histological examination of livers 
infected with the mutant staphylococci revealed that hepatic virulence occurs despite the 
recruitment of polymorphonuclear (PMN) cells (Figure 10C).  More specifically, the 
∆hrtA-induced abscesses were characterized by collections of purulent material 
containing PMNs, injured hepatocytes, and dense fibrous tissue (Figure 10C).  Together, 
these findings demonstrate that S. aureus lacking hrtA exhibit altered hepatic virulence. 
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Figure 10. Perturbed virulence properties of S. aureus ∆hrtA.  A. Photographs of 
livers dissected from BALB/c mice infected with S. aureus wild type (wt) and ∆hrtA 
(1x106 CFUs for all strains) 96 hr post-infection. Arrowheads mark ∆hrtA-induced hepatic 
abscesses. Photographs are representative of all livers analyzed. B. S. aureus 
multiplication in infected mouse organs as measured by tissue homogenization, dilution, 
and colony formation on agar media 96 hr post-infection. Each symbol represents data 
from one infected animal. The limit of detection in these experiments is 100 CFUs. The 
horizontal line denotes the mean of the log, and the asterisks denote statistically 
significant differences from wild type as determined by Student’s t-test (p < 0.05). C. 
Representative hematoxylin and eosin (H&E) staining of liver sections from mice 
infected with wt and ∆hrtA at 40X magnification. Arrowheads mark ∆hrtA-induced 
hepatic abscesses.  Adapted from Torres et al., (2007) (Ref. 169).  Experiments were 
performed by VJT. 
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Heme induces a secreted protein profile shift in S. aureus ∆hrtA.  The perturbed 
hepatic virulence of S. aureus ∆hrtA suggests a tip in the balance of the bacteria-
phagocyte interaction in favor of S. aureus.  S. aureus pathogenesis is characterized by 
the secretion of numerous virulence factors that defend against immune cell killing (56).  
Thus, we investigated whether ∆hrtA differs from wild type in its secreted protein profile 
following growth in medium containing heme.  We found that exposure to heme induces 
changes in the abundance of multiple secreted proteins in ∆hrtA compared to wild type 
(Figure 11A).  In contrast, the complemented ∆hrtA mutant strain displays a secreted 
protein profile similar to the wild type strain (Figure 11A).  Mass spectrometry-based 
identification of the proteins overrepresented in the supernatants of ∆hrtA grown in heme 
revealed the increased expression and/or secretion of at least eight staphylococcal 
proteins (Figure 11B).  These proteins have known roles in immunomodulation 
(exotoxin, exotoxin-3, -5, and -8) (181), inhibition of phagocyte recruitment (Map-w) (33), 
inhibition of opsonophagocytosis (fibrinogen-binding protein) (56, 98), and inhibition of 
neutrophil activation and chemotaxis (FLIPr) (131). Together, these data provide a 
potential mechanistic explanation for the perturbed virulence observed for ∆hrtA 
staphylococci. It is compelling to speculate that an increased expression of genes 
encoding for secreted proteins with known immunomodulatory functions is responsible 
for the altered virulence of staphylococcal strains unable to overcome heme toxicity. 
 
Staphylococci lacking hrtA induce a dramatic transcriptional response to heme.  
S. aureus ∆hrtA increases the expression of a number of immunomodulatory toxins in 
response to heme (Figure 11).  In an effort to understand the gene regulatory response 
of ∆hrtA to growth in heme, we performed genome-wide microarray analysis on S. 
aureus wild type and ∆hrtA grown in the presence and absence of a sub-inhibitory 
concentration of heme to identify transcripts with altered abundances. 
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Figure 11. S. aureus ∆hrtA secretes virulence factors in response to heme. A. S. 
aureus wild type (wt) transformed with plasmid pOS1, ∆hrtA with pOS1 (p.), or ∆hrtA 
with pOS1 encoding hrtA (phrtA) were grown for 15 hr in RPMI (-) or RPMI + 1 µM heme 
(+). Culture supernatants were collected, filtered, TCA precipitated, and proteins were 
resolved by SDS-PAGE. Gels were stained with colloidal Coomassie blue. B. Indicated 
proteins were excised from the gel, digested with trypsin, and tryptic fragments were 
subjected to mass spectrometry. The identities of the proteins are indicated.  Adapted 
from Torres et al., (2007) (Ref. 169).  Experiments were performed in collaboration with 
VJT. 
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 While wild type S. aureus does not exhibit a significant transcriptional response 
to 1 µM heme, over 500 transcripts are changed in abundance greater than 2-fold in S. 
aureus ∆hrtA exposed to this same concentration of heme (156).  Comparison of the 
global expression profile of heme-exposed S. aureus ∆hrtA with the global expression 
profiles of S. aureus upon cold shock, heat shock, SOS induction, stringent response 
induction, acid shock, alkaline shock, Mn2+ starvation or Zn2+ starvation indicates that the 
stringent response most closely resembles the heme response of S. aureus ∆hrtA 
(37.4% similarity, Table 6) (6, 38).  The bacterial stringent response is induced under 
carbon or amino acid insufficiency through ribosome stalling, which leads to an increase 
in the intracellular concentration of (p)ppGpp (31).  This occurs through the induction of 
the stringent response regulatory factor RelA (SACOL1689), the transcript of which is 
up-regulated upon treatment of S. aureus with the stringent response-inducing 
antimicrobial agent mupirocin and is increased 9.2-fold in S. aureus ∆hrtA exposed to 
heme (6, 156).  A number of other stringent response-induced transcripts are increased 
in S. aureus ∆hrtA upon growth in heme, including those encoding virulence factors such 
as the transpeptidase sortase A (7.4-fold in stringent response, 9.5-fold in S. aureus 
∆hrtA + heme) and fibrinogen-binding protein (7.9-fold in stringent response, 32.3-fold in 
S. aureus ∆hrtA + heme) (6, 156).  These results indicate that in S. aureus ∆hrtA, heme 
induces a response that displays similarity to the S. aureus stringent response.   
A dramatic increase in expression of a number of transcripts coding for virulence 
factors was observed in S. aureus ∆hrtA exposed to heme, consistent with the heme-
induced secreted protein profile of this strain (Table 7).  These include the transcripts for 
eight of the eleven staphylococcal superantigen-like exotoxins encoded within the SaPI 
pathogenicity island in strain Newman (NWMN_0388, NWMN_0389, NWMN_0392, 
NWMN_0393, NWMN_0394, NWMN_0395, NWMN_0396, NWMN_0397) as well as two 
predicted exotoxins located outside of this locus (NWMN_1077, NWMN_1503) (Table 7) 
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(10).  In addition, the expression of a number of pore-forming toxins was dramatically 
repressed in S. aureus ∆hrtA exposed to heme.  These include the transcripts encoding 
all three of the gamma-hemolysin subunits (SACOL2419, SACOL2421, SACOL2422) as 
well as the transcript for a leukotoxin (SACOL1637) (Table 7). Only one characterized 
class of cell wall-anchored virulence factors, the fibronectin and fibrinogen binding 
proteins (fnbA, efb) were differentially expressed within mutant cells (Table 7).  
Together, these data indicate that upon exposure to heme, S. aureus ∆hrtA undergoes a 
shift in toxin expression from cell lytic factors to immunomodulatory factors. 
 In addition to toxins, a number of transcripts encoding transcriptional regulatory 
factors are dramatically altered in expression in S. aureus ∆hrtA exposed to heme, 
providing a possible mechanistic explanation for the broad changes in gene transcription 
seen in heme-exposed S. aureus ∆hrtA (156).  Regulatory systems with increased 
expression in S. aureus ∆hrtA exposed to heme include a number of characterized and 
uncharacterized two-component systems (including hssS, 4.2-fold; lytS, 8.1-fold; lytR, 
20.5-fold; vraS, 10.4-fold; SACOL1354, 6.6-fold; SACOL1905, 9.1-fold; SACOL2645-6, 
7.1-fold), known transcriptional repressors (fur, 9.5-fold; czrA, 42.9-fold; sirR, 5.2-fold), 
as well as other uncharacterized putative transcriptional regulators, some of which 
display dramatic alterations in expression (SACOL0403, 21.5-fold decrease; 
SACOL1904, 24.7-fold increase) (156).  These data indicate that heme induces a 
profound alteration in the gene expression pattern of S. aureus ∆hrtA, possibly through 
novel transcriptional regulatory mechanisms.  This expression change leads to an 
alteration in virulence gene expression (Figure 11) and may lead to the perturbed 
virulence of this mutant in a mouse model of systemic infection (Figure 10). 
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Inactive HrtA point mutants complement the heme-induced secreted protein 
response of ∆hrtA.  S. aureus ∆hrtA undergoes a profound transcriptional response to 
heme, leading to the secretion of proteins that may alter the virulence properties of this 
strain (Tables 6 and 7, Figures 10 and 11).  However, a potential mechanism explaining 
how exposure of ∆hrtA to heme results in changes in gene expression is lacking.  
Originally, it was proposed that unrelieved heme toxicity experienced by ∆hrtA may 
trigger the activation of a stress-responsive regulatory system responsible for this 
transcriptional response.  However, a number of observations are inconsistent with such 
an explanation.  First, wild type S. aureus does not undergo a shift in secreted proteins 
even in the presence of heme concentrations that significantly inhibit its growth.  
However, even heme concentrations that do not impair the growth of ∆hrtA elicit a 
response by this strain (data not shown).  Second, only ∆hrtA and not ∆hrtAB or other 
equally heme-sensitive strains (see Chapter IV) displays a heme-induced change in 
secreted proteins.  This introduces a discontinuity between susceptibility to heme toxicity 
and the secreted protein profile of ∆hrtA and implies that ∆hrtA experiences a stress 
secondary to growth in the presence of heme. 
 One possible explanation for this phenomenon is that upon heme exposure, the 
absence of HrtA as part of the functional ABC transporter HrtAB may artificially lead to 
the severe stress experienced by this strain.  To assess this possibility, we compared 
the heme-induced secreted protein profile of ∆hrtA to that of ∆hrtA expressing 
catalytically inactive HrtA mutants.  Remarkably, even catalytically inactive HrtA mutants 
are able to complement the secreted protein response of ∆hrtA to heme (Figure 12).  
∆hrtA expressing these mutants exhibit heme sensitivity identical to ∆hrtA alone, 
eliminating the possibility that strains expressing catalytically inactive HrtA are merely of 
an intermediate heme resistance (Figure 9).  These data suggest that ∆hrtA does not 
undergo a change in secreted proteins due to its susceptibility to heme toxicity, but 
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rather due to a lack of the HrtA protein (whether functional or not) as part of HrtAB.  We 
hypothesize that in the absence of HrtA, high levels of HrtB expression may induce a 
significant portion of the stress experienced by ∆hrtA exposed to heme.  This is 
consistent with data showing significant hrtAB promoter activity in the presence of heme 
concentrations used to elicit a secreted protein response by ∆hrtA (Figure 15B).  It is 
possible that expression of HrtB may damage the staphylococcal membrane, and that by 
associating with its cognate permease, even non-functional HrtA mutants may protect 
∆hrtA from this effect. 
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Figure 12. Catalytically inactive HrtA point mutants complement the ∆hrtA 
secreted protein response.  Staphylococcus aureus wild type (wt) transformed with 
pOS1 (p.), ∆hrtA + pOS1, ∆hrtA + pOS1 encoding wild type hrtA-myc (phrtA-myc), and 
∆hrtA transformed with phrtA-myc containing the indicated point mutations were grown 
overnight in RPMI + 1 µM heme.  Secreted proteins were precipitated with TCA, 
resolved by SDS-PAGE using a 15% acrylamide gel, and visualized by Coomassie blue 
staining.  Experiment was performed in collaboration with VJT. 
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Discussion 
 Herein, we have begun to elucidate the mechanism through which S. aureus 
avoids heme toxicity, the potentially detrimental consequence of heme acquisition by 
bacteria that associate with vertebrate tissues rich in heme.  We show that S. aureus is 
sensitive to heme toxicity, but can adapt to heme through expression of HrtAB, a heme 
detoxification system.  S. aureus lacking HrtAB easily succumb to heme toxicity and 
cannot adapt to growth in its presence.  We demonstrate that HrtA constitutes the 
ATPase component of HrtAB, and displays in vitro ATPase activity dependent on 
physicochemical conditions and residues consistent with its class of ATPases.  
Furthermore, we show that S. aureus lacking the hrtA gene display perturbed virulence 
in a murine model of abscess formation, likely due to the heme-induced overexpression 
and secretion of immunomodulatory virulence factors.   
The import of molecules and ions into the cytoplasm and the export of wastes or 
toxic compounds across the plasma membrane is a tightly controlled process that is 
essential to the viability of bacteria (78, 94, 129).  Many transport pathways in bacteria 
depend on ABC transporters, which couple the cleavage of ATP to the transport of 
solutes across the membrane.  S. aureus encodes over 50 characterized or hypothetical 
ABC transporters (data not shown), an indication of the importance of this particular 
transport scheme to staphylococci.  Staphylococcal ABC transporters with described 
functions are involved in critical processes as diverse as fluoroquinolone resistance 
(NorA, (170, 185)), antimicrobial peptide and/or glycopeptide resistance (GraRS/ApsRS 
and VraFG (74, 101, 114)), metal ion acquisition (FhuC (155), SirABC (41), MntABC 
(81)), molybdate transport (ModABC (122)), and oligopeptide import (Opp-3, (77)).  
Heme-iron acquisition, a process important to the outcome of infection, also depends on 
ABC transporters (IsdDEF and HtsABC (112, 151)).  In addition, the proper metabolism 
of heme at high concentrations is critically dependent on the ABC transporter HrtAB.   
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Importantly, the identity of the transport substrate for HrtAB is unknown.  We 
have postulated that HrtAB is capable of exporting heme that accumulates to toxic levels 
within the cytoplasm of S. aureus, thereby alleviating heme toxicity (169).  However, 
inductively coupled plasma mass spectrometry (ICPMS)-based tracking experiments 
using isotopically labeled heme have failed to reveal a role for HrtAB in heme efflux from 
staphylococcal cells (data not shown).  Furthermore, it is not clear that heme export 
would alleviate heme toxicity, especially if the Isd and Hts systems are continually and 
efficiently importing heme into the cytoplasm and if the cytoplasm is not the 
compartment in which heme exerts its toxic effects.  Biochemical fractionation 
experiments suggest that most exogenous non-degraded heme accumulates in the S. 
aureus membrane fraction and not the cytoplasm (150).  Based on these observations 
and speculations, we favor the idea that heme is accumulating in the staphylococcal 
membrane and perturbing S. aureus metabolism or respiration in a way that leads to the 
formation of reactive oxygen species, inducing cell death.  Furthermore, heme is known 
to damage lipid bilayers through lipid peroxidation and disruption of membrane fluidity 
(53, 95, 134, 161, 162).  We hypothesize that, rather than exporting heme directly, HrtAB 
may protect against heme-mediated cell damage through the export of as-yet-
unidentified toxic compounds that accumulate in S. aureus when this organism 
encounters heme. 
Here, we have provided insight into the biochemical details of HrtA function and 
into the gene regulatory response of S. aureus ∆hrtA to growth in the presence of heme.  
We demonstrate that HrtA is capable of cleaving ATP in vitro, an activity that is 
dependent on temperature, pH, substrate concentration, and metal cofactor.  We further 
show that HrtA ATPase activity is sensitive to perturbations in predicted nucleotide 
binding residues, and that these residues are critical for the ability of S. aureus to adapt 
to the toxicity of heme.  These latter observations demonstrate that the catalytic activity 
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of HrtA and thus the functionality of HrtAB are essential for the survival and growth of S. 
aureus in the presence of heme.  The fact that HrtA mutants that are unable to cleave 
ATP exhibit dominant negative activity against wild type HrtAB in vivo suggests that 
these mutants are capable of associating with endogenous HrtA, HrtB, or both in order 
to block the normal functioning of HrtAB.  ABC transporter permeases typically function 
as dimers, with one associated ATPase per monomer (78, 144).  The dominant negative 
activity of HrtA point mutants that we observe is consistent with the known associations 
that occur between ABC transporter ATPases and their cognate permeases.  It is also 
consistent with the finding that in many ABC transporters, a single functioning ATPase 
per transporter multimer is insufficient for proper function, but that both ATPases need to 
be functional (83, 105, 146).   
Expression analysis revealed that S. aureus ∆hrtA induces changes in the 
abundance of over 500 transcripts when exposed to heme, many of which encode for 
important virulence factors, gene regulatory systems, and as-yet-uncharacterized 
systems.  Interestingly, many (37.4%) S. aureus ∆hrtA heme-induced transcripts are 
components of the staphylococcal stringent response (Table 6).  Consistent with this 
observation, RelA, the major activator of the stringent response, was up-regulated > 9-
fold within heme challenged mutant cells. This observation may suggest that heme 
accumulation redirects transcript synthesis in a manner that promotes up-regulation of 
alternative transport systems which are major components of the stringent response; this 
may represent an attempt to overcome heme toxicity.   
Based on the fact that no virulence defect is observed for S. aureus ∆hrtA, it is 
likely that in our murine model of infection staphylococci do not encounter enough heme 
to induce cell death in this heme-sensitive strain.  However, the observations of 
perturbed virulence and heme-induced overexpression of a number of toxins in S. 
aureus ∆hrtA indicate that S. aureus may encounter low levels of heme for use as an 
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iron source.  This is consistent with the fact that low heme concentrations induce 
changes in the secreted protein profile of ∆hrtA (0.5 µM), while significantly higher heme 
levels are needed to inhibit growth of ∆hrtA (>5 µM; data not shown).  It is possible that 
during infection, enough heme is acquired to satisfy the nutrient iron requirement of S. 
aureus and to induce virulence perturbation in ∆hrtA.  This possibility is consistent with 
virulence defects observed for strains inactivated for Isd genes (133, 150, 168).  
Currently, it is unclear why virulence perturbation is only observed in the murine liver.  It 
is possible that more heme is acquired in the liver than in other tissues; it is also possible 
that the local microenvironment in the liver may predispose staphylococci to the toxicity 
of heme, leading to HrtAB expression.  This latter possibility is supported in part by 
experiments suggesting that HrtAB levels may respond to the severity of heme toxicity, 
rather than to levels of heme itself (see Chapter VI). 
The toxin transcript expression profile of S. aureus ∆hrtA exposed to heme may 
reveal new regulatory mechanisms or signals that S. aureus recognizes in order to 
coordinate a specific toxin expression profile upon exposure to distinct host 
environments.  It is important to note that not only does the total quantity of toxins 
secreted by S. aureus ∆hrtA exposed to heme appear to be altered, but the profile of 
toxin secretion is dramatically changed to decrease the expression of host cell lytic 
toxins and increase the expression of immunomodulatory toxins such as the 
staphylococcal superantigen-like toxins.  It may be that certain types of stress, such as 
that experienced by S. aureus ∆hrtA grown in heme, may mimic a physiologically 
relevant cue which S. aureus senses in order to adjust its toxin expression and secretion 
profile accordingly.  It is tempting to speculate that this stressor is one that represents a 
signal for invading staphylococci to switch from a cytolytic toxin secretion profile to an 
immunoevasive response.  Importantly, it is unclear at this point what fraction of the 500 
transcripts regulated by ∆hrtA in heme results from the sensitivity of this strain to heme 
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toxicity, and what fraction is altered as a result of the lack of HrtA as part of the 
functional holotransporter, HrtAB (see Inactive HrtA point mutants complement the 
heme-induced secreted protein response of ∆hrtA).  Protein secretion experiments 
suggest that the latter fraction may be quite large.  It is possible that we have 
serendipitously stumbled upon a strain that reveals key toxin regulatory mechanisms 
linked to membrane integrity, as this is the likely compartment of the S. aureus cell 
perturbed by expression of dysregulated HrtAB.   
  Taken together, these studies have identified a mechanism whereby S. aureus 
avoids the toxicity of heme imported into cells for use as a nutrient iron source.  Upon 
heme exposure, staphylococci dramatically increase the expression of the ABC 
transporter HrtAB, which alleviates heme toxicity, likely through the export of a toxic 
small molecule induced by heme in the S. aureus cytoplasm.  It has not escaped our 
attention that as a member of the ABC transporter superfamily, HrtAB bears similarity to 
detoxification systems that provide antibiotic resistance to many bacteria.  We have not 
been able to demonstrate a role for HrtAB in resistance to any member of a large set of 
clinically relevant antibiotics.  However, it is possible that ABC transporters such as 
HrtAB may alleviate more general types of cellular stress, conferring antibiotic resistance 
in spite of the fact that such transporters were clearly not selected throughout the course 
of evolution to specifically alleviate the toxicity of novel antibiotics (such as is almost 
certainly the case for fluoroquinolone resistance conferred by NorA (170, 185)).  It is 
possible that HrtAB may also have a broader role in staphylococcal physiology.  This 
possibility will be more clearly assessable as the transport substrate for HrtAB is 
identified and as the mechanism of HrtAB regulation is elucidated. 
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CHAPTER IV 
 
REGULATION OF HrtAB EXPRESSION BY THE HssRS 
TWO-COMPONENT SYSTEM 
 
Introduction 
 Staphylococcus aureus induces expression of the heme-regulated transporter 
HrtAB when exposed to heme and staphylococci require HrtAB for adaptation to and 
survival in otherwise toxic concentrations of heme.  However, the mechanism of HrtAB 
regulation remains uncharacterized.  To this end, we sought to elucidate the mechanism 
by which heme is sensed, leading to an increase in HrtAB expression and the alleviation 
of heme toxicity. 
 Here, we show that hrtAB is genomically co-localized with a previously 
uncharacterized two-component system (TCS) on the staphylococcal chromosome.  
This TCS is required for HrtA induction and for promoter-driven expression of the hrtAB 
genes in response to heme.  We designated this TCS the heme sensor system (HssRS), 
and show that HssS signaling to HssR impinges on a critical direct repeat within the 
hrtAB promoter, driving expression of HrtAB.  These studies begin to elucidate the 
mechanism by which HrtAB is regulated at a transcriptional level, and characterize the 
signaling events critical to the function of a novel staphylococcal TCS that responds to a 
host-specific molecule. 
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 Methods  
Bacterial strains and plasmids – S. aureus ∆hssR was created by following a similar 
protocol to that described for generation of ∆hrtA (see Chapter III Methods).  An hssS 
knockout was obtained from the Phoenix (N) library; clone PhiNE 01562 (SAV2362) (11) 
was transduced into Newman. 
2D-DIGE – Triplicate samples of cytoplasmic extract from S. aureus wild type or an 
isogenic ∆hssR mutant grown for 15 hours at 37 °C with shaking at 180 rpm in the 
presence or absence of 5 µM heme were subjected to 2D-DIGE.  Samples were 
prepared, labeled, resolved and individual protein features with altered expression 
patterns were identified as described (Chapter II Methods). 
Purification of HssR and HssS – The entire hssR open reading frame and the signaling 
domain of hssS (corresponding to amino acids 185-457) were cloned into the E. coli 
expression plasmid pET15b, making pET15b.hssR and pET15b.hssS for the expression 
of hexahistidine N-terminal fusions of both proteins.  Pfu mutagenesis (176) was used to 
create expression constructs for the mutants HssR:D52A and HssS:H249A.  
pET15b.hssR:D52A and pET15b.hssS:H249A were verified by sequencing (Vanderbilt 
University DNA sequencing facility).  Protein expression and purification was performed 
as described previously (Chapter 3 Methods, Purification of HrtA and HrtA mutants).  
In vitro phosphorelay - 70 µl of HssS or HssS:H249A labeling reaction was prepared (50 
mM Tris, pH 8.0, 5 mM MgCl2, 200 mM KCl, 0.2 mM DTT, 10 % glycerol, 20 µM ATP, 5 
µM HssS or HssS:H249A).  Twenty µCi of [γ-32P]ATP (Amersham biosciences) was 
added to both labeling reactions and samples were incubated at 37 °C.  At 5, 15, and 45 
minutes after the addition of radiolabeled ATP, 10 µl samples were removed and mixed 
with 2X SDS loading buffer.  At 45 minutes, HssR or HssR:D52A were added to the 
appropriate reactions to a final concentration of 17.5 µM.  Ten µl samples were taken 5, 
15, and 45 minutes after the addition of HssR or HssR:D52A.  Samples were loaded 
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onto 15% polyacrylamide gels and after SDS-PAGE, gels were dried and analyzed using 
a PhosphorImager.   
XylE reporter constructs/hrtAB Promoter Truncations and Mutations – Construction of 
phrtAB.xylE was generated by PCR-SOE (82).  A reporter construct in which the xylE 
gene is controlled by the S. aureus lipoprotein diacylglycerol transferase (lgt) promoter 
(29) was made by removing an NdeI site from xylE by Pfu mutagenesis (176) and 
cloning xylE lacking an NdeI site into pOS1plgt (29) between the NdeI and BamHI sites 
of this vector, making plgt.xylE.  Using phrtAB.xylE as a template, five truncations were 
made in the hrtAB promoter by PCR amplification using 5 different 5’ primers which 
anneal to sites within the hrtAB promoter and a 3’ primer matching the 3’ end of xylE.  
These promoter-xylE fragments were inserted into pOS1 (143), making phrtAB.xylE.T1-
5.  Mutations were confirmed by sequencing from the 5’ end of the hrtAB promoter to the 
3’ end of xylE.  Four residues within the direct repeat sequence upstream of the hrtAB 
start site were mutated by PCR-SOE.  phrtAB.xylE with 4 direct repeat base mutations 
(phrtAB.xylE.DR) was confirmed by sequencing as above.   
Complementation constructs – A plasmid containing a copy of hssR under the control of 
its native promoter was created by PCR amplifying hssR with its promoter using S. 
aureus Newman genomic DNA as a template and inserting amplified DNA into pOS1, 
making phssR.  A plasmid containing a copy of hssS under the control of the lgt 
promoter was created by PCR amplifying hssS and inserting amplified DNA into 
pOS1plgt, creating phssS. A C-terminal c-myc tagged hssR was created by PCR 
amplifying hssR from S. aureus genomic DNA using a 5’ primer within the hssR 
promoter and a 3’ primer matching the 3’ end of hssR and including the coding 
sequence for the c-Myc epitope (EQKLISEEDL).  Amplified DNA was inserted into 
pOS1, creating phssR-myc.  A C-terminal c-myc tagged hssS was created in the same 
manner as for hssR.  Amplified DNA was inserted into pOS1plgt, generating phssS-myc.  
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The hssR-myc D52N mutation and the hssS-myc H249A mutation were introduced as 
described above for the generation of E. coli expression constructs, generating phssR-
myc:D52N and phssS-myc:H249A.  Mutations were confirmed and secondary mutations 
were ruled out by sequencing.   
HssS-Myc and HssR-Myc immunoblotting - Expression of tagged HssS and HssR was 
tested by preparing bacterial extracts and immunoblotting as follows.  For HssR-Myc, 15 
ml cultures of bacteria grown for 15 hours were centrifuged, washed with wash buffer 
(50 mM Tris, pH 7.5, 150 mM NaCl), and lysed in 800 µl of lysis buffer (wash buffer 
containing 2 complete protease inhibitor tablet per ml (Roche Diagnostics)) by 
mechanical disruption using a FastPrep 24 (MP Biomedicals).  For HssS-Myc, bacteria 
were grown and washed as above.  Bacteria were then re-suspended in TSM (100 mM 
Tris, pH 7.0, 500 mM sucrose, 10 mM MgCl2, 20 µg/ml lysostaphin), incubated at 37 °C 
for 30 minutes, and protoplasts were harvested by centrifugation.  Protoplasts were re-
suspended in 800 µl of lysis buffer as above and were sonicated.  Triton X-100 was 
added to 1%, insoluble material was removed by centrifugation, and supernatant was 
removed for analysis.  Thirty µg of lysate from HssR-Myc or HssS-Myc expressing S. 
aureus was subjected to SDS-PAGE, transferred to nitrocellulose, and blotted with sc-
789 polyclonal rabbit anti-c-Myc primary (Santa Cruz Biotechnology) and AlexaFluor-
680-conjugated anti-rabbit secondary (Invitrogen) antibodies.  Membranes were dried 
and scanned using an Odyssey Infrared Imaging System (LI-COR Biosciences). 
S. aureus Growth Kinetics – Growth curve experiments were performed as described 
previously (see Chapter III Methods, Growth curve assays and heme adaptation 
analysis) 
XylE activity assay – Appropriate strains were grown overnight at 37 °C with shaking at 
180 rpm and were then subcultured into 1.5 ml Eppendorf tubes containing TSB with 
heme dilutions and were grown for 5 hours.  Bacteria were pelleted by centrifugation, 
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and spent medium was aspirated. The pellet was washed once with 500 ml of 20 mM 
potassium phosphate (pH 7.6) and re-suspended in 150 µl of 100 mM potassium 
phosphate buffer (pH 8.0), 10% (v/v) acetone, and 25 mg/ml lysostaphin. After a 20 
minute incubation at 37°C and 5 minute incubation on ice, samples were centrifuged at 
20,000 g for 30 minutes at 4°C. 20 µl of supernatant was added to a 96-well plate, and 
200 µl of 100 mM potassium phosphate (pH 8.0), 0.2 mM pyrocatechol was added to 
each well. Formation of 2-hydroxymuconic semialdehyde was tracked by measuring the 
absorbance at 375 nm every minute for 30 minutes on a Varian MP 50 microplate 
reader. Protein concentration in samples was determined by BCA (Pierce). One unit of 
specific activity of XylE in a sample is defined as the formation of 1 nmol of 2-
hydroxymuconic semialdehyde per minute per milligram of cellular protein at 30°C (35). 
Magnetic bead pull-down – For capture of HssR-Myc from S. aureus extracts, S. aureus 
harboring phssR-myc was subcultured 1:100 from an overnight culture into 100 ml of 
TSB with or without 7 µM heme.  Bacteria were grown for 7 hours at 37 °C with shaking 
at 180 rpm and were then pelleted, washed with 20 ml of 50 mM Tris, pH 7.5, 150 mM 
NaCl, and re-suspended in 20 ml of TSM for 30 minutes.  Bacterial protoplasts were 
then pelleted, re-suspended in 10 ml of lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 
0.1 mM EDTA, 2 mM MgCl2), and lysed by French press.  Mechanically sheared salmon 
sperm DNA was added to lysates to a final concentration of 10 µg/ml.  Bead-DNA 
complexes were prepared by adding 5 µg of biotinylated 300 base pair hrtB coding 
sequence DNA or hrtAB promoter DNA prepared by PCR using a 5’-biotinylated primer 
to 500 µg of Dynabeads M-280 streptavidin (Dynal Biotech) in 400 µl of bead binding 
and wash buffer (50 mM Tris, pH 7.5, 1 M NaCl, 0.5 mM EDTA) and rotating on a 
rotisserie at room temperature for 15 minutes.  DNA-bead complexes were washed 
three times in 1 ml of bead binding and wash buffer, re-suspended in 50 µl of lysis 
buffer, and added to 5 ml of S. aureus cytoplasmic extract. Mixtures were rotated for 30 
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minutes at room temperature and DNA-bead complexes were washed four times with 1 
ml of lysis buffer and were eluted with 50 µl of 50 mM Tris, pH 7.5, 500 mM NaCl.  For 
oligonucleotide elution experiments, DNA-protein-bead complexes were prepared using 
extracts from heme-treated S. aureus as above and were eluted in increasing 
concentrations (0.001, 0.01, 0.1, 1, 12.5 µM) of double-stranded oligonucleotides 
dissolved in 50 mM Tris, pH 7.5, and prepared by allowing complementary 40-mers 
corresponding to the wild type 
(AAAAACAATTGTTCATATTGAGTTCATATTTCAACCTTAT) or mutant 
(AAAAACAATTGTACATATAGAGATCTTATTTCAACCTTAT) hrtAB direct repeat to cool 
to room temperature from 90 °C.  Samples from triplicate experiments were analyzed by 
SDS-PAGE and immunoblotting as described above.  For quantification, band intensities 
were determined using Odyssey Infrared Imaging System software (LI-COR 
Biosciences).  For each elution series, band intensities were adjusted for background 
intensity, summed, and each band intensity was expressed as a percentage of the sum.  
For pull-down of in vitro phosphorylated purified HssR, 200 µl phosphorylation reactions 
were prepared by incubating 1 µM HssR or HssR:D52A in 50 mM Tris, pH 7.5, 50 mM 
KCl, 2 mM MgCl2 with or without 20 µM potassium acetyl phosphate for 2 hours at 37 
°C.  Samples were centrifuged at 13000 rpm for 2 minutes to remove precipitated protein 
and 10 µl of soluble protein was removed for SDS-PAGE analysis.  25 µl of bead-DNA 
complexes prepared as described above were added to 75 µl of soluble protein in 1 ml 
of 50 mM Tris, pH 7.5, 150 mM NaCl, 0.1 mM EDTA, 2 mM MgCl2, 10 µg/ml sheared 
salmon sperm DNA.  Samples were rotated on a rotisserie at room temperature for 15 
minutes, after which beads were washed four times and eluted with 50 µl of 50 mM Tris, 
pH 7.5, 500 mM NaCl.  Samples were analyzed by SDS-PAGE followed by 
immunoblotting using an anti-hexahistidine tag antibody as described for the detection of 
c-Myc-tagged proteins. 
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Results 
hrtAB is co-localized on the S. aureus chromosome with a putative heme sensing 
system required for heme resistance.  Conceivably, heme-induced HrtAB expression 
could be regulated by any class of regulator at any location on the S. aureus 
chromosome.  However, in bacteria genes with associated functions are often found co-
localized spatially on the chromosome.  We therefore analyzed the genomic context of 
hrtAB for potential heme sensing systems. 
 Remarkably, the two genes upstream of hrtAB (SAV2361/62) encode a putative 
two-component system (TCS, Figure 13A).  TCS represent a major regulatory scheme 
shared by most bacterial species (15, 17, 109).  Typically, TCS consist of a membrane-
localized or cytoplasmic histidine kinase and a cytoplasmic response regulator.  Histidine 
kinases typically detect an input stimulus, triggering histidine autophosphorylation.  
Phosphorylated histidine kinases are then recognized by a cognate cytoplasmic 
response regulator, which triggers trans-phosphorylation, leading to response regulator 
activation.  Activated response regulators carry our effector functions, including gene 
regulation.  In S. aureus, SAV2362 is predicted to encode a membrane-localized 
histidine kinase, while SAV2361 is predicted to encode a cytoplasmic response regulator 
with a DNA-binding domain involved in gene regulation.  To reflect the genomic 
localization of SAV2361/2 with hrtAB, we named this TCS the heme sensor system 
(hssRS; hssR, response regulator; hssS, histidine kinase, Figure 13A).   
 Next, we tested whether hssRS is required for heme resistance in S. aureus.  We 
found that S. aureus lacking hssR or hssS display a heme-sensitive phenotype similar to 
S. aureus ∆hrtA, and that HssRS is required for the adaptation of S. aureus to heme 
toxicity (Figure 13B, 13C).  These data connect HssRS with HrtAB and suggest that 
HssRS may detect heme to induce expression of HrtAB, alleviating heme toxicity. 
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Figure 13. HssS and HssR are required for adaptation of S. aureus to heme 
toxicity. A. Schematic of the S. aureus hssRS/hrtAB locus.  hrtAB is predicted to 
encode a putative co-transcribed ABC transporter (consisting of an ATPase, hrtA, and a 
permease, hrtB); arrow indicates the direction of transcription.  hssRS is predicted to 
encode a putative co-transcribed two-component system (consisting of a response 
regulator, hssR, and a histidine kinase, hssS).  B. S. aureus ∆hssS harboring an empty 
vector (∆hssS + p.) or a plasmid harboring a full-length copy of hssS (∆hssS + phssS) 
were grown overnight in medium without heme (solid squares) or medium containing 2 
µM heme (empty squares).  Overnight cultures were then subcultured into medium 
without heme (solid lines) or medium containing 10 µM heme (dashed lines).  In all 
assays, 600 nm absorbance readings were taken on triplicate cultures at the indicated 
times after inoculation and averages +/- one standard deviation are shown (in most 
cases, error bars are too small to be seen).  C. ∆hssR harboring an empty vector 
(∆hssR + p.) or a plasmid harboring a full-length copy of hssR (∆hssR + phssR) were 
grown overnight and subcultured as in A.  Adapted from Torres et al., 2007 (Ref. 169) 
and Stauff et al., 2008 (Ref. 158). 
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hssRS is required for heme-induced expression of HrtA.  To test whether the TCS 
response regulator HssR is required for the heme-induced increase in abundance of 
HrtA and to identify additional HssR-regulated proteins, we performed 2D-DIGE.  
Cytoplasmic extracts were prepared in triplicate from S. aureus wild type or ∆hssR 
grown in the presence or absence of 5 µM heme, the highest heme concentration in 
which ∆hssR is able to grow with near-wild type kinetics.  Proteins were labeled with 
amino-reactive fluorescent dyes, resolved on two-dimensional gels, and protein features 
with differential expression patterns were excised and identified by mass spectrometry.   
Upon exposure of wild type to 5 µM heme, HrtA increased in abundance by a 
factor of 2.44 (p = 0.024) (Figure 14 and Table 8).  This heme-dependent increase in 
HrtA expression is less than we have previously observed (Table 5) (61) because of the 
lower concentration of heme used in the present experiment.  Importantly, strains 
inactivated for hssR did not up-regulate HrtA expression upon exposure to heme (Figure 
14 and Table 8). Furthermore, no cytoplasmic protein features that require HssR for a 
heme-dependent increase in expression other than HrtA were identified by 2D-DIGE 
analysis (Table 8).  Although HrtB is likely to be expressed in a heme-dependent, HssR-
dependent manner as judged by the localization of hrtB in a bicistronic operon with hrtA, 
HrtB is predicted to be a membrane protein and is not present in the cytoplasmic 
fractions used in our 2D-DIGE experiment.  A number of stress-related and metabolic 
proteins displayed changes in abundance only in ∆hssR exposed to heme, consistent 
with a role for HssR in protection of S. aureus from heme toxicity through regulation of 
HrtAB expression. Based on these results, we conclude that hssR is necessary for the 
heme-induced increase in HrtA and that, within the window of the S. aureus cytosolic 
proteome resolvable by 2D-DIGE, HrtA is the major target of activation by HssR upon 
exposure of S. aureus to heme. 
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Figure 14.  HssR is required for the heme-dependent increase in expression of 
HrtA.  Cytoplasmic extracts were prepared from wild type S. aureus (wt) or ∆hssR 
grown without heme (- heme) or in the presence of 5 µM heme (+ heme).  Extracts from 
triplicate cultures were labeled with fluorescent dyes and were resolved by two-
dimensional difference gel electrophoresis (2D-DIGE).  The standardized log 
abundances of one protein feature corresponding to HrtA are shown for each tested 
condition.  The asterisk above the HrtA abundances from wild type grown in heme 
denotes that the observed change is statistically significant when compared with the 
other three conditions (p < 0.05).  Quantification of changes in HrtA abundance as well 
as additional proteins with differential expression are listed in Table 8.  Adapted from 
Stauff et al., 2007 (Ref. 158).  Experiments were performed in collaboration with DBF 
and CW. 
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HssR and HssS are required for heme-dependent activation of the S. aureus hrtAB 
promoter.  HssR is predicted to be a TCS response regulator that contains an N-
terminal phosphoacceptor domain and a C-terminal DNA binding domain.  Response 
regulators with this type of domain architecture often bind the promoters of the genes 
they regulate, recruiting RNA polymerase and inducing gene transcription.  We therefore 
reasoned that HssR may regulate HrtAB expression by activating the hrtAB promoter. 
 To analyze hrtAB promoter activity, we fused the hrtAB promoter to the coding 
sequence for XylE, a common reporter enzyme used in Gram-positive organisms (35).  
We found that when S. aureus is transformed with a plasmid containing this hrtAB 
promoter-xylE fusion, heme induces expression of XylE (Figure 15A).  This activity is 
specific to the hrtAB promoter, as a promoterless xylE plasmid does not respond to 
heme (Figure 15A).  Furthermore, mutation of hssR or hssS eliminates hrtAB promoter 
heme responsiveness.  Importantly, strains bearing a plasmid that constitutively 
expresses XylE are not reduced in activity upon heme treatment, allowing us to conclude 
that a lack of XylE activity in the absence of heme is not due to heme toxicity in the 
heme-sensitive strain ∆hssR (Figure 15B).  Furthermore, hrtAB promoter reporter 
activity is dose-dependent with respect to heme (Figure 15B).  These data are consistent 
with those presented in Figure 14 and suggest that the hrtAB promoter requires a 
functional HssRS TCS to respond to heme. 
 Next, we tested whether HssRS-dependent hrtAB promoter activation is triggered 
by exposure to numerous relevant iron sources.  We found that neither iron sulfate nor 
transferrin (which is not a heme-containing protein) activate the hrtAB promoter (Figure 
15C).  In contrast, hemoglobin and blood (which contain heme) both induce robust hrtAB 
promoter activity.  This connects HssRS-mediated hrtAB promoter activation specifically 
to heme and heme-containing proteins that represent a biologically relevant source of 
nutrient iron for staphylococci. 
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Figure 15.  HssRS is required for activation of the S. aureus hrtAB promoter in 
response to heme and host-derived heme sources.  A. Wild type, ∆hssR, and ∆hssS 
S. aureus transformed with either a promoterless xylE-containing plasmid (pxylE) or an 
hrtAB promoter-xylE fusion-containing plasmid (phrtAB.xylE) were grown in medium 
lacking heme or containing 5 µM heme.  Following growth to stationary phase, XylE 
activity was measured.  B. hssR is required for dose-responsive activation of the hrtAB 
promoter.  S. aureus wild type and ∆hssR harboring either phrtAB.xylE or a plasmid with 
xylE under the control of the constitutive lgt promoter (a positive control) were grown in 
triplicate in the presence of the indicated concentration of heme and XylE activity was 
measured.  C.  S. aureus wild type or ∆hssR harboring phrtAB.xylE were grown in TSB 
(-) or TSB supplemented with FeSO4, transferrin (Tf), heme, hemoglobin (Hb), or mouse 
blood and XylE activity was determined.  Adapted from Torres et al., 2007 (Ref. 169) 
and Stauff et al., 2007 (Ref. 158). 
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A direct repeat within the hrtAB promoter is necessary for heme-dependent 
promoter activation.  Based on the predicted function of HssR as a DNA-binding 
response regulator, and based on the role of HssR in induction of hrtAB promoter activity 
in response to heme, it is likely that HssR binds to promoter sequences upstream of 
hrtAB upon exposure of staphylococci to heme in order to regulate transcription.  To 
identify candidate DNA sequences upstream of hrtAB required for HssR-dependent 
expression, we aligned the hrtAB promoter (shown in schematic form in Figure 16A) 
from eight different species of Gram-positive bacteria that contain potential orthologues 
of the Hss/Hrt (Figure 16B).  This analysis reveals a perfectly conserved direct repeat 
(DR) sequence within the predicted hrtAB promoter of S. aureus and other Firmicutes 
predicted to contain homologues of hssRS and hrtAB.  A number of bases are invariant 
across genera and a greater degree of variation exists in the bases between and outside 
of the repeats, suggesting that this DR is critical for HssRS/HrtAB function.  Because 
TCS response regulators are known to bind to DR sequences (22), we hypothesized that 
this DR is the cis-acting element with which HssR interacts. 
 To test whether the DR upstream of hrtAB is necessary for promoter activation, a 
series of truncation mutants within the hrtAB promoter were constructed within the 
context of the hrtAB promoter-xylE reporter construct and tested for heme-induced 
reporter activity.  While truncation of the hrtAB promoter up to the DR sequence has no 
effect on promoter activity (Figure 16C), removal of half or all of the DR eliminates 
heme-induced reporter activity (Figure 16C).  Furthermore, induction of the hrtAB 
promoter by heme is eliminated by the mutation of four bases that are conserved within 
the DR of all organisms analyzed.  Promoters containing any of the listed alterations to 
the DR display reporter activity at comparable levels to those of hrtAB promoters lacking 
a predicted TATA box or ribosome binding site.  We conclude that the DR present within 
the hrtAB promoter is essential for the induction of promoter activity by heme. 
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Figure 16.  A direct repeat within the hrtAB promoter is required for heme-
dependent promoter activity.  A. Schematic of the hrtAB promoter showing the direct 
repeat (light grey), predicted TATA box (dark grey), ribosome binding site (RBS, black), 
and the hrtAB and hssRS coding sequences.  Numbers indicate base position with 
respect to the hrtB start codon.  B. Alignment of the direct repeat from several Gram-
positive bacteria.  Residues in bold occur at the given position in more than 50% of the 
examined sequences and match the S. aureus direct repeat.  Asterisks above residues 
indicate absolute conservation across the sequences examined.  C. hrtAB promoter 
truncation and mutation analyses using the phrtAB.xylE reporter construct from A.  
Sequences within the hrtAB promoter were deleted as indicated.  In addition, four 
conserved residues within the hrtAB promoter were mutated in the context of the full-
length reporter construct (asterisks denote mutated bases).  S. aureus harboring the 
indicated constructs were grown in triplicate in medium lacking heme (white bars) or 
containing 5 µM heme (grey bars) and reporter activity was measured.  Asterisks denote 
that the observed changes are statistically significant (p < 0.05 using Student’s t-test).  
Adapted from Stauff et al., 2007 (Ref. 158). 
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HssS-HssR undergo phosphotransfer in vitro.  HssS and HssR display significant 
sequence and domain similarity to other bacterial TCS histidine kinases and response 
regulators, respectively.  Upon receiving appropriate signals, bacterial histidine kinases 
undergo autophosphorylation at a specific histidine residue, allowing a cognate response 
regulator through which they signal to subsequently catalyze phosphotransfer to an 
aspartate residue  (109).  To predict the HssR and HssS residues that participate in 
phosphotransfer, the intracellular domain of HssS was aligned with the 
dimerization/phosphorylation domain from five characterized bacterial TCS histidine 
kinases (Figure 17A) (PhoQ (117); EnvZ (118); CheA (75); YycG (54); KdpD (121)).  
Likewise, HssR was aligned with the phosphoacceptor domain from five known bacterial 
TCS response regulators (Figure 17B) (PhoP (70); OmpR (164); CheY (160); YycF (54); 
KdpE (173)).  Consistent with their assignment as members of TCS, a conserved 
histidine residue was identified in the predicted dimerization/phosphorylation domain of 
HssS (H249) and a conserved aspartate residue was identified in the predicted 
phosphoacceptor domain of HssR (D52) (Figures 17A & 17B).   
To determine whether HssS undergoes autophosphorylation and whether HssR 
catalyzes phosphotransfer, and to determine whether H249 of HssS and D52 of HssR 
are the signaling residues of HssRS, in vitro phosphotransfer experiments were 
performed using purified HssS and HssR as well as alanine substitution mutants at both 
putative signaling residues.  The signaling domain from both wild type and mutant HssS 
(HssS and HssS:H249A) and full-length wild type and mutant HssR (HssR and 
HssR:D52A) were expressed as hexahistidine-tagged fusion proteins in E. coli and 
purified to homogeneity.    Because in vitro autophosphorylation of sensor kinase 
signaling domains is a common property of TCS histidine kinases that occurs in the 
absence of any ligand or other signaling input, we added γ32P-ATP to HssS and tested 
autophosphorylation by SDS-PAGE followed by autoradiography.  We found that 
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exposure of HssS to γ32P-ATP results in rapid autophosphorylation that is not observed 
with HssS:H249A (Figures 17C & 17D).  Addition of HssR to phosphorylated HssS 
results in the dephosphorylation of HssS and phosphorylation of HssR, while HssS 
dephosphorylation and HssR phosphorylation are not observed when HssR:D52A is 
added (Figures 17C, 17D & 17E).  These results are consistent with a model in which 
HssS undergoes autophosphorylation at histidine 249 and subsequently transfers its 
phosphate group to aspartate 52 of HssR.   
 
HssS-HssR phosphotransfer residues are required for resistance of S. aureus to 
heme toxicity. To test whether phosphotransfer between HssS and HssR is required by 
S. aureus for resistance to a high concentration of heme, we tested HssS and HssR 
phosphotransfer mutants for functionality in vivo.  Full-length c-Myc-tagged versions of 
wild type HssS and HssR as well as their respective phosphotransfer site mutants were 
cloned into an S. aureus expression vector, transformed into S. aureus ∆hssS and 
∆hssR, and assessed for complementation.  While S. aureus wild type resists 10 µM 
heme, in ∆hssS growth is arrested (Figure 18A).  Expression of HssS-Myc in trans in 
∆hssS restores heme adaptation.  However, HssS-Myc:H249A is not able to 
complement the heme-sensitive phenotype of ∆hssS (Figure 18A) in spite of expression 
levels similar to those of wild type HssS-Myc (Figure 18B).  In similar experiments, we 
found that an epitope-tagged HssR-Myc is able to complement the heme-sensitive 
phenotype of ∆hssR (Figure 18C).  HssR-Myc:D52N, a phosphotransfer site mutant 
chosen instead of HssR-Myc:D52A due to poor expression of HssR-Myc:D52A in S. 
aureus, is not able to complement in spite of significant expression (Figure 18C, 18D).  
Taken together with the data presented in Figures 13 through 15, these data suggest 
that functional signaling between HssS and HssR is necessary for the adaptation of S. 
aureus to heme toxicity, presumably through the regulated expression of HrtAB. 
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Figure 17. S. aureus HssS-HssR phosphotransfer is dependent on conserved 
signaling residues.  A.  Alignment of phosphorylated histidine residues from bacterial 
histidine kinases.  Histidine residues are in bold.  The predicted phosphotransfer 
histidine of HssS (H249) is boxed.  B.  Alignment of phosphorylated aspartic acid 
residues from cognate response regulators to histidine kinases from A.  
Phosphoacceptor aspartate residues are shown in bold.  The predicted phosphorylated 
aspartate of HssR (D52) is boxed.  C.  In vitro phosphotransfer between HssS and 
HssR.  HssS or mutant HssS:H249A were added to γ32P-ATP and samples were 
collected at intervals after the start of labeling.  Following 45 minutes of labeling, HssR 
or mutant HssR:D52A were added to HssS (vertical arrow) and samples were collected.  
Proteins were separated by SDS-PAGE and gels were exposed by autoradiography.  D.  
Quantification of HssS phosphorylation from triplicate experiments described in D.  
Addition of HssR is indicated by a diagonal arrow.  Asterisks denote statistically 
significant differences in HssS-P amount when compared to any other condition at that 
time point by Student’s t-test (p < 0.05).  x axis represents time after the start of labeling.  
E. Quantification of HssR 32P-phosphorylation (HssR-P) as described for HssS in E.  x 
axis represents time after the start of labeling (or 5, 15, or 45 minutes after the addition 
of HssR).  Error bars correspond to one standard deviation from the mean.  Adapted 
from Stauff et al., 2007 (Ref. 158). 
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Figure 18. Residues essential for HssRS-HssR phosphotransfer are required for 
resistance of S. aureus to heme toxicity.  A. Sensitivity of S. aureus ∆hssS 
expressing HssS:H249A to heme toxicity.  S. aureus wild type harboring an empty 
plasmid (wt + p., solid squares), ∆hssS harboring an empty plasmid (∆hssS + p., solid 
circles), ∆hssS harboring phssS-myc (∆hssS + phssS-myc, solid diamonds) and ∆hssS 
harboring phssS-myc:H249A (∆hssS + phssS-myc:H249A, empty diamonds) were 
cultured in medium lacking heme (solid lines) or containing 10 µM heme (dashed lines).  
A600 readings were taken on triplicate cultures at the indicated times after inoculation and 
averages +/- one standard deviation are plotted.  B. Anti-c-Myc immunoblot (I.B.: α-c-
Myc) of protoplasts from S. aureus strains described in A.  Immunoblot is representative 
of results obtained from three independent experiments.  Asterisk denotes a consistently 
observed cross-reactive band.   C. Sensitivity of S. aureus ∆hssR expressing 
HssR:D52N to heme toxicity.  S. aureus wild type harboring an empty plasmid (wt + p., 
solid squares), ∆hssR harboring an empty plasmid (∆hssR + p., solid circles), ∆hssR 
harboring phssR-myc (∆hssR + phssR-myc, solid diamonds) and ∆hssR harboring 
phssR-myc:D52N (∆hssR + phssR-myc:D52N, empty diamonds) were grown and 
analyzed as described in A.  D. Anti-c-Myc immunoblot (I.B.: α-c-Myc) of cytoplasmic 
fractions of S. aureus strains described in C.  Immunoblot is representative of results 
obtained from three independent experiments.  Adapted from Stauff et al., 2007 (Ref. 
158). 
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HssR binds to the hrtAB promoter when phosphorylated and when S. aureus 
encounters heme.  Phosphorylation of bacterial TCS response regulators induces 
conformational changes that lead to the binding of these proteins to their target DNA 
sequences (26).  To test whether HssR can bind to the hrtAB promoter when 
phosphorylated, purified HssR and its phosphotransfer site mutant HssR:D52A were 
incubated with the phosphorylating reagent acetyl phosphate.  After incubation, proteins 
remain soluble (Figure 19A, top) but only phosphorylated HssR and not HssR:D52A is 
captured by streptavidin-conjugated beads coated with biotinylated hrtAB promoter DNA 
(Figure 19A, bottom).  Binding of phosphorylated HssR to DNA is specific to the hrtAB 
promoter, as HssR is not captured by beads coated with biotinylated hrtB coding 
sequence DNA.  This suggests that HssR specifically binds to the hrtAB promoter when 
it is phosphorylated at aspartate residue 52.   
 To test whether HssR binds to the hrtAB promoter upon exposure of S. aureus to 
heme, cytoplasmic extracts were prepared from heme-treated and untreated ∆hssR 
carrying a plasmid encoding an epitope-tagged hssR-myc.   Extracts were added to the 
same bead-DNA complexes described above and capture of HssR-Myc was tested by 
eluting bound proteins, performing SDS-PAGE, and immunoblotting against the epitope 
tag of HssR-Myc.  We found that HssR-Myc is only captured by hrtAB promoter DNA, 
consistent with the binding specificity observed with in vitro phosphorylated protein 
(Figure 19B).  Furthermore, HssR-Myc only associates with the hrtAB promoter when S. 
aureus encounters heme (Figure 19B).  This indicates that in S. aureus, phosphorylation 
of HssR by HssS is the mechanism by which binding of HssR to the hrtAB promoter is 
controlled. 
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Figure 19. HssR binds to the hrtAB promoter when phosphorylated and when S. 
aureus encounters heme.  A.  Purified HssR and HssR:D52A were incubated in the 
absence (-) or presence (+) of acetyl phosphate (AcP) and soluble protein was analyzed 
by SDS-PAGE and coomassie blue staining (top).  Acetyl phosphate-treated or 
untreated HssR or HssR:D52A was added to streptavidin-conjugated magnetic beads 
bound to biotinylated DNA corresponding to the hrtB coding sequence or the hrtAB 
promoter (bottom).  Beads were removed with a magnet, washed four times, and bound 
protein was eluted with high salt buffer.  Samples were analyzed by SDS-PAGE followed 
by immunoblotting with an anti-hexahistidine tag antibody (I.B.: α-his6).  Both panels 
(HssR and HssR:D52A) are from a single membrane; result is representative of triplicate 
independent experiments.  B.  Cytoplasmic extract was prepared from wild type S. 
aureus harboring phssR-myc and grown to early stationary phase in the absence of 
heme (-) or in the presence of 7 µM heme (+).  Bead-DNA complexes prepared as 
described in A were added to lysate from heme-treated or untreated S. aureus, removed 
with a magnet, washed four times, and proteins were eluted with high salt buffer.  
Samples were analyzed by SDS-PAGE followed by anti-c-Myc immunoblotting (I.B.: α-c-
Myc).  Lysate represents 1% of input into binding reactions; vertical bar designates 
cropped empty wells.  Result is representative of triplicate independent experiments.  
Adapted from Stauff et al., 2007 (Ref. 158). 
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HssR binds to the direct repeat within the hrtAB promoter.  To test whether HssR-
Myc specifically associates with the direct repeat sequence within the hrtAB promoter, 
HssR-Myc bound to hrtAB promoter DNA-complexed beads was eluted in a competitive 
elution experiment.   Double-stranded 40-mer oligonucleotides were prepared that 
correspond to the hrtAB promoter direct repeat or a direct repeat mutated in the four 
conserved residues essential for heme-induced promoter activity (Figures 16C).  Bound 
proteins were sequentially eluted with increasing concentrations of double-stranded 
oligonucleotides and were detected by SDS-PAGE followed by immunoblotting against 
the epitope tag of HssR-Myc (Figure 20A).  While double-stranded oligonucleotides 
containing a wild type direct repeat elute HssR-Myc from the hrtAB promoter at 
concentrations as low as 0.1 µM, oligonucleotides with a mutant direct repeat do not 
elute HssR-Myc at concentrations up to 12.5 µM, a result that is reproducible across 
multiple experiments (Figure 20B).  Taken together, these results suggest that HssR 
binds to the direct repeat sequence within the hrtAB promoter in order to induce 
expression of HrtAB when S. aureus senses heme. 
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Figure 20. HssR binds to the direct repeat within the hrtAB promoter.  A.  Double-
stranded 40-mer oligonucleotides were synthesized that match the sequences adjacent 
to and including the wild type hrtAB promoter direct repeat and a direct repeat in which 
four conserved residues are mutated (grey residues).  Lysate from heme-treated S. 
aureus harboring phssR-myc was applied to streptavidin-conjugated magnetic beads 
bound to biotinylated hrtAB promoter DNA.  Increasing concentrations (0.001, 0.01, 0.1, 
1, 12.5 µM) of wild type and mutant direct repeat double-stranded oligonucleotides were 
used to sequentially elute bound proteins.  Remaining protein was eluted with high salt 
buffer.  Samples were analyzed by SDS-PAGE followed by anti-c-Myc immunoblotting 
(α-c-Myc).  B.  Quantification of results from triplicate experiments described in A.  
Individual band intensities were determined and are expressed as the percentage of 
total band intensity for a given elution series.  Asterisks denote that the difference in the 
average percent intensity of bands corresponding to an indicated elution is statistically 
significant when compared to any other average percent intensity within the elution 
series (p < 0.05 using Student’s t-test).  Error bars represent one standard deviation 
from the mean.  Adapted from Stauff et al., 2007 (Ref. 158). 
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Discussion 
Gene regulation is one of the most widely studied areas of S. aureus physiology.  
To date, six different staphylococcal TCS histidine kinases and their cognate response 
regulators have been characterized: AgrAC, SaeRS, SrrAB/SrhRS, ArlRS, LytRS, 
YycGF, and GraRS/ApsRS (28, 36, 48, 57, 64, 74, 84, 101, 114, 132, 166, 184).  
Although these systems have been identified and confirmed to play important roles in 
gene regulation, the signals that are recognized and the molecular mechanisms 
responsible for signal transduction have only been well-characterized in a few cases.  
Herein, we have provided insight into the mechanism by which hrtAB expression is 
induced upon exposure of S. aureus to heme.  We show that the TCS HssRS regulates 
expression of the hrtAB promoter in response to heme and is required for heme 
resistance in S. aureus.  We present evidence that hrtA is the major cytoplasmic target 
of activation by HssRS.  Furthermore, we elucidate the signaling events by which HssRS 
controls expression of HrtAB in response to heme.  Our observations are consistent with 
the model presented in Figure 21.  We propose that (1) heme liberated from host 
hemoglobin is imported into the staphylococcal cytoplasm through the Isd and Hts 
systems, (2) resulting in HssS activation that leads to (3) autophosphorylation and (4) 
phosphotransfer to HssR.  (5) Phosphorylated HssR binds to the hrtAB promoter direct 
repeat, (6) increasing the transcription of the hrtAB genes by recruitment of RNA 
polymerase.  (7) Newly synthesized HrtAB alleviates heme toxicity (8) through the export 
of an unknown molecule that accumulates in the S. aureus cytoplasm upon heme 
exposure (for discussion of the potential HrtAB transport substrate, see Chapters III and 
VI).  These studies connect HssRS with the adaptive response of staphylococci to heme 
and reveal the functional details of a newly identified S. aureus TCS.   
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Figure 21.  Signaling events that connect heme sensing by the HssRS two-
component system to up-regulation of HrtAB and heme detoxification.  (1) Heme is 
imported into the staphylococcal cytoplasm through the Isd and Hts systems.  (2) Heme 
activates HssS, possibly by sensing the heme-induced accumulation of a toxic 
metabolite.  Activation of HssS results in (3) HssS autophosphorylation and (4) 
phosphotransfer to HssR.  (5) Phosphorylated HssR binds to a direct repeat within the 
hrtAB promoter, (6) increasing the transcription of the hrtAB genes by recruitment of 
RNA polymerase.  (7) Newly synthesized HrtAB alleviates heme toxicity (8) through the 
export of an unknown molecule that accumulates in the S. aureus cytoplasm upon heme 
exposure.  Adapted from Stauff et al., 2008 (Ref. 157). 
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The mechanism by which HssS senses heme is unknown.  Although HssS may 
sense heme by direct binding, HssS also could sense one of the toxic effects that heme 
has on the cell.  Genomics-based approaches have not revealed a potential heme-
binding domain in HssS, and the predicted sensing domain of this kinase has little 
sequence similarity to any protein with a known function (169).  Furthermore, no amino 
acids that typically engage in axial coordination of the iron atom of heme are conserved 
in the putative sensing domain of all of the potential HssS orthologues (unpublished 
observations).  Identification of the ligand for HssS will lay the groundwork for a 
mechanistic understanding of how this histidine kinase is activated upon heme exposure 
(see Chapter VI).  This would represent a significant advance for understanding HssS 
function and the mechanism employed by S. aureus to regulate the tight balance 
between heme acquisition and heme toxicity. 
HssS is one of the few histidine kinases that respond to a molecular marker of 
vertebrate tissue.  Importantly, other TCS that recognize heme are found in the Gram-
positive pathogen Corynebacterium diphtheriae, a bacterium that is not closely related to 
S. aureus (20, 21, 140, 141).  In C. diphtheriae, the TCS ChrAS and HrrAS are capable 
of responding to heme or hemoproteins (140).  However, in addition to the absence of 
any significant sequence identity between the staphylococcal and corynebacterial 
systems, two major aspects of ChrAS and HrrAS distinguish them from the S. aureus 
HssRS system.  First, ChrAS and HrrAS both regulate expression of the C. diphtheriae 
heme oxygenase HmuO, while HssRS does not appear to regulate expression of the S. 
aureus heme oxygenases (21, 140, 158).  HmuO is capable of catabolizing heme and is 
therefore a critical factor required for heme metabolism in C. diphtheriae (142).  In S. 
aureus, IsdG and IsdI are iron-regulated heme oxygenases that also break down heme 
(134, 149, 182).  However, our 2D-DIGE experiments have failed to reveal a role for 
HssRS in the regulation of IsdG/I expression, indicating that HssRS does not regulate 
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these heme-degrading enzymes in S. aureus (Table 8).  Second, despite the fact that 
HssRS from S. aureus and ChrAS/HrrAS from C. diphtheriae both respond to heme, the 
histidine kinase HssS and the kinases ChrS/HrrS differ dramatically in terms of the 
predicted structure of their signal-sensing domains.  While HssS is predicted to have an 
N-terminal periplasmic sensing domain flanked by two transmembrane helices, 
ChrS/HrrS are predicted to have sensing domains composed of five transmembrane 
helices flanked by short loops (21, 169).  This difference in predicted structure suggests 
that HssS may sense heme through a mechanism that is different from that of ChrS/HrrS 
or that these TCS might sense different effects that heme has on the Gram-positive 
bacterial cell.  Interestingly, C. diphtheriae strains lacking the chrAS genes exhibit 
elevated heme sensitivity that is not dependent on reduced HmuO expression (20).  This 
suggests the presence of a ChrAS-regulated heme-detoxification system in 
Corynebacterium diphtheriae (20).  Accordingly, interrogation of the C. diphtheriae 
genome using S. aureus hrtAB as query reveals the presence of genes encoding an 
HrtAB-like ABC transporter (DIP2323/24, unpublished data).  Remarkably, these genes 
are a single open reading frame away from chrAS on the C. diphtheriae chromosome.  
This indicates that C. diphtheriae DIP2323/24 may be heme- and ChrAS-regulated 
orthologues of the S. aureus HrtAB system that protect this organism from heme toxicity.   
The ability of bacterial pathogens to sense and respond to heme is not limited to 
Gram-positive organisms.  The Gram-negative mammalian pathogen Bordetella 
pertussis also encodes a heme sensing system (25, 89-91, 171, 172).  In B. pertussis, 
the heme receptor BhuR binds to heme, transducing signals into the periplasm that 
activate the cytoplasmic membrane protein RhuR (89, 90, 172).  RhuR alters the activity 
of the cytoplasmic protein RhuI, which regulates the expression of the B. pertussis heme 
uptake system BhuRSTUV (89, 90, 172).  Through this mechanism, B. pertussis is able 
to sense exogenous heme and increase the expression of systems required for heme 
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uptake from the host.  Thus the B. pertussis RhuIR/BhuR system differs from the HssRS 
system of S. aureus in that the former is devoted to the sensing of host heme for the 
purposes of heme acquisition, whereas the latter is required for sensing host heme to 
avoid heme toxicity (25, 89-91, 120, 158, 169, 171, 172).  Furthermore, HssRS is a two-
component system, while RhuI is an extracytoplasmic function sigma factor and RhuR is 
a regulator of RhuI activity.  Thus, the mechanism by which heme is sensed by these 
systems as well as the details of signaling appear to be distinct.  It appears that the 
pathogens S. aureus and B. pertussis are both able to sense host heme and transduce 
signals that alter gene expression, but that these events occur through distinct 
mechanisms and for different reasons. 
We demonstrate here that binding of phosphorylated HssR to hrtAB promoter 
DNA is sensitive to alterations in the direct repeat sequence to which it binds.  A 
consensus sequence for HssR (GTTCATATT(N)2GTTCATATT) can be predicted by 
comparing the hrtAB direct repeat across all available bacterial genomes.  Using 
genomic analyses, we have been unable to identify an S. aureus gene or operon other 
than hrtAB that contains this perfect direct repeat within its promoter (data not shown).  
However, an HssR consensus site containing 3-4 mismatches can be detected in the 
predicted promoter region of 14 S. aureus genes.  Three of these with potential roles in 
the pathogenesis of S. aureus include SAV1553 (the superoxide dismutase sodA), 
SAV1159 (a predicted fibrinogen-binding protein precursor), and SAV2644 (a predicted 
autolysin) (data not shown).  Although 2D-DIGE analyses did not reveal protein features 
other than HrtA that are up-regulated in a heme-dependent,  HssR-dependent manner, it 
remains a possibility that additional S. aureus genes are regulated by HssR upon 
exposure of staphylococci to high concentrations of heme.   
  This study is one of the first examples of the in vitro reconstitution of a S. aureus 
TCS; furthermore, it represents the characterization of signaling and DNA binding events 
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important for the functioning of one of the few bacterial TCS that is responsible for 
sensing an abundant host molecule.  Understanding the mechanisms by which bacterial 
pathogens recognize host molecules will provide insight into the ways in which 
pathogenic bacteria sense and respond to the host environment.   
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CHAPTER V 
 
CONSERVATION OF HEME SENSING AMONG GRAM-POSITIVE BACTERIA  
 
Introduction 
 The evolutionarily related Gram-positive pathogens Staphylococcus aureus and 
Bacillus anthracis are both capable of causing devastating disease upon breaching host 
epithelial barriers (46, 59, 119).  S. aureus, a commensal of the skin and nares, is able 
to infect virtually any site within the human body, leading to diseases including skin and 
soft tissue infections, endocarditis, and pneumonia (59).  In contrast, B. anthracis is a 
spore-forming livestock pathogen that causes a rare zoonotic disease in humans known 
as anthrax (46, 119).  Anthrax arises when spores germinate within host tissues and can 
progress to systemic bacteremia followed by sudden death (46, 119).  Although the life 
cycles and pathogenic strategies of S. aureus and B. anthracis differ markedly, both 
pathogens must circumvent mechanisms of innate immunity including host-mediated 
sequestration of iron.  
To overcome cellular stress resulting from iron paucity, both S. aureus and B. 
anthracis express similar (Isd) systems devoted to the acquisition and degradation of 
host heme for nutrient iron needs (106, 107, 112, 151).  The fact that S. aureus and B. 
anthracis express functionally similar Isd systems implies that nutrient iron acquisition is 
a challenge that is faced and met in a similar way by both pathogens despite differences 
in their life cycles and mechanisms of pathogenesis.  Although it is known that both 
bacteria acquire heme from the host during infection, it is currently unclear whether 
heme sensing and detoxification is a general feature of Gram-positive pathogens that 
associate with host tissues rich in heme.  It is likely that a pathogen such as B. anthracis, 
which is capable of replicating to a high density within the bloodstream of its host (46), 
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inducing hemolysis (147), and acquiring heme (106, 107), may require systems devoted 
to the avoidance of heme toxicity.   
 Here, we demonstrate that B. anthracis encodes functional HssRS and HrtAB 
systems required for protection from heme toxicity.  We show that differential heme 
resistance within the Bacilli correlates with the presence of hssRS/hrtAB genes.  
Furthermore, B. anthracis HssRS exhibits an elevated autophosphorylation and 
phosphotransfer rate that correlates with the increased in vivo activity of this TCS.  More 
specifically, we report that domains of the histidine kinase HssS are likely responsible for 
the elevated function of B. anthracis HssS.  B. anthracis is highly sensitive to heme 
toxicity in the absence of HrtAB function, and may therefore require an increased ability 
to mount a heme detoxification response through heme sensing by HssS and signal 
transduction through HssR.  We also present evidence implicating the previously 
uncharacterized signal recognition domain of HssS in heme sensing.  Last, we show that 
the hrtAB promoter is activated in a cutaneous model of anthrax, suggesting a role for 
heme sensing during B. anthracis infection.  These results demonstrate that heme 
sensing by HssRS and subsequent heme detoxification by HrtAB are conserved in B. 
anthracis and that heme stress may be encountered by a wide range of pathogenic or 
saprotrophic Gram-positive bacteria. 
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Methods 
Bacterial strains and growth conditions –B. cereus, B. thuringiensis, B. israelensis, B. 
licheniformis, and B. subtilis were acquired from the Bacillus Genetic Stock Center 
(College of Biological Sciences, The Ohio State University, www.bgsc.org).  B. anthracis 
Sterne was used for all experiments (159).  S. aureus was grown in TSB or BHI; Bacilli 
were grown in BHI or LB.  All plasmid construction was performed using Escherichia coli 
DH5α.  Plasmid DNA to be introduced into B. anthracis was propagated in the E. coli 
strain K1077 (88).  Plasmid selection was performed in S. aureus and B. anthracis by 
supplementing media with 10 µg/ml chloramphenicol (complementation and reporter 
plasmids) or 20 µg/ml kanamycin (knockout constructs).   
Genetic manipulation of S. aureus – Genetic manipulation of S. aureus and construction 
of S. aureus ∆hssRS was performed as described previously (12, 158). 
Genetic manipulation of B. anthracis – Electroporations were performed as previously 
described (88), with modifications.  E. coli K1077 harboring plasmids to be introduced 
into B. anthracis were grown overnight in 15 ml of LB in 50 ml conical tubes.  DNA was 
miniprepped from K1077 and dialyzed against water to remove traces of salt prior to 
electroporation.  Electrocompetent B. anthracis cells were prepared by growing bacteria 
in BHI + 0.5 M D-sorbitol to OD600 = 0.2 and washing cells three times in SMG (0.5 M 
D-sorbitol, 0.5 M D-mannitol, 10% glycerol) without proteinase K treatment.  Four µl of 
DNA was added to 50 µl competent cells and mixtures were incubated on ice 10 
minutes.  Electroporations were carried out in 1 mm gap cuvettes with a Bio-Rad Gene 
Pulser using an exponential decay protocol set to 2500 V, 1 ms time constant.  After 
electroporation, cells were recovered in BHI + 0.5 M D-sorbitol for 2 hours at 30 °C with 
shaking and plated onto BHI + antibiotic.  For generation of B. anthracis hrtA, hssRS, 
and hssS knockout constructs for insertion/deletion mutagenesis, the erythromycin 
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resistance gene ermC was inserted between 1 kilobase regions flanking hrtA, hssRS, or 
hssS in the thermosensitive mutagenesis plasmid pLM4 (86).  Mutagenesis was 
performed as described previously (86).  The incorporation of mutations, loss of pLM4, 
and maintenance of pXO1 were confirmed by PCR. 
Epitope tagging of hssS – A C-terminal c-myc epitope tag was incorporated into S. 
aureus and B. anthracis hssS alone and hssS within the hssRS operon using a PCR-
based approach as described previously (158).  Briefly, PCR reactions were assembled 
containing a 5’ primer annealing to the 5’ end of hssR (for amplification of hssR-hssS-
myc) or hssS (for hssS-myc), dilutions of a 3’ primer annealing to the 3’ end of hssS-myc 
and encoding the c-Myc epitope tag (EQKLISEEDL), and excess of a 3’ primer 
annealing to the c-myc coding region and incorporating a restriction endonuclease site.   
Tagged hssS is designated hssS-myc and tagged hssRS is designated hssR-hssS-myc. 
Construction of complementation plasmids – All complementation and reporter plasmids 
were constructed in a pOS1 (143) or pOS1plgt (29) background.  A B. anthracis hrtA 
complementation construct was generated by PCR-SOE (82) using a method described 
previously (169).  This resulted in a seamless fusion between the B. anthracis hrtAB 
promoter and the B. anthracis hrtA open reading frame.  PCR-SOE DNA was digested 
with EcoRI and BamHI and inserted into pOS1plgt.  For generation of a 
complementation plasmid containing B. anthracis hssRS under the control of its native 
promoter, hssRS was amplified by PCR and inserted into pOS1 between the PstI and 
BamHI sites.  For generation of complementation plasmids containing S. aureus/B. 
anthracis hssR-hssS-myc under the control of the S. aureus hssRS promoter, the S. 
aureus hssRS promoter was first inserted between the EcoRI and NdeI sites of 
pOS1plgt to make pOS1phssRS.  Promoterless S. aureus and B. anthracis hssR-hssS-
myc were then amplified by PCR and inserted between the NdeI and BamHI sites of 
pOS1phssRS.  For generation of complementation plasmids containing S. aureus/B. 
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anthracis hrtAB under the control of their native promoters, hrtAB was amplified by PCR 
and inserted into pOS1plgt between the XhoI and EcoRI sites.  To construct plasmids 
encoding hssS-myc under the control of the S. aureus hssRS promoter, hssS-myc was 
PCR amplified and inserted into pOS1phssRS between the NdeI and BamHI sites.  
Chimeric forms of hssS-myc were constructed by cloning S. aureus and B. anthracis 
hssS-myc in tandem in pCR2.1 (Invitrogen) and joining HssS domains together by 
inverse PCR followed by blunt-end ligation (see Construction of XylE reporter plasmids 
below).  Chimeric forms of hssS-myc were then inserted into pOS1phssRS. 
B. anthracis HssS alignment and mutagenesis – An alignment of conserved residues in 
HssS was created by assembling HssS amino acid sequences from all available 
sequenced Firmicute genomes (with the exception of Exiguobacterium sibiricum, which 
clusters outside of the Staphylococcus, Listeria, and Bacillus clusters) and aligning by 
Clustal V method using the Lasergene 6 software package. 
HssS-Myc immunoblotting – For S. aureus HssS-Myc immunoblots, cell lysates were 
prepared from bacteria grown in 5 ml TSB in 15 ml conical tubes for 15 hours at 37 °C 
with shaking.  For B. anthracis HssS-Myc immunoblots, cell lysates were prepared from 
bacteria grown in 5 ml BHI in 15 ml conical tubes for 12 hours at 30 °C with shaking.  
Bacteria were pelleted, washed in 5 ml TBS (50 mM Tris, pH 7.5, 150 mM NaCl), 
digested in 0.5 ml TSM (100 mM Tris, pH 7.0, 500 mM sucrose, 10 mM MgCl2) with 12.5 
µg/ml lysostaphin (S. aureus) or 2 mg/ml lysozyme (B. anthracis), and protoplasts were 
sonicated in 0.5 ml TBS.  Equal amounts of lysate and 2X SDS loading buffer were 
mixed, boiled and loaded onto 10% acrylamide gels, subjected to SDS-PAGE, and 
transferred to nitrocellulose membranes.  Membranes were probed with 9E10 anti-c-Myc 
monocolonal primary and AlexaFluor-680-conjugated anti-mouse secondary (Invitrogen) 
antibodies.  Membranes were dried and scanned using an Odyssey Infrared Imaging 
System (LI-COR Biosciences). 
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Construction of XylE reporter plasmids –Mutagenesis of the S. aureus hrtAB promoter-
xylE fusion was carried out by inverse PCR-based mutagenesis.  Briefly, a non-
overlapping non-mutagenic primer and a primer introducing the desired mutation were 
designed which amplify in opposite directions on the plasmid template.  Inverse PCR 
was carried out using S. aureus hrtAB promoter-xylE fusion as template and 5’ 
phosphorylated oligos.  Amplified DNA was blunt end ligated, transformed into E. coli, 
miniprepped, and mutagenized constructs were validated by DNA sequencing. 
Construction of Lux reporter plasmids – To generate a construct in which the Lux genes 
of pXen-1 (Xenogen) (58) are under the control of the S. aureus hrtAB promoter, primers 
containing a 5’ EcoRI site and a 3’ BamHI site were used to amplify the hrtAB promoter 
from S. aureus genomic DNA.  PCR-amplified DNA was inserted into pXen-1 to create 
the plasmid phrt.Lux.   
Construction of plasmids for expression of recombinant proteins – For construction of 
expression constructs for S. aureus HssR:D52N and B. anthracis HssR, HssS, 
HssS:H248A and HssR:D54N, B. anthracis hssR or hssS were amplified by PCR and 
inserted between the NdeI and BamHI sites of pET15b (Invitrogen).  Constructs were 
validated by sequencing and were then mutagenized by inverse PCR.  Protein 
expression was carried out as previously described (see Chapter III Methods).  To 
validate the integrity of recombinant HssS, S. aureus and B. anthracis HssS were 
analyzed by mass spectrometry (Vanderbilt University Proteomics Core Facility).  Intact 
masses were determined for both proteins and N- and C-termini were validated by 
MS/MS following digestion with trypsin protease. 
XylE reporter assays –Bacteria harboring reporter plasmids were grown overnight in BHI 
(S. aureus and B. anthracis when analyzing heme induction of hrtAB promoter) or LB (B. 
anthracis when analyzing heme-independent hrtAB promoter activity) and subcultured 
1:50 into 2 ml BHI in 15 ml conical tubes.  Bacteria were grown for 5 hours at 37 °C and 
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cytoplasmic fractions were prepared and analyzed as previously reported (Chapter IV 
Methods) except that for B. anthracis, lysozyme (2 mg/ml) was used instead of 
lysostaphin.  Absolute XylE activities were determined for B. anthracis reporters due to 
lysozyme interference during protein quantification. 
Bacterial growth curve analyses – Triplicate cultures of bacteria were grown 12 hours at 
30 °C with shaking in 5 ml of BHI (B. anthracis) or TSB (S. aureus) in 15 ml tubes.  Each 
culture was subcultured 1:50 into 150 µl fresh medium in a 96-well round-bottom plate.  
Plates were wrapped to avoid evaporation and were grown at 37 °C with shaking at 180 
rpm.  600 nm absorbance readings were taken on a Cary 50 MPR microplate reader 
coupled to a Cary 50 Bio UV-visible spectrophotometer (Varian, Inc.).  For all 
experiments, absorbance readings of the triplicate subcultures were averaged and one 
standard deviation from the mean was plotted as error bars. 
Heme preparation and concentrations - Heme (Fluka) stocks were made by dissolving 
heme in 0.1 M NaOH to a concentration of 10 mM.  Heme concentrations were chosen 
based on the following considerations.  For all experiments attempting to assess hrtAB 
promoter activity without any detectable interference of heme toxicity with strain growth 
(such as in heme-sensitive mutants), promoter induction, or XylE synthesis, 2 µM heme 
was utilized.  Five µM heme fully induces the hrtAB promoter in S. aureus with no 
detectable heme toxicity and was therefore utilized to pre-adapt B. anthracis to heme 
toxicity.  Ten µM heme was selected for growth curve analysis of B. anthracis hss/hrt 
mutants as a heme concentration known to completely inhibit growth of S. aureus hss/hrt 
mutants within 12 hours of subculture, and as a heme concentration known to slightly 
inhibit growth of wild type S. aureus in TSB.  Twenty µM heme is known to inhibit growth 
of S. aureus in BHI and was therefore used to inhibit growth of Bacilli; 20 µM heme also 
completely inhibits growth of S. aureus and B. anthracis ∆hssS up to 24 hours and was 
therefore used in experiments assessing the heme resistance of complemented 
 102
derivatives of ∆hssS.  Thirty µM heme was used to inhibit the growth of S. aureus and B. 
anthracis ∆hssRS due to the significant heme resistance of strains harboring hssRS 
complementation plasmids.  Fifty µM heme was chosen in experiments analyzing the 
native or pre-adapted heme resistance of wild type strains in BHI due to the inherent 
heme resistance of these strains. 
HssS-HssR autophosphorylation and phosphotransfer assays –Autophosphorylation of 
S. aureus and B. anthracis HssS signaling domain was carried out similar to previously 
described assays (see Chapter IV Methods).  Briefly, 25 µl reaction mixtures were 
prepared containing 288 µg/ml HssS, 50 mM Tris, pH 8.0, 5 mM MgCl2, 200 mM KCl, 
0.2 mM DTT, 10 % glycerol, 20 µM unlabeled ATP, 5 µCi [γ32P]ATP.  Five µl samples 
were mixed with 2X SDS-PAGE loading buffer at various time points after the addition of 
radiolabeled ATP, samples were resolved by SDS-PAGE, and gels were dried and 
analyzed using a PhosphorImager.  To analyze phosphotransfer from HssS to HssR, B. 
anthracis and S. aureus HssS were labeled for 15 and 50 minutes, respectively, in 
reaction mixtures described above.  HssR or HssR mutant was added to this reaction to 
a final concentration of 890 µg/ml.  Samples were taken and analyzed as described 
above. 
Bacterial heme killing assays – 5 ml cultures of S. aureus and B. anthracis wild type and 
∆hrtA were grown in 15 ml conical tubes for 12 hours at 30 °C with shaking at 180 rpm.  
Bacteria were subcultured 1:100 into BHI or BHI + 10 µM heme and incubated at 37 °C 
for 4 hours.  At the time of subculture and following incubation, bacterial colony forming 
units (CFU) were enumerated by performing serial dilutions in PBS and plating cells on 
BHI agar. 
B. anthracis infections and in vivo imaging system (IVIS)-based imaging – Spores for 
infection of mice were prepared as described previously (108) with modifications.   
Briefly, B. anthracis harboring pXen-1 or phrt.Lux were grown for 12 hours in 5 ml 2X SG 
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medium (100) in 15 ml conical tubes at 30 °C with shaking.  Cells were subcultured 
1:100 into 250 ml flasks containing 30 ml 2X SG and were shaken at 37 °C for 4 days.  
Spore-containing cultures were then pelleted and washed three times with water, heated 
to 70 °C for 30 minutes, and then washed again with water.  Purified spores were serially 
diluted and plated onto BHI to obtain a viable spore count.  Spore preparations were 
stained using malachite green to microscopically confirm the presence of spores and the 
absence of vegetative bacilli.  For injection of 200 or 2000 wild type or ∆hrtA B. anthracis 
spores for virulence studies, spore preparations were diluted to a concentration of 2 or 
20 spores/µl in sterile PBS.  100 µl of spore dilutions were injected subcutaneously into 
the inguinal region of 6-week-old A/J mice (two groups of 10 on different weeks).   
Following spore inoculation, mice were monitored for signs of disease and were 
sacrificed when found to be moribund.  Mice were grouped according to the 12-hour 
interval in which they were sacrificed.  For IVIS studies, spores harboring Lux plasmids 
were diluted to a concentration of 200 spores/µl in sterile PBS. 100 µl of spore dilutions 
(20000 spores/mouse) were injected subcutaneously into the inguinal region of 6-week-
old A/J mice (two groups of 5 mice).   Following spore inoculation, mice were visualized 
at 12-hour intervals using a Xenogen IVIS 200.  Mice were monitored for signs of 
disease and were sacrificed when found to be moribund. 
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Results 
Multiple Gram-positive bacteria encode putative orthologues of S. aureus HrtAB 
and HssRS. Consistent with the supposition that B. anthracis may need to avoid the 
lethal side effects of heme acquisition, Van Heyningen demonstrated in 1948 that B. 
anthracis is capable of proliferating on plates containing a high amount of heme (76).  
Interestingly, B. subtilis (a bacterium not commonly associated with vertebrate tissues 
containing heme) is sensitive to heme toxicity (76).  We found a potential explanation for 
this observation while interrogating Firmicute genomes for putative hssRS/hrtAB 
systems.  These searches revealed that B. anthracis encodes putative orthologues of S. 
aureus hssRS/hrtAB (Figure 22), whereas hss/hrt genes are absent from the genome of 
B. subtilis.  Furthermore, a number of other Firmicutes with pathogenic or saprotrophic 
lifestyles are also predicted to encode hss/hrt (Figure 22).  This implies that B. anthracis 
and other pathogenic or saprotrophic Firmicutes may overcome heme toxicity through a 
similar mechanism to that utilized by S. aureus. 
 
Phylogenetically related Bacilli display differential heme resistance.  To test 
whether encoding hss/hrt correlates with resistance to heme toxicity, we assessed the 
heme resistance of four Bacilli that contain these genes (B. anthracis, B. cereus, B. 
thuringiensis, and B. israelensis) and two with no identifiable hss/hrt orthologues (B. 
licheniformis and B. subtilis) (Figure 23).  We found that each of the four Bacilli encoding 
putative Hss/Hrt systems are able to proliferate in 20 µM heme, while both Bacilli lacking 
Hss/Hrt systems are unable to proliferate in this concentration of heme (Figure 23).  
These data link the presence of hss/hrt genes with resistance to heme toxicity. 
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Figure 22. Conservation of HssRS and HrtAB across Gram-positive bacteria.  
Sequenced bacterial genomes were interrogated for potential orthologues of S. aureus 
hssRS and hrtAB by BLAST analyses.  The indicated bacterial strains were found to 
encode potential Hss/Hrt systems.  Boxes indicate open reading frames and point in the 
direction of transcription. Dark grey boxes: HrtA; light grey boxes: HrtB, empty boxes: 
HssR, boxes with diagonal lines: HssS; black boxes: non-Hss/Hrt open reading frames 
(other genes).  Numbers within boxes indicate the annotated gene number.  Numbers 
below boxes are percent similarities with respect to the corresponding S. aureus COL 
Hss/Hrt gene.  Percent similarities were calculated at the amino acid level using a 
Lipman-Pearson Protein Alignment (gap penalty = 4, gap length penalty = 12).  Single 
asterisk denotes large separation between genes; double asterisk denotes that this 
potential HssR orthologue is split into two open reading frames in the genome of this 
species.  Adapted from Stauff et al., 2008 (Ref. 157). 
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Figure 23.  Bacillus species exhibit differential heme resistance.  Growth curve 
analysis was performed on triplicate cultures of Bacillus anthracis, B. cereus, B. 
thuringiensis, B. israelensis, B. licheniformis, and B. subtilis grown in triplicate in BHI 
without heme (solid lines), BHI + 20 µM heme (a heme concentration observed to inhibit 
growth of S. aureus in previous experiments; dotted lines with diamonds) or BHI + 50 µM 
heme (a heme concentration similar to that used by Van Heyningen et al. to inhibit 
Bacilli; dotted lines with boxes).  Culture densities were determined and averaged at 2-
hour intervals following subculture.  Error bars correspond to one standard deviation 
from the mean density of the three cultures. 
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B. anthracis encodes hss/hrt genes required for heme resistance.  We chose to 
investigate Hss/Hrt function in B. anthracis based on the fact that this organism is a 
mammalian pathogen and one that displays an intimate association with host blood 
during infection.  B. anthracis HrtAB and HssRS share significant amino acid identity 
with the corresponding proteins in S. aureus (Figure 22) (157, 169).  The hrtAB and 
hssRS operons of B. anthracis are located less than 3 kb apart on the chromosome and 
are separated by two open reading frames, one of which encodes an uncharacterized 
transcription factor (BAS3024, Figure 24A).  An HssR consensus binding site can be 
found within the promoter of B. anthracis hrtAB (GTTCATATT(N2)GTTCATATT) (43, 
158), suggesting that HssRS may regulate HrtAB expression in B. anthracis (Figure 
24A).  Furthermore, we found that B. anthracis is capable of adapting to heme toxicity 
(Figure 24B), a phenotype that is likely due to expression of HrtAB in heme-treated cells 
prior to exposure to toxic levels of heme (169).  These observations are consistent with 
the proposition that B. anthracis adapts to heme through HssRS-dependent expression 
of HrtAB. 
 Accordingly, we assessed the ability of B. anthracis mutants lacking hrtA and 
hssRS to resist heme toxicity.  While wild type B. anthracis is able to proliferate in 10 µM 
heme, B. anthracis ∆hrtA and ∆hssRS are unable to proliferate in this heme 
concentration, phenotypes that can be complemented by providing a full-length copy of 
the corresponding gene in trans (Figure 24C-F).  Importantly, B. anthracis ∆hrtA and 
∆hssRS display no growth defect in the absence of heme (Figure 24C, 24D).  This 
demonstrates that B. anthracis requires functional Hss/Hrt systems for heme resistance. 
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Figure 24. Bacillus anthracis requires HrtAB and HssRS for heme resistance.  A. 
Schematic of the B. anthracis hss/hrt locus.  Open arrows represent open reading 
frames (ORF).  Designations above ORFs denote predicted gene function.  Numbers 
below ORFs correspond to gene numbers in the B. anthracis Sterne genome.  Double 
asterisks signify a putative HssR binding site upstream of hrtAB; alignment shows the 
known S. aureus (S.a.) and predicted B. anthracis (B.a.) HssR binding sites.  B. B. 
anthracis adapts to heme toxicity.  B. anthracis grown in BHI (black lines) or BHI + 5 µM 
heme (grey lines) was subcultured in triplicate into BHI (solid lines) or BHI + 50 µM 
heme (dashed lines).  Bacterial proliferation was tracked by growth curve.  C. 
Contribution of hrtAB to heme resistance of B. anthracis.  B. anthracis wild type (wt, 
black lines) and ∆hrtA (grey lines) were grown in BHI (solid lines) or BHI + 10 µM heme 
(dashed lines).  Growth was followed as in B.  D. Complementation of B. anthracis 
∆hrtA.  B. anthracis wild type harboring an empty plasmid (p.) or ∆hrtA harboring either 
an empty plasmid or a plasmid containing B. anthracis hrtA (phrtA) were analyzed as 
described in C.  Culture densities at 12 hours are shown.  E. Contribution of B. anthracis 
HssRS to heme resistance.  B. anthracis wild type and ∆hssRS were analyzed as 
described in C.  F. Complementation of B. anthracis ∆hssRS.  B. anthracis wild type 
harboring an empty plasmid or ∆hssRS harboring an empty plasmid or a plasmid 
containing B. anthracis hssRS (phssRS) were analyzed as described in C.  Culture 
densities at 12 hours are shown.  All results are representative of at least three 
independent experiments.  Error bars correspond to one standard deviation from the 
mean of triplicate samples within the same experiment; asterisks denote statistically 
significant differences by Student’s t test (p<0.05). 
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The B. anthracis hrtAB promoter displays enhanced constitutive and heme-
induced activity.  Although S. aureus and B. anthracis both require HrtAB for heme 
resistance, it is unclear whether these systems display overlapping function.  We 
therefore performed interspecies complementation experiments and found that B. 
anthracis or S. aureus hrtAB restore heme resistance to S. aureus ∆hrtAB, suggesting 
orthology at the level of transporter function between HrtAB from these organisms 
(Figure 25A).  In addition, we found that in S. aureus both the S. aureus and B. anthracis 
hrtAB promoters respond to heme in a similar manner (Figure 25B).  These results 
confirm that S. aureus HssR is capable of activating the S. aureus and B. anthracis 
hrtAB promoters, consistent with the presence of an HssR consensus site within these 
promoters (Figure 24A). 
 However, in B. anthracis the hrtAB promoter exhibits elevated levels of activation 
in response to heme (Figure 25C).  Furthermore, the B. anthracis hrtAB promoter 
displays increased activity in the absence of heme when compared with the S. aureus 
hrtAB promoter (Figure 25C).  In keeping with this, we tested whether the elevated 
constitutive activity of the B. anthracis hrtAB promoter depends on HssRS signaling and 
binding of HssR to the hrtAB promoter DR.  Mutation of the DR or disruption of hssRS 
eliminates the heme responsiveness and reduces the constitutive activity of the B. 
anthracis hrtAB promoter (Figure 25D).  This demonstrates that B. anthracis HssRS 
responds to heme and activates the hrtAB promoter in a DR-dependent manner.  
Furthermore, these data suggest that in B. anthracis, HssRS constitutively induces 
HrtAB expression even in the absence of heme, an activity not exhibited by S. aureus 
HssRS (158, 169).   
 The fact that hrtAB promoters from both species respond to heme in a similar 
manner in S. aureus (Figure 25B) but not in B. anthracis (Figure 25C) despite similar DR 
sequences indicates that bases outside of the hrtAB promoter DR may be important for 
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promoter activity in B. anthracis.  Accordingly, we found that single-base DR mutations 
have similar effects on the ability of S. aureus and B. anthracis HssR to activate the 
hrtAB promoter.  Specifically, we found that mutation of four conserved DR residues, or 
removal or addition of spacer residues between the repeats eliminates the ability of S. 
aureus and B. anthracis HssR to activate the S. aureus hrtAB promoter in response to 
heme (Figure 25E, constructs 3, 8 - 10).  Furthermore, mutation of T3 of the first repeat 
or T2 of the second repeat decreases heme responsiveness in both species to the same 
extent (Figure 25E, constructs 5 and 7).  While B. anthracis HssR is more sensitive to 
mutation of A5 of repeat 2 and S. aureus is more sensitive to mutation of T9 of repeat 1 
(Figure 25E, constructs 4 and 6), both mutations decrease hrtAB promoter activity in 
response to heme.  This provides the first indication that HssR is exquisitely sensitive to 
alterations in the distance between each repeat and mutation of single DR residues.  
Overall, this suggests that HssR-hrtAB promoter interactions display similarity in S. 
aureus and B. anthracis, pointing to sequences outside of the DR for heme-independent, 
HssRS-dependent hrtAB promoter activity observed specifically in B. anthracis.   
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Figure 25. Orthology of S. aureus and B. anthracis HrtAB.  A. Complementation of 
S. aureus ∆hrtAB with S. aureus/B. anthracis hrtAB.  S. aureus wild type (wt) 
transformed with pOS1 (p.), ∆hrtAB + pOS1, ∆hrtAB + pOS1 encoding S. aureus hrtAB 
(phrtAB.Sa)), and ∆hrtAB + pOS1 encoding B. anthracis hrtAB (phrtAB.Ba) were grown 
in TSB + 10 µM heme.  Proliferation was tracked by growth curve analysis.  Culture 
densities at 6 hour and 8 hour time points are shown.  B. Reporter assay monitoring S. 
aureus/B. anthracis hrtAB promoter activity in S. aureus.  S. aureus harboring either an 
S. aureus (phrtAB.Sa.xylE, solid lines) or B. anthracis (phrtAB.Ba.xylE, dashed lines) 
hrtAB promoter XylE reporter were grown in the indicated concentration of heme and 
reporter activity was measured.  C. Reporter assay monitoring S. aureus and B. 
anthracis hrtAB promoter activity in B. anthracis.  D. Dependence on HssRS and the 
hrtAB promoter direct repeat (DR) for constitutive and heme-induced hrtAB promoter 
activity in B. anthracis.  B. anthracis wild type (wt) or ∆hssRS harboring either 
promoterless xylE (-), phrtAB.Ba.xylE (hrt), or phrtAB.Ba.xylE with four DR base 
mutations (hrt(DR)) were grown in +/- 2 µM heme and XylE activity was measured.  
Asterisk denotes that activity for wild type in the absence of heme is statistically different 
from wt + hrt(DR), ∆hssRS + hrt, and ∆hssRS + hrt(DR) in the presence or absence of 
heme (p < 0.05).  E. Reporter assay measuring sensitivity of S. aureus and B. anthracis 
HssRS to perturbations in the hrtAB promoter DR.  S. aureus or B. anthracis harboring 
promoterless xylE (construct 1), phrtAB.Sa.xylE (2), or phrtAB.Sa.xylE with DR 
mutations (3-10) were grown in +/- 2 µM heme.  Reporter activity was measured and is 
expressed as the percent of heme-induced activity observed for the wild type promoter.  
Error bars correspond to one standard deviation from the mean; asterisks denote 
statistically significant differences by Student’s t test (p<0.05). 
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S. aureus and B. anthracis HssRS provide differential heme resistance.  We next 
tested whether S. aureus and B. anthracis HssRS display differential activity in vivo by 
assessing the ability of HssRS from S. aureus and B. anthracis to complement S. aureus 
∆hssRS.  To account for potential differences in protein abundance, we tagged hssS in 
the context of an hssRS-encoding plasmid, creating hssR-hssS-myc plasmids for the 
expression of HssR and HssS-Myc from either species.  We found that both S. aureus 
and B. anthracis HssS-Myc are expressed in these strains and that HssR-HssS-Myc 
from either species is able to complement S. aureus ∆hssRS (Figure 26A).  
Furthermore, we noticed that B. anthracis HssR-HssS-Myc provides significantly greater 
complementation than HssR-HssS-Myc from S. aureus (Figure 26A), a difference that is 
conserved in B. anthracis (Figure 26B).  These results indicate that the molecular 
function of B. anthracis HssRS may differ from that of S. aureus HssRS in a way that 
provides for an increased ability to sense and respond to heme. 
 
S. aureus and B. anthracis HssS exhibit differential function in vivo.  The ability of 
B. anthracis HssR-HssS-Myc to impart elevated heme resistance may be due to 
differences in HssR, HssS, or both.  We reasoned that HssS differences are likely to 
contribute to differential TCS activity, as B. anthracis/S. aureus HssS share significantly 
less sequence identity than HssR (Figure 22).  Accordingly, we found that B. anthracis 
HssS-Myc provides greater heme resistance to S. aureus ∆hssS than HssS-Myc from S. 
aureus (Figure 27A).  We next attempted to repeat these observations in B. anthracis.  
Notably, HssS-Myc from B. anthracis complements B. anthracis ∆hssS, while HssS-Myc 
from S. aureus fails to complement this strain in spite of similar expression of both 
proteins (Figure 27B).  These results suggest that, although S. aureus and B. anthracis 
HssRS are functionally orthologous TCS, B. anthracis HssRS provides elevated heme 
resistance to bacteria due to differences in HssS function. 
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Figure 26. S. aureus and B. anthracis HssRS display differential activity in vivo.  A. 
Complementation of S. aureus ∆hssRS by S. aureus and B. anthracis HssRS.  Top: 
triplicate cultures of S. aureus wild type (wt) harboring pOS1 (p.), ∆hssRS with pOS1, 
∆hssRS with pOS1 encoding S. aureus HssR-HssS-Myc (phssR-hssS-myc.Sa), and 
∆hssRS with pOS1 encoding B. anthracis HssR-HssS-Myc (phssR-hssS-myc.Ba) were 
grown in TSB + 30 µM heme.  Proliferation was tracked by growth curve analysis.  
Average culture density at 8 hour (white bars) and 16 hour (grey bars) time points are 
shown.  Bottom: anti-c-Myc immunoblot showing expression of S. aureus and B. 
anthracis HssS-Myc in S. aureus ∆hssRS.  Lane 1: molecular weight ladder (L).  Lanes 
2-4: S. aureus ∆hssRS transformed with empty plasmid (-), phssR-hssS-myc.Sa (Sa), or 
phssR-hssS-myc.Ba (Ba).  B. Top: Complementation of B. anthracis ∆hssRS by S. 
aureus and B. anthracis HssRS (same plasmids described in A).  Experiment was 
carried out as described in A, except that earlier time points (6 hour (white) and 12 hour 
(grey)) are shown due to sporulation and autolysis observed at late time points in B. 
anthracis cultures.  Bottom: anti-c-Myc immunoblot showing expression of S. aureus and 
B. anthracis HssS-Myc in B. anthracis ∆hssRS.  Lanes are the same as those described 
in A.  All results are representative of at least three independent experiments.  Error bars 
correspond to one standard deviation from the mean of triplicate samples within the 
same experiment. Asterisks denote statistically significant differences in 
complementation by Student’s t-test (p < 0.05) 
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Figure 27.  B. anthracis HssS displays elevated heme sensing activity in vivo.  A. 
Top: Complementation of S. aureus ∆hssS by S. aureus and B. anthracis HssS.  Top: S. 
aureus wild type harboring plasmid pOS1, ∆hssS with pOS1, ∆hssS with pOS1 
encoding S. aureus HssS-Myc (phssS-myc.Sa), and ∆hssS with pOS1 encoding B. 
anthracis HssS-Myc (phssS-myc.Ba) were grown in TSB + 20 µM heme.  Proliferation 
was tracked by growth curve analysis.  Average culture density at 8 hour (white bars) 
and 16 hour (grey bars) time points are shown.  Bottom: anti-c-Myc immunoblot showing 
expression of S. aureus and B. anthracis HssS-Myc in S. aureus ∆hssS.  Lane 1: 
molecular weight ladder (L).  Lanes 2-4: S. aureus ∆hssS transformed with empty 
plasmid (-), phssS-myc.Sa (Sa), or phssS-myc.Ba (Ba).   B. Top: Complementation of B. 
anthracis ∆hssS by S. aureus and B. anthracis HssS.  Experiment was performed as 
described in A.  Bottom: anti-c-Myc immunoblot showing expression of S. aureus and B. 
anthracis HssS-Myc in B. anthracis ∆hssS.  Lanes are the same as those described in 
A.  All results are representative of at least three independent experiments.  Error bars 
correspond to one standard deviation from the mean of triplicate samples within the 
same experiment. Asterisks denote statistically significant differences in 
complementation by Student’s t-test (p < 0.05) 
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HssS chimeras reveal a complex domain interplay leading to elevated B. anthracis 
HssS activity.  The ability of B. anthracis HssS to provide greater heme resistance than 
S. aureus HssS may be due to differences in the function of any of the domains 
comprising HssS.  A membrane-localized histidine kinase, HssS is predicted to contain 
four domains: an N-terminal signal recognition domain flanked by two transmembrane 
helices (109), and a tripartite signaling domain consisting of a HAMP linker domain (8), a 
phosphate-accepting and response regulator recognition HisKA domain (68), and a C-
terminal ATPase domain (68). 
To define HssS domains required for the increased in vivo activity of B. anthracis 
HssS, we constructed chimeric forms of HssS-Myc with either the sensing, HAMP, 
HisKA, or ATPase domain of S. aureus HssS in place of the respective B. anthracis 
HssS domain (Figure 28). The function of each chimera was then tested in S. aureus.  
Surprisingly, all chimeras that are expressed in S. aureus and contain a single S. aureus 
domain allow this organism to proliferate to similar levels as S. aureus expressing full 
length B. anthracis HssS-Myc (Figure 28).  In contrast, all chimeras containing two or 
more S. aureus HssS domains (with the exception of a chimera containing the entire S. 
aureus signaling domain, which is non-functional) function similar to S. aureus HssS in 
vivo, requiring over 8 hours to proliferate in 20 µM heme (Figure 28).  These data 
indicate that B. anthracis HssS is able to withstand single domain swapping with S. 
aureus HssS and retain its elevated function.  It is likely that a complex interplay 
between HssS domains is responsible for the differential activity between S. aureus and 
B. anthracis HssS, an interplay that is perturbed by the insertion of more than one S. 
aureus HssS domain into B. anthracis HssS.   
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Figure 28. Rescue of S. aureus ∆hssS by S. aureus/B. anthracis HssS chimeras.  
Left: schematic of HssS chimeras.  Black: S. aureus HssS; grey: B. anthracis HssS; 
white: C-terminal c-Myc epitope tag.  TMD1/2, predicted transmembrane domains; ECD, 
predicted extracytoplasmic sensing domain; HAMP, intracytoplasmic linker domain; 
HisKA, phosphate acceptor domain; ATPase, ATP hydrolysis domain.  Right side: 
chimera functional data.  Column 1: Expression of HssS chimeras.  Triplicate cultures of 
S. aureus ∆hssS expressing each shown HssS variant were prepared and HssS 
expression was analyzed by immunoblot followed by LiCor-based quantification.  
Chimera levels relative to abundance of S. aureus HssS were determined and averaged.  
Standard deviations are shown.  Data corresponding to chimeras with less than 50% 
expression are highlighted in grey.  Columns 2 and 3: rescue of ∆hssS by HssS 
chimeras.  Column 2: strains were inoculated into medium containing 20 µM heme and 
proliferation was tracked by growth curve analysis.  The length of time required to initiate 
growth (OD600 = 0.2) was determined.  Column 3: strains were inoculated into medium 
containing 10, 20, or 30 µM heme.  The highest heme concentration each strain was 
able to grown in by 24 hours is indicated.  Results are representative of at least three 
experiments. 
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B. anthracis HssS requires conserved residues in the predicted extracytoplasmic 
sensing domain for heme recognition.  In HssS, signal recognition is predicted to 
occur within the putative extracytoplasmic domain, which is flanked by transmembrane 
helices (see Figure 29A for schematic).  However, no studies have addressed the 
importance of this input domain in HssS function.  In this regard, we subjected the 
predicted HssS sensing domain to mutational analysis to test whether it is required for 
heme recognition.  First, we identified residues required for HssS-dependent heme 
sensing by aligning HssS sequences from Firmicutes predicted to encode hss/hrt.  This 
analysis revealed a number of conserved residues within the predicted sensing domain 
(Figure 29B).  We selected 15 perfectly or highly conserved residues and a single non-
conserved residue in B. anthracis HssS for alanine substitution mutational analysis, 
focusing on two patches of conserved residues (T124-N129 and F149-F165, Figure 
29B).  We also mutated the predicted phosphorylated histidine residue (H248) of HssS.  
We then expressed these point mutants in B. anthracis ∆hssS and analyzed their 
expression and function. 
By immunoblotting against the C-terminal c-Myc epitope tag added to HssS, we 
found that all point mutants with the exception of HssS:F149A are expressed to levels 
similar to wild type HssS (Figure 29C).  As expected, HssS:H248A is unable to rescue 
the heme sensitivity of B. anthracis ∆hssS, presumably due to an inability to signal to 
HssR (Figure 29D).  Furthermore, HssS:Q145A, a mutant in a non-conserved HssS 
residue, complements ∆hssS at levels similar to wild type HssS (Figure 29D).  However, 
many of the point mutants are unable to complement B. anthracis ∆hssS (Figure 29D).  
Specifically, B. anthracis HssS mutants at residues K42, T124, F127, R151, E160, or 
R162 are unable to complement ∆hssS to varying degrees.  These data confirm that the 
predicted HssS sensing domain is involved in signal recognition, the initial event in heme 
recognition and detoxification by HssRS/HrtAB. 
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Figure 29. HssS sensing domain residues required for heme recognition.  A.  
Schematic of HssS.  B.  Alignment of conserved HssS sensing domain residues.  An 
HssS consensus sequence was generated from an alignment performed using data from 
all species with complete genome sequences that are predicted to contain hss/hrt 
(capital letters).  Greyscale code indicates level of conservation (light grey, little 
conservation; black, absolute conservation).  Asterisks above residues designate amino 
acids subjected to alanine substitution mutagenesis.  The signaling domain 
autophosphorylated histidine residue (H248) was also selected for mutagenesis.  C.  
Expression of B. anthracis HssS point mutants.  Triplicate cultures of B. anthracis ∆hssS 
expressing each HssS point mutant were prepared and HssS expression was analyzed 
by immunoblot followed by LiCor-based quantification.  Mutant levels relative to 
abundance of wild type B. anthracis HssS were determined and averaged.  Error bars 
correspond to standard deviations; asterisk denotes point mutant with expression 
significantly lower than wild type.  This point mutant was not selected for subsequent 
analyses.  D.  Rescue of B. anthracis ∆hssS by HssS point mutants.  Strains were 
inoculated into BHI containing 20 µM heme and grown for 12 hours.  The mean optical 
density of triplicate cultures was determined.  Error bars correspond to standard 
deviations; asterisks denote strains with culture density significantly lower than wild type. 
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B. anthracis HssS-HssR undergoes rapid autophosphorylation and 
phosphotransfer.  Because autophosphorylation is the major catalytic activity of 
histidine kinases (109), we hypothesized that differences in autophosphorylation 
between S. aureus and B. anthracis HssS may correlate with the increased ability of B. 
anthracis HssS to provide heme resistance (Figure 27A, Figure 28).  In vitro, B. 
anthracis HssS undergoes autophosphorylation that is dependent on conserved histidine 
248 (Figure 30B), correlating with its lack of functionality in vivo (Figure 29D).  
Significantly, we found that the autophosphorylation rate of B. anthracis HssS is 208 (+/- 
50) times greater than that of S. aureus HssS (Figure 30A, 30B).  This correlates with 
the ability of B. anthracis HssS to provide enhanced heme resistance to S. aureus 
∆hssS (Figure 27A, Figure 28). 
We next tested HssS-HssR phosphotransfer and found that both S. aureus and 
B. anthracis HssRS are capable of engaging in intraspecies phosphotransfer dependent 
on a conserved aspartic acid residue of HssR (Figure 30C).  We next analyzed 
interspecies phosphotransfer using S. aureus HssS and found that B. anthracis HssR 
fails to catalyze phosphotransfer from S. aureus HssS (Figure 30D, 30F), providing a 
potential explanation for the inability of S. aureus HssS to complement B. anthracis 
∆hssS (Figure 27B).  This indicates that evolutionary divergence has occurred between 
S. aureus and B. anthracis HssRS.  We also tested interspecies phosphotransfer with B. 
anthracis HssS and found that HssR from both species are capable of catalyzing 
phosphotransfer from B. anthracis HssS (Figure 30C, 30E, 30G).  Notably, when 
phosphorylated B. anthracis HssS is incubated with S. aureus HssR, phosphorylated B. 
anthracis HssS levels do not decrease because of the fact that B. anthracis HssS 
continues to undergo autophosphorylation even after HssR is added. 
In these experiments, we observed differences in the rate of B. anthracis and S. 
aureus HssS-HssR phosphotransfer.  Specifically, we found that B. anthracis HssS-
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HssR phosphotransfer occurs rapidly (peaking in under 10 seconds, Figure 30G) while 
S. aureus HssS-HssR phosphotransfer occurs at a relatively slow rate (peaking at about 
10 minutes, Figure 30F).  Phosphotransfer rate appears to be a property of HssR rather 
than HssS, as slow phosphotransfer on the part of S. aureus HssR also occurs in a 
phosphotransfer reaction containing B. anthracis HssS (Figure 30G).  These results 
indicate evolutionary divergence between S. aureus and B. anthracis HssR that favors 
rapid phosphorylation of B. anthracis HssR.  Importantly, the increased rate of B. 
anthracis HssS phosphorylation and HssS-HssR phosphotransfer may in part explain 
the ability of this TCS to provide elevated heme resistance to S. aureus (Figure 26A). 
 
B. anthracis ∆hrtA is more sensitive to heme toxicity than S. aureus ∆hrtA.  We 
reasoned that the enhanced function of B. anthracis HssRS may confer elevated heme 
resistance to B. anthracis when compared with S. aureus.  However, we found that both 
species display similar heme resistance by growth curve analysis (Figure 31A).  We next 
reasoned that in the absence of Hss/Hrt function, B. anthracis may display enhanced 
sensitivity to heme toxicity and may therefore require elevated HssRS activity to 
compensate.  We therefore tested the relative heme sensitivity of S. aureus ∆hrtA and B. 
anthracis ∆hrtA and found that after 4 hours in 10 µM heme, S. aureus ∆hrtA exhibits a 
slight growth inhibition, while B. anthracis ∆hrtA exhibits a dramatic decrease in 
surviving bacteria (Figure 31B).  Together with previous data, these results suggest that 
B. anthracis may  have evolved a highly active HssRS system to cope with the fact that 
this organism is extremely susceptible to heme toxicity. 
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Figure 30.  Phosphotransfer between S. aureus and B. anthracis HssS and HssR.  
Symbols for proteins used in A and B.  Black lines: wild type HssS (S. aureus HssS in 
A, B. anthracis HssS in B); grey lines: mutant HssS with alanine substituted for 
phosphohistidine residue (HssS:H>A).  A. Autophosphorylation of S. aureus HssS.  
HssS and HssS:H>A were incubated with 32P-ATP for the indicated time and samples 
were analyzed by SDS-PAGE followed by quantification via PhosphorImager analysis.  
B. Autophosphorylation of B. anthracis HssS and HssS:H>A.  C. Intraspecies HssS-
HssR phosphotransfer.  Phosphorylated S. aureus (left panels) or B. anthracis (right 
panels) HssS (HssS-32P) was added to wild type HssR (wt, top panels) or HssR mutated 
at phosphoaspartate residue (D>N, bottom panels).  Samples were analyzed as 
described in A.  D through G: interspecies phosphotransfer.  Symbols for reactions 
analyzed in D through G:  Black lines with squares: reactions containing HssS (S. 
aureus in D and F, B. anthracis in E and G) and wild type S. aureus HssR (HssR.Sa); 
black lines with diamonds: reactions containing HssS and wild type B. anthracis HssR 
(HssR.Ba).  Reactions were repeated in quadruplicate, and phosphorylated proteins 
were quantified and averaged.  D. Amount of HssS-32P after initiation of reactions 
containing S. aureus HssS.  E. Amount of HssS-32P in reactions containing B. anthracis 
HssS.  F. HssR-32P levels in phosphotransfer reactions containing S. aureus HssS.  G. 
HssS-32P levels in phosphotransfer reactions containing B. anthracis HssS. 
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Figure 31.  Differential heme sensitivity of S. aureus and B. anthracis ∆hrtA.  A. 
Proliferation of wild type S. aureus and B. anthracis in heme.  Growth curve analysis was 
performed on S. aureus (black lines) and B. anthracis (grey lines) grown in BHI without 
heme (no symbols), BHI + 10 µM heme (a heme concentration that inhibits hss/hrt 
mutants; boxes), or BHI + 50 µM heme (a heme concentration that inhibits wt S. aureus 
and B. anthracis; diamonds).  B. Resistance of wild type and ∆hrtA S. aureus and B. 
anthracis to heme.  S. aureus (Sa) and B. anthracis (Ba) wild type (wt) and ∆hrtA were 
grown overnight and subcultured into BHI or BHI + 10 µM heme.  At the time of 
subculture and after the four-hour incubation, serial dilutions were performed and plated 
and colony forming units (CFU) were enumerated.  Data is presented as the fold change 
in CFU following incubation in the presence or absence of heme (log scale).  Asterisks 
denote statistically significant differences by Student’s t-test (p < 0.05).  All results are 
representative of triplicate independent experiments.  Error bars correspond to one 
standard deviation from the mean of triplicate samples within the same experiment; 
asterisks denote statistically significant differences by Student’s t test (p<0.05). 
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B. anthracis experiences heme stress during growth within vertebrates.   Given the 
capacity of B. anthracis to acquire heme (62, 106, 107, 148) and to avoid heme toxicity 
through HssRS-regulated expression of HrtAB (Figure 24 and Figure 25), we wondered 
whether B. anthracis lacking the ability to respond to heme toxicity would display 
attenuation of virulence.  To test this, we infected mice with spores of B. anthracis wild 
type or ∆hrtA and tracked the survival of mice over time (32, 66, 96, 175).  We found a 
slight but not statistically significant increase in survival of mice infected with B. anthracis 
∆hrtA compared to wild type using this infection model (Figure 32).   
Although the Hss/Hrt system does not appear to be required for full virulence in 
our murine model of infection, we wondered whether HssRS nonetheless senses heme 
to activate HrtAB expression during systemic anthrax infection.  To this end, we 
constructed a luminescence-based hrtAB promoter reporter by fusing the S. aureus 
hrtAB promoter to the luxABCDE operon in the plasmid pXen-1 (58).  We utilized the S. 
aureus hrtAB promoter instead of the B. anthracis hrtAB promoter because the latter 
displays significant activity in the absence of heme (Figure 25C).  When B. anthracis is 
transformed with this construct, bacilli undergo luminescence in response to heme 
(Figure 33A). 
 We next infected mice subcutaneously with spores prepared from B. anthracis 
harboring either pXen-1 or phrt.Lux and tracked bioluminescence of germinating B. 
anthracis cells over time.  We found that B. anthracis harboring pXen-1 do not undergo 
detectable bioluminescence during infection (Figure 33B, top), but that B. anthracis 
harboring phrt.Lux induces detectable levels of bioluminescence 24-36 hours post 
infection (Figure 33B, bottom).  Although the amount of heme encountered by B. 
anthracis does not appear to be high enough to result in a significant virulence defect in 
strains inactivated for hrtAB (Figure 32), these data suggest that during infection, B. 
anthracis HssRS senses heme to control expression of HrtAB.   
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Figure 32. Effect of hrtA mutation on B. anthracis pathogenesis.  A high dose 
(2000) or low dose (200) of spores from B. anthracis wild type or ∆hrtA was used to 
infect groups of 10 A/J mice using a sub-dermal inoculum.  Survival was tracked 
following inoculation with spores.  Shown is the compiled result from two independent 
experiments (20 mice per group).  No statistically significant differences were observed 
at any time point between wild type and ∆hrtA using Fisher’s exact test. 
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Figure 33. HrtAB expression during anthrax infection.  A. Heme-dependent 
luminescence of B. anthracis harboring phrt.Lux.  B. anthracis harboring promoterless 
pXen-1 or pXen-1 with the Lux genes under the control of the hrtAB promoter (phrt.Lux) 
were grown on BHI agar containing no heme, BHI + 1 µM heme, or BHI + 10 µM heme.  
Plates were visualized by IVIS.  B. Activation of the hrtAB promoter during anthrax 
infection.  Spores of B. anthracis harboring pXen-1 or phrt.Lux were used to infect 
groups of five A/J mice via a sub-dermal injection in the left inguinal region.  
Luminescence of B. anthracis was tracked every 12 hours post infection (p.i.) by IVIS.  
Shown is one mouse representative of each group. 
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Discussion 
 Bacillus anthracis is a pathogen that is capable of invading host tissues to cause 
disease.  During infection, B. anthracis is capable of acquiring host heme to satisfy 
nutrient iron needs (62, 106, 107, 134).  It appears that for B. anthracis, amassing of 
exogenous heme as a nutrient must be balanced with the need to overcome the toxicity 
of the heme molecule. 
 We have demonstrated a high level of orthology between the S. aureus and B. 
anthracis Hss/Hrt systems.  S. aureus and B. anthracis mutants lacking members of 
these operons display a similar heme-sensitive phenotype (Figures 5, 13, 24).  Also, B. 
anthracis hssRS and hrtAB are able to complement S. aureus mutants lacking these 
genes, indicating orthologous function of both systems (Figure 25, 26, 27).  Furthermore, 
our data demonstrate functional overlap between the S. aureus and B. anthracis heme 
sensor systems at the levels of signal sensing, signal transduction, autophosphorylation 
by HssS, phosphotransfer to HssR, interaction between HssR and the hrtAB promoter, 
and activation of the hrtAB promoter by HssR (Figure 26, 27, 30).  These similarities 
point to the overall evolutionary conservation of Hss/Hrt function between S. aureus and 
B. anthracis, a further indication that these systems are important for the fitness of both 
bacteria at some point throughout their life cycles. 
Nonetheless, we have observed significant functional differences between 
HssRS/HrtAB from S. aureus and B. anthracis.  First, the B. anthracis hrtAB promoter 
displays significant activity in the absence of heme (Figure 25).  This activity is 
dependent on HssRS and the DR to which HssR binds, suggesting that B. anthracis 
HssRS engages in constitutive signaling that induces low-level activation of the hrtAB 
promoter.  The fact that this occurs only in B. anthracis and that most DR mutations are 
tolerated to a similar extent by both species points to sequences outside of the DR that 
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may be important for HrtAB expression.  It is possible that other unidentified factors 
expressed only by B. anthracis (such as the putative transcriptional regulator located 
between hssRS and hrtAB, Figure 1A) may interact with the hrtAB promoter outside of 
the DR, functioning with HssR to increase expression of HrtAB.  Alternatively, another B. 
anthracis-specific two-component systems may utilize the hrtAB promoter DR, 
overlapping with HssRS to induce expression of HrtAB.  This latter possibility is 
becoming increasingly likely given the bioinformatics-based discovery of an HssRS-like 
TCS widespread amongst the cereus-group Bacilli (43).  Annotated in the B. anthracis 
Sterne genome as BAS1816/17, this TCS is also predicted to bind the HssR consensus 
site (GTTCATATT(N2)GTTCATATT) and auto-regulate its own expression and that of a 
co-transcribed ABC transporter (BAS1814/15) through an HssR consensus sequence-
like motif upstream of BAS1814 (43).  It is intriguing to speculate that BAS1816/17 may 
overlap with HssRS to activate HrtAB expression, a possibility supported by small but 
significant HssRS-independent, DR-dependent hrtAB promoter activity observed in B. 
anthracis (Figure 25D).  Future studies will be aimed at assessing the role (if any) of 
BAS1816/17 in hrtAB promoter regulation, as well as the potential of BAS1814-17 
promoter regulation by HssRS. 
Another key functional difference between the S. aureus and B. anthracis heme 
sensor systems occurs at the levels of HssS autophosphorylation and phosphotransfer 
to HssR (Figure 30).  The signaling domain of B. anthracis HssS displays a significantly 
elevated rate of autophosphorylation in vitro compared to the corresponding S. aureus 
HssS domain, and B. anthracis HssS-HssR phosphotransfer occurs more rapidly than S. 
aureus HssS-HssR phosphotransfer.  These activities are likely to allow the rapid 
induction of HrtAB expression in B. anthracis, alleviating heme toxicity.  Accordingly, S. 
aureus expressing B. anthracis HssRS is significantly more resistant to heme toxicity 
than wild type S. aureus.  These results suggest that a certain degree of functional 
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divergence has occurred throughout the course of evolution between S. aureus and B. 
anthracis HssRS. 
In the absence of the ability to respond to growth in the presence of heme, B. 
anthracis is hypersensitive to heme toxicity (Figure 31).  It is possible that B. anthracis 
may amass heme more rapidly than S. aureus or that B. anthracis may be more 
sensitive to heme-induced perturbation than S. aureus.  It should be noted that the Isd 
heme iron acquisition system is not expressed in the conditions used in these 
experiments (data not shown), indicating that heme toxicity can occur independent of 
Isd-mediated heme uptake.  Regardless of the reason for increased heme susceptibility 
in the absence of a functional heme detoxification response, the heme resistance of wild 
type B. anthracis is similar to that of wild type S. aureus.  This is an indication that in B. 
anthracis, HssRS and/or HrtAB function more efficiently than the corresponding systems 
in S. aureus.  Throughout the course of evolution, B. anthracis may have accumulated 
amino acid substitutions in HssRS that lead to constitutive activity of this TCS, increased 
autophosphorylation of HssS, and rapid HssS-HssR phosphotransfer.  It is possible that 
these activities compensate for the heme sensitivity of B. anthracis and that such 
compensatory mutations may have been necessitated by the association between B. 
anthracis and host tissues rich in heme. 
As the first component in the HssRS/HrtAB-mediated process of heme 
detoxification, the histidine kinase HssS controls heme resistance by detecting 
exogenous heme and transducing signals through the membrane.  However, the 
mechanism of heme sensing by this histidine kinase remains elusive.  Here, we present 
data showing that mutation of any of a number of conserved residues in the predicted 
HssS sensing domain eliminates the ability of B. anthracis to respond to heme.  These 
residues cluster within two conserved patches, a possible indication that these regions of 
the protein interface with the HssS ligand.  Although these studies do not identify the 
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signal directly recognized by HssS, they do highlight the importance of the previously 
uncharacterized sensing domain in heme detection.  The fact that this sensing domain is 
flanked by transmembrane helices and is predicted to reside in the extracytoplasmic 
space indicates that HssS detects a signal located either between the membrane and 
the cell wall, or within the membrane itself.  We hypothesize that the HssS ligand may be 
heme or a molecule that is either modified or induced by heme exposure, and that this 
molecule is recognized by conserved HssS sensing domain residues shown here to be 
required for HssS activity. 
 B. anthracis activates the hrtAB promoter during infection of vertebrates (Figure 
33).  However, HrtAB does not appear to be required for full virulence of B. anthracis in a 
mouse model of infection (Figure 32).  It is possible that during the type of infection 
replicated with our animal model, enough heme is acquired by B. anthracis to activate 
HssRS, but not enough is imported into bacterial cells to necessitate HrtAB function.  
This is consistent with the observations that the hrtAB promoter is significantly activated 
in response to 1 µM heme, (Figure 25) but that ∆hrtA is not significantly inhibited by this 
heme concentration (data not shown).  It is also possible that the A/J mouse model of 
anthrax infection using a non-encapsulated B. anthracis strain does not provide the 
sensitivity needed to dissect subtle virulence defects (47, 177).  In general, mouse 
models of B. anthracis infection appear to be limited in sensitivity, as is evidenced by the 
apparent lack of a pathogenic defect for strains containing deletions of virulence factors 
including anthrax toxin in mouse models of infection (73).  Further studies utilizing a fully 
virulent strain of B. anthracis lacking hssRS/hrtAB in a more susceptible host will be 
needed to conclusively test the role of these genes in anthrax pathogenesis.  It is also 
possible that during a different type of anthrax infection in which bacilli are immersed in 
high levels of host heme sources (e.g. B. anthracis bacteremia associated with 
inhalational anthrax), HrtAB function may be necessary for full bacterial virulence.  
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Future studies will be directed at addressing the question of whether HrtAB/HssRS are 
involved in anthrax pathogenesis using a variety of strains and infection models. 
A number of pathogenic and saprotrophic relatives of S. aureus and B. anthracis 
including B. cereus and Listeria monocytogenes are predicted to express HssRS/HrtAB 
(157, 169).  It is therefore likely that heme sensing and detoxification are processes 
engaged in by a number of related Gram-positive organisms.  This is supported by the 
observation made by Van Heyningen of differential heme resistance among 
phylogenetically related Bacilli (76).  Van Heyningen’s method may have differentiated 
organisms that express functional Hss/Hrt systems from those that do not based solely 
upon the heme resistance of the organism.  Importantly, the fact that HssRS/HrtAB 
orthologues are only found in those Bacilli that exhibit pathogenic or saprotrophic 
lifestyles indicates that these systems are not required for the fitness of bacteria that do 
not encounter exogenous heme throughout their life cycles. 
It has been suggested that heme sensing and detoxification evolved in dense 
microbial communities rich in heme-synthesizing bacteria (116, 127).  This may explain 
the recent discovery of a heme-regulated HrtAB orthologue required for heme resistance 
in the lactic acid bacterium Lactococcus lactis (127).  Although L. lactis is not a 
pathogen, it may encounter environmental heme synthesized by nearby bacteria (163), 
necessitating HrtAB function (127).  Notably, L. lactis does not possess hssRS genes 
and may regulate expression of hrtAB through a mechanism other than TCS-based 
signal sensing (127).  This indicates evolutionary conservation of HrtAB function but 
divergence of HrtAB regulation between the Lactobacillales (which include the 
Streptococci as well as L. lactis) and the Bacillales (including S. aureus and B. 
anthracis). 
Throughout the course of evolution, the pathogenic or saprotrophic Firmicutes 
may have acquired heme detoxification systems from bacteria such as L. lactis, thereby 
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being provided with a means to facilitate survival within host tissues rich in heme.  Within 
the Firmicutes, selective pressure to maintain a heme sensor system and a heme 
detoxification system may only be exerted on bacteria that commonly associate with 
exogenous heme.  The evolutionary origin of the bacterial heme detoxification response 
will become clearer as the mechanism of heme sensing and detoxification are elucidated 
and as more organisms are identified that are capable of sensing and responding to 
heme toxicity. 
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CHAPTER VI 
 
A SMALL MOLECULE SCREEN FOR ACTIVATORS OF THE HssRS TWO-
COMPONENT SYSTEM 
 
 
Introduction 
 Upon exposure of Gram-positive bacteria to heme, the TCS HssRS is activated, 
leading to expression of HrtAB and the alleviation of heme toxicity.  Although progress 
has been made toward developing an understanding of the signaling events connecting 
HssRS activation to HrtAB expression in both S. aureus and B. anthracis, little is known 
about the mechanism by which the histidine kinase HssS senses heme.  Understanding 
the signal that is directly sensed by HssS will be a critical step in discerning the 
mechanism of heme sensing and detoxification by Hss/Hrt.  Furthermore, such a 
mechanism will represent a significant advance in understanding of histidine kinase 
activation in general, as the molecules that directly activate histidine kinases are only 
known in a limited number of cases. 
 Here, we unlink the metalloporphyrin structure from HssRS activation by 
demonstrating that closely related non-heme metalloporphyrins display differential 
capacity to activate HssS depending on whether these compounds are toxic to S. 
aureus.  We also present preliminary results of a small molecule library screen designed 
to identify molecules other than heme that activate HssRS, with the intention of 
collecting a set of similar structures that may point toward the identity of the HssS ligand.  
One non-metalloporphyrin compound identified in this screen activates S. aureus HssRS 
and displays a similar dependence on conserved sensing domain residues of HssS to 
that observed with heme.  These results begin to clarify the mechanism of HssS 
activation, and point toward an indirect mechanism for heme sensing in Gram-positive 
bacteria. 
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Methods 
Metalloporphyrins and XylE assays – Heme (Fluka) and metalloporphyrins (Frontier) 
were dissolved to 10 mM in 0.1 M NaOH.  Serial dilutions were performed in 0.1 M 
NaOH, and metalloporphyrins were diluted into TSB.  Overnight cultures of S. aureus 
harboring phrtAB.xylE were subcultured into 1.5 ml snap-cap tubes containing 
metalloporphyrins, bacteria were grown at 37 °C with shaking for 4 hours, and XylE 
activity was determined as described previously (see Chapter IV Methods). 
Luminescence-based reporter assays – The S. aureus hrtAB promoter or sortase A 
(srtA) promoter were inserted between the 5’ EcoRI site and 3’ BamHI sites of  pXen-1 
(Xenogen) (58) as described previously (See Chapter V methods).   
Small molecule screen – Columns 1-22 of clear-bottom 384-well plates were loaded with 
5 nmol of compound from the Vanderbilt University small molecule library.  Column 24 
was loaded with a standard dilution series of heme, and column 23 was left empty to 
prevent crossover luminescence in adjacent wells.  Seventy-five µl of TSB + 10 µg/ml 
chloramphenicol containing exponentially growing (OD600 = 0.2) S. aureus harboring 
phrtAB.Lux were added to each well.  Cultures were grown for an additional 4 hours, 
after which luminescence readings were determined.  Compounds corresponding to 
wells showing luminescence greater than that observed in the presence of 1 µM heme 
were purchased and analyzed by XylE assay as previously described (Chapter IV 
methods). 
Construction of S. aureus HssS point mutant expression/reporter constructs – A dual 
reporter/complementation construct was created as follows.  S. aureus hssS-myc was 
PCR amplified as described previously (See Chapter IV methods, Complementation 
Constructs) and inserted between the NdeI and BamHI sites of plasmid pOS1plgt, 
making pOS1plgt.hssS-myc.  Next, the hrtAB promoter-xylE fusion described previously 
(see Chapter IV methods) was amplified from phrtAB.xylE using a 5’ primer containing 
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an EcoRI site and annealing to the hrtAB promoter, and a 3’ primer also containing an 
EcoRI site and annealing to the 3’ end of xylE.  Amplified DNA was inserted into the 
EcoRI site upstream of the lgt promoter in pOS1plgt.hssS-myc, creating phrt.xylE/hssS-
myc.  Orientation of the hrtAB promoter-xylE fusion was confirmed by PCR and errors 
were ruled out by sequencing.  As a template for the construction of hssS-myc point 
mutants, S. aureus hssS-myc was also inserted into pCR2.1 (Invitrogen).  Residues 
were mutated by Pfu mutagenesis (176) and mutations were confirmed by sequencing.  
Mutant hssS-myc DNAs were inserted into phrt.xylE/hssS-myc in place of wild type 
hssS-myc.  
Immunoblotting – Immunoblotting against HssS-Myc was performed as described 
previously (See Chapter V methods). 
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Results 
Toxic metalloporphyrins activate HssRS.  It is possible that HssS senses heme by 
directly binding to it; alternatively, it is possible that HssS senses a toxic by-product of 
heme that accumulates within staphylococci.  To determine which mode of activation is 
most likely, we attempted to separate heme toxicity from HssS activation.  We acquired 
a series of non-heme metalloporphyrins, which contain first and second-series transition 
metals encircled by the porphyrin ring.  Importantly, S. aureus displays differential 
sensitivity to these metalloporphyrins: while manganese (MnPPIX), iron (FePPIX, heme), 
zinc (ZnPPIX), and gallium (GaPPIX) protoporphyrin IX exert a bactericidal activity 
against S. aureus at low-micromolar concentrations, chromium (CrPPIX), cobalt 
(CoPPIX), nickel (NiPPIX), copper (CuPPIX), and tin (SnPPIX) protoporphyrin IX do not 
inhibit the growth of staphylococci (162)).  Remarkably, every toxic metalloporphyrin 
tested activates HssS, while none of the non-toxic metalloporphyrins induce more than 
1% activity in HssS (Figure 34).  These data disconnect the metalloporphyrin structure 
from HssRS activation, and instead connect metalloporphyrin toxicity to the activation of 
this TCS.  Based on the fact that heme-binding proteins are capable of binding even 
non-activating, non-toxic metalloporphyrins (27, 69, 99), these results suggest that HssS 
senses heme through an indirect mechanism.  Importantly, only toxic metalloporphyrins 
and not stress-inducing antibiotics, oxidizing reagents, detergents, or adverse growth or 
environmental conditions activate HssRS (data not shown), suggesting that HssRS 
specifically responds to a cellular stress imposed by toxic metalloporphyrins.   
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Figure 34. Toxic metalloporphyrins activate S. aureus HssRS.  S. aureus harboring 
phrtAB.xylE were grown in TSB supplemented with the indicated concentration of 
metalloporphyrin (FePPIX: heme) in triplicate.  Reporter activity was measured.  
Asterisks denote metalloporphyrins that are toxic to S. aureus (Ref. 162). 
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Development of a small molecule screen to identify HssRS-activating compounds.  
If HssS senses heme through binding a molecule other than heme itself, it is possible 
that an HssS ligand-like molecule may be present within compiled libraries of small 
molecules covering a broad molecular space.  We therefore developed a strategy for 
screening such libraries for the purpose of identifying HssS-activating compounds.  First, 
we developed a luminescence-based hrtAB promoter reporter.  The hrtAB promoter 
appears to be the main if not only target of activated HssR in S. aureus (Chapter IV).  
Furthermore, no literature has been published demonstrating hrtAB promoter activation 
by any compound, condition, or cellular stress other than heme exposure.  We therefore 
reasoned that hrtAB promoter activity is a reasonable surrogate for directly analyzing 
HssRS activation.  Accordingly, we fused the S. aureus hrtAB promoter to the luxABCDE 
operon of P. luminescens (the same construct used to image hrtAB promoter activation 
during anthrax infection, Figure 33) and transformed S. aureus with this plasmid.  We 
found that wild type S. aureus harboring phrtAB.Lux undergoes HssRS-dependent 
luminescence on plates and in liquid culture following heme exposure (Figure 35).  
Importantly, LuxABCDE is responsible not only for the oxidation of the luciferase 
substrate coupled to the emission of electromagnetic radiation, but it is also responsible 
for the synthesis of the luciferase substrate using precursors made by S. aureus (58).  
We therefore reasoned that S. aureus harboring phrtAB.Lux would be amenable to a 
simple high-throughput screen for HssRS activators, as compounds would simply need 
to be included in the growth medium of this strain, with the readout being luminescence 
of live staphylococci.   
 Accordingly, we were able to validate the use of this strain in a trial high-
throughput screen.  In this trial, heme was loaded onto 384-well plates in a checkerboard 
pattern, medium with growing S. aureus harboring phrtAB.Lux were added to the plates, 
and luminescence was monitored.  We found that such a screening method is valid, with 
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a large signal gap between heme-containing wells and those lacking heme.  We 
therefore began screening a large library of compounds available at Vanderbilt 
University for HssRS activation.  In this screen, we included a standard heme dilution 
series on each 384-well screening plate, along with 336 different library compounds.  
Potential hits were identified as compounds that activate the hrtAB promoter at levels 
equal to or higher than a specified concentration of heme. 
 Hits were subsequently confirmed in two independent assays.  First, as HssRS-
activating compounds induce expression of HrtAB, and the level of HrtAB at the time of 
heme exposure dictates the resistance of S. aureus to heme toxicity, we tested the 
ability of potential HssRS activators to pre-adapt S. aureus to heme toxicity.  Second, we 
analyzed the ability of compounds to activate the hrtAB promoter in the more sensitive 
XylE-based reporter assay, which is also capable of sensitively assessing the HssRS 
dependence of hrtAB promoter activators. 
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Figure 35. A luminescence-based reporter monitoring HssRS activity in S. aureus.  
A. Luminescence of S. aureus harboring an hrtAB promoter-luxABCDE fusion on agar 
plates.  S. aureus transformed with empty vector (pXen1, upper right), a plasmid 
containing the Lux genes under the control of the constitutively expressed srtA promoter 
(psrtA.Lux; lower right), or a plasmid containing the Lux genes under the control of the 
hrtAB promoter (phrtAB.Lux, left) were streaked on TSA without heme (right plate) or 
TSA + 5 µM heme (left plate).  Plates were grown at 37 °C and were scanned by IVIS.  
B.  Luminescence of S. aureus harboring an hrtAB promoter-luxABCDE fusion in liquid 
culture.  The strains described in A, as well as ∆hssR harboring phrtAB.Lux, were grown 
for 3 hours in TSB lacking heme (-) or containing 2 µM heme (+) and tubes were 
scanned by IVIS. 
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C3 activates the hrtAB promoter in an HssRS-dependent manner.  One potential 
HssRS-activating small molecule identified in this high-throughput screen was 
designated compound 3, or C3.  C3 is capable of pre-adapting S. aureus to heme 
toxicity (data not shown); importantly, C3 also activates the hrtAB promoter in a dose-
dependent manner using a XylE-based assay (Figure 36A).  Although an approximately 
10-fold higher dose of C3 is required to activate the hrtAB promoter to a similar extent as 
heme, C3 is still capable of inducing robust XylE activity driven by the hrtAB promoter at 
mid-micromolar concentrations (Figure 36A).   Importantly, C3 bears no structural 
resemblance to a metalloporphyrin (Figure 36B). 
 In a first attempt to connect C3 to HssS activation, we next tested whether 
activation of the hrtAB promoter by C3 depends on HssRS.  We found that mutation of 
hssRS eliminates the ability of C3 to activate the hrtAB promoter at any dose tested, a 
further indication that treatment of staphylococci with C3 activates the histidine kinase 
HssS, leading to hrtAB promoter induction (Figure 37).  Importantly, C3 is not toxic to S. 
aureus wild type or strains lacking Hss/Hrt (data not shown), a possible indication that in 
the case of C3, HssS is not merely sensing a by-product of growth in the presence of a 
toxic compound.  Also, these data demonstrate that C3 fills our criteria for an HssRS-
activating compound, further validating the phrtAB.Lux-harboring S. aureus strain as a 
useful reagent for the detection of HssRS-activating compounds. 
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Figure 36. C3 induces hrtAB promoter activation in S. aureus.  A. Dose-dependent 
hrtAB promoter activation by heme and C3.  S. aureus wild type transformed with 
phrtAB.xylE was grown in the indicated concentrations of heme (black line) or C3 (grey 
line) and reporter activity was measured.  B. Structure of C3. 
 142
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 37. Activation of the hrtAB promoter by C3 requires HssRS.  S. aureus wild 
type (wt) transformed with either phrtAB.xylE (white bars), promoterless pxylE (grey 
bars), or ∆hssRS with phrtAB.xylE (black bars) were grown in triplicate in TSB alone (-) 
or TSB supplemented with the indicated concentration of heme or C3.  Reporter activity 
was measured following 5 hours of growth.  Error bars correspond to one standard 
deviation from the mean.  Asterisk denotes that ∆hssRS succumbed to heme toxicity in 
this experiment.  Experiment performed by OA. 
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S. aureus HssS-Myc point mutants display signaling defects in vivo.  Although 
induction of the hrtAB promoter by C3 requires HssRS, it is possible that heme and C3 
activate HssS by different mechanisms.  In an attempt to connect the mode of HssS 
activation by C3 to the mode of HssS activation by heme, we returned to an HssS 
mutagenesis strategy.  We reasoned that if mutagenesis of sensing domain residues 
shown to be critical for the activity of B. anthracis HssS is tolerated to a similar extent by 
heme and C3, the most likely explanation would be that both compounds activate HssS 
through a similar mechanism.  However, such a strategy requires a reporter-based 
readout as opposed to a phenotypic readout.  This is because subtle changes in HssS 
signaling need to be detectable, and because C3 is not toxic to S. aureus. 
 To assess HssS point mutant function using a reporter-based readout, we 
generated a dual hrtAB promoter reporter/complementation plasmid.  This plasmid 
encodes the hrtAB promoter-xylE fusion joined to a divergently transcribed lgt promoter-
hssS-myc fusion.  Such a plasmid should complement S. aureus ∆hssS, allow for 
quantification of HssS-Myc abundance by anti-c-Myc immunoblotting, and be useful for 
XylE reporter assay-based detection of hrtAB promoter induction.  Furthermore, mutant 
hssS-myc cassettes should be easily introduced into such a system. 
 Next, we generated an array of S. aureus HssS-Myc point mutants in the 
predicted sensing domain (Figure 38: residue locations can be determined by 
comparison to alignment presented in Figure 29, noting that S. aureus HssS encodes an 
additional N-terminal residue; for example, B. anthracis HssS K42 aligns with S. aureus 
HssS K43).  Of the HssS point mutants that expressed (Figure 38A), most retained 
some function in vivo in terms of their ability to rescue the heme-sensitive phenotype of 
∆hssS (Figure 38B).  With the exception of HssS:K43A (which is required in  B. 
anthracis but not S. aureus), residues dispensable for heme protection in B. anthracis 
are also dispensable for heme protection in S. aureus (Figure 29 & 38).  Importantly, 
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three mutants (T125A, F128A, and R163A) fail to complement S. aureus ∆hssS; these 
residues are also required for the function of B. anthracis HssS (Figure 29 & 38). 
 Next, we analyzed HssS point mutant function using the more sensitive hrtAB 
promoter reporter-based assay (Figure 40).  This assay revealed subtle defects in a 
number of HssS point mutants that were not observable using phenotypic 
complementation studies alone.  For example, although HssS:R159A provides 
significant complementation to S. aureus ∆hssS, both single-dose (Figure 40A) and 
dose-responsive (Figure 40B) XylE assays reveal a significant signaling defect in this 
mutant.  In fact, only those point mutants with a profound signaling defect fail to at least 
partially complement ∆hssS (Figure 40).  Using reporter data, we were able to group 
point mutants into those that display no obvious signaling defect (K43A, S146A), those 
with a mild signaling defect (R94, F127, N130, R152, F159, F165), and those with a 
significant signaling defect (T125, F128, R163).  Importantly, all HssS point mutants 
reduce the high basal hrtAB promoter activity of ∆hssS (Figure 40A), which presumably 
results from the lack of a negative regulatory activity exerted by HssS on HssR, such as 
trans-phosphatase activity observed for other histidine kinases (109).  This is an indirect 
indication that these signaling-deficient point mutants are not merely misfolded, 
mislocalized, or generally dysfunctional. 
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Figure 38. Expression and complementation by S. aureus HssS point mutants. A. 
Expression of S. aureus HssS-Myc point mutants.  S. aureus ∆hssS was transformed 
with dual complementation/reporter constructs encoding either no hssS-myc (-), wild 
type S. aureus hssS-myc (wt), or hssS-myc mutated at the indicated residue.  Triplicate 
cultures of each strain were prepared and protoplast lysates were subjected to SDS-
PAGE, anti-c-Myc immunoblotting, and LiCor-based quantification of bands 
corresponding to HssSmyc.  Band intensities were averaged and are expressed as the 
percent of band intensity corresponding to wild type HssS-Myc.  Point mutants with 
significantly reduced expression compared to wild type are denoted with asterisks; these 
point mutant-expressing strains were omitted from subsequent analyses.  B.  
Complementation of S. aureus ∆hssS by HssS-Myc point mutants.  The strains 
described above were grown overnight and subcultured in triplicate into medium 
containing 10 µM heme.  Twenty-four hours following subculture, culture densities were 
determined and averaged.  Bars represent standard deviations. 
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Figure 39. Regulation of hrtAB promoter induction by S. aureus HssS point 
mutants. A. Single-dose hrtAB promoter induction by HssS point mutants.  S. aureus 
∆hssS harboring dual complementation/hrtAB promoter reporter constructs encoding 
either wild type hssS-myc (wt) or hssS-myc mutated at the indicated residue, ∆hssS 
harboring phrtAB.xylE (no HssS), and ∆hssS harboring pOS1 (no xylE) were grown in 
triplicate in TSB (no heme, white bars) or TSB + 4 µM heme (grey bars).  Reporter 
activity was measured.  B. Dose-dependent hrtAB promoter induction by HssS point 
mutants.  The strains described in A were grown in the indicated concentration of heme 
(n = 1 per heme concentration) and reporter activity was measured.  Mutants were 
classified according to data shown in A.  Low: mutations with no detectable effect on 
heme-induced hrtAB promoter activity; medium: mutants that retain the ability to induce 
greater than 1 unit of XylE activity in response to heme; high: mutants that drive less 
than 1 unit of XylE activity in response to heme.   
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Alanine substitution point mutants connect the C3 mode of HssS activation to that 
of heme.  Next, we compared C3- and heme-dependent hrtAB promoter activation 
controlled by wild type HssS and three HssS point mutants that display signaling 
perturbation to differing extents (R94A, T125A, F165A).  We observed a similar trend in 
terns of the effect of residue mutagenesis on HssS activation by both compounds: for 
both C3 and heme, a slight decrease in compound responsiveness is observed for 
HssS:F165A, a greater decrease is observed for HssS:R94A, and a profound decrease 
is observed for HssS:T125A.  The fact that heme and C3 depend on the same residues 
for HssS activation to a similar extent is a possible indication that HssS activation by 
both compounds occurs through a similar mechanism. 
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Figure 40. Heme and C3 require the same sensing domain residues for HssS 
activation. A. Heme dose-dependent hrtAB promoter activation by HssS point mutants. 
S. aureus ∆hssS harboring dual complementation/hrtAB promoter reporter constructs 
encoding either wild type hssS-myc (phrt.xylE/hssS-myc) or hssS-myc mutated at the 
indicated residue, ∆hssS harboring phrtAB.xylE, and ∆hssS harboring pOS1 with 
promoterless xylE (pxylE) were grown in TSB with the indicated heme concentration and 
reporter activity was measured.  B. C3 dose-dependent hrtAB promoter activation by 
HssS point mutants.  Strains were grown in TSB with the indicated concentration of C3 
and reporter activity was measured.  
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Discussion 
 Here, we unlink metalloporphyrin structure from HssS activation.  We show that 
only toxic metalloporphyrins activate HssS, while closely related non-toxic 
metalloporphyrins do not activate this histidine kinase.  We also present initial results 
from a small molecule screen for activators of HssS.  We demonstrate that one small 
molecule activates the hrtAB promoter in a manner that requires HssRS.  Furthermore, 
we show a similar sensitivity to HssS sensing domain perturbations between this 
compound and heme.  These results begin to clarify the mechanism of heme sensing by 
HssS. 
 Although the simplest mechanism for HssS activation would appear to be a direct 
interaction between heme and the sensing domain of HssS, a number of theoretical and 
experimental lines of evidence suggest this may not be the case.  First, the sensing 
domain of HssS bears no resemblance to a heme-binding protein, both in terms of 
predicted domain structure and a lack of conserved canonical heme-coordinating 
residues.  Second, if coordination of heme by HssS led to activation of this histidine 
kinase, it would be likely that all metalloporphyrins regardless of toxicity would activate 
HssS.  Third, we have identified a non-metalloporphyrin HssS activator, further 
separating metalloporphyrin structure from HssS activation.   Last, it is unclear that the 
mere presence of heme would necessitate a heme detoxification response.  
Susceptibility to heme toxicity is influenced by the composition of the medium bacteria 
are grown in as well as the overall iron abundance and degree of aerobic respiration 
exhibited by the bacterium (data not shown).  If heme binding controlled the heme 
detoxification response, a similar response would be initiated regardless of the 
susceptibility to heme toxicity.  On the other hand, if HssS were to detect heme toxicity 
rather than heme itself, then the extent of the heme detoxification response would be in 
tune with the need for cells to alleviate heme toxicity. 
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 It is likely that the identity of the HrtAB transport substrate is closely related to the 
signal recognized by HssS, as is the case for other linked ABC transporter/TCS operons 
(137).  Originally, it was thought that heme itself is recognized by HssS, and that HrtAB 
removes heme from the staphylococcal cytoplasm.  Given the results presented herein, 
a more complex scheme would appear likely.  We favor the hypothesis that heme 
perturbs a fundamental cellular process of Gram-positive bacteria, leading to the 
accumulation of toxic metabolites that need to be exported to alleviate heme toxicity.  It 
is possible that HssS senses this class of metabolites, whether in the extracytoplasmic 
space or in the membrane, leading to HrtAB expression and the export of these 
metabolites leading to protection against heme toxicity.   
 It is unclear at this point how C3, the HssS-activating compound identified 
through screening a small library, leads to HssS activation.  It is possible that C3 directly 
activates HssS.  This would be consistent with the observed dependence on conserved 
sensing domain residues as well as the fact that C3 is not toxic to S. aureus.  In this 
scenario, C3 may not activate HssS as well as the heme-induced endogenous ligand, 
explaining higher doses of C3 needed to activate HssS and the fact that the plateau of 
C3 activation is much lower than that of heme.  However, it is also possible that C3 is 
another indirect activator of HssS, inducing the production of HssS-activating 
endogenous ligands.  In this scenario, C3 may not be as efficient as heme at inducing 
the formation of such ligands, explaining its lack of toxicity and the lower hrtAB promoter 
activation plateau.  Discerning which mechanism is most likely must await the 
development of an in vitro assay for directly analyzing activation of HssS (see Future 
Directions).  Also, it is possible that identification of the HrtAB transport substrate will 
give important clues concerning the identity of the HssS ligand.  An understanding of the 
mechanism for heme sensing by HssS and heme detoxification by HrtAB will 
significantly enhance understanding of the function of Hss/Hrt in alleviating heme 
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toxicity.  Such a mechanism would also represent a significant advance in the 
understanding of bacterial TCS and ABC transporters in general. 
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CHAPTER VII 
 
SUMMARY 
 
Conclusions 
 The acquisition of nutrient iron from the host during infection is a fundamental 
process engaged in by almost all bacterial pathogens (30).  Iron acquisition in bacteria is 
necessitated due to a dependence on critical biological processes carried out by proteins 
with iron or iron-containing co-factors (40).  It appears that mammalian tissues take 
advantage of this stringent iron requirement exhibited by bacteria to prevent the 
proliferation of broad classes of prokaryotic pathogens.   Nutritional immunity as it 
applies to physiologic iron concentration is an effective strategy to prevent infection, a 
fact highlighted by increased susceptibility to infection observed in patients with diseases 
leading to elevated iron levels within tissues (16). 
 In the important human pathogen Staphylococcus aureus, dependence on iron 
acquisition is highlighted by virulence defects observed for strains unable to efficiently 
amass iron or metabolize iron properly (133, 150, 168, 183).  Although much attention 
has been given to iron acquisition in S. aureus, the global response of staphylococci to 
genetic or biochemical perturbation of iron acquisition or iron metabolism has not been 
elucidated.  Accordingly, we have identified a subset of the S. aureus proteome altered 
in response to depletion of iron or disruption of the staphylococcal regulator of iron 
acquisition and metabolism, Fur (Chapter II).  These studies have revealed a Fur-
mediated shift to fermentative metabolism upon iron starvation.  The commensurate 
decrease in pH of the local environment surrounding S. aureus cells resulting from the 
secretion of acidic end products of fermentative metabolism may lead to increased iron 
availability through release from host iron-sequestering proteins.  The results presented 
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herein combine with those from other laboratories to highlight the remarkable metabolic 
elasticity of S. aureus, a flexibility essential for overcoming deeply conserved 
mechanisms of innate immunity that target fundamental biological processes of 
prokaryotes (135, 136, 152).  It is likely that unique aspects of S. aureus metabolism 
combine with the well-studied arsenal of staphylococcal virulence factors as well the 
ability of this organism to acquire new virulence and resistance determinants to 
overwhelm mechanisms of innate immunity, adaptive immunity, and therapeutic 
intervention (34, 136).  These are all probable contributing factors to the remarkable 
success of S. aureus as a pathogen.   
 During infection, S. aureus employs an additional and important mechanism to 
overcome nutritional immunity.  Invasive staphylococci are able to circumvent the 
paucity of free iron within host tissues by tapping into the most abundant source of iron 
within the mammalian body, namely heme in the context of hemoglobin (134, 151).  To 
utilize heme as an iron source, staphylococci must lyse red blood cells, bind hemoglobin, 
remove heme, import heme into the cytoplasm, and degrade the heme molecule to 
release iron for incorporation into bacterial iron-containing proteins.  These processes 
are carried out by the staphylococcal Fur- and iron-regulated surface determinants, the 
Isd system (134, 151).  The importance of Isd-mediated heme acquisition is highlighted 
by virulence defects observed for strains inactivated for Isd genes (133, 150, 168).   
Although heme is a valuable source of iron for invasive staphylococci, heme is a 
toxic molecule capable of generating reactive oxygen species and killing bacterial cells 
(53, 134, 161, 162, 169).  Many examples of heme acquisition systems have been well-
characterized in both Gram-negative and Gram-positive bacteria; however, 
comparatively little attention has been devoted to mechanisms whereby bacteria that 
acquire heme avoid or relieve heme toxicity.  Here, we demonstrate that S. aureus 
relieves heme toxicity by sensing heme and expressing a heme detoxification system, 
 154
the heme-regulated transporter HrtAB (Chapter III).  The importance of HrtAB 
expression to the avoidance of heme toxicity is highlighted by the heightened heme 
sensitivity of strains inactivated for this transport system.  Furthermore, S. aureus lacking 
hrtA display perturbed virulence in a murine model of abscess formation leading to the 
formation of hepatic abscesses and increased liver colonization.  These virulence 
properties are likely due to the heme-induced secretion of virulence factors in this heme-
sensitive strain.  These studies have elucidated the function of a novel transport system 
conserved across Gram-positive bacteria that may be expressed specifically during the 
association of bacterial pathogens with their host.  Importantly, the mechanism of 
increased toxin secretion in strains lacking hrtA may be an avenue for the identification 
of systems required for the regulation of immunomodulatory toxins known to be 
important in the host-pathogen interaction (156, 157).   
 We also demonstrate that HrtAB expression is regulated by a novel TCS 
designated the heme sensor system HssRS (Chapter IV).  HssS is a heme-responsive 
histidine kinase that controls the phosphorylation of the response regulator HssR.  Upon 
phosphorylation, HssR binds to a direct repeat in the hrtAB promoter, inducing 
expression of HrtAB and thereby controlling the heme detoxification response.  These 
studies clarify the function of one of the previously uncharacterized staphylococcal two-
component systems; furthermore, HssRS represents an elusive host molecule-specific 
TCS.  It is possible that heme sensing by HssRS and subsequent heme detoxification by 
HrtAB expression may tailor the interaction between staphylococci and heme, allowing 
the amassing of heme molecules by circumventing accompanying heme toxicity.   
In addition to the insight into novel biological processes of staphylococci provided 
by these studies, there may be important practical outcomes of the discovery of HssRS 
for S. aureus research in general.  To this point, staphylococcal research has suffered 
from the absence of a tightly controlled inducible promoter-containing plasmid for in vivo 
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expression studies.  Because of absolute dependence on HssRS-mediated induction, 
which is critically dependent on exogenous heme in staphylococci, the hrtAB promoter 
appears to be one of the most tightly controlled, highly inducible promoters in S. aureus.  
Therefore, it is quite likely that the hrtAB promoter will form the basis for an inducible 
expression system in S. aureus whereby a DNA of interest (such as an open reading 
frame for expression studies or an antisense RNA for knockdown experiments) is 
inserted in front of the hrtAB promoter for heme-induced expression.  As heme induces 
hrtAB promoter activity in a dose-dependent manner and sub-toxic levels of heme are 
capable of inducing profound promoter activity, such a system may be of broad interest 
to the S. aureus research community. 
Multiple Gram-positive bacteria evolutionarily related to S. aureus including 
Bacillus anthracis and Listeria monocytogenes are capable of Isd-mediated heme 
acquisition (23, 106, 107, 123, 148).  Here, we demonstrate that Isd-mediated heme 
uptake may be coupled to Hss/Hrt-mediated heme detoxification in these other 
pathogens as well (Chapter V).  Genes encoding hssRS and hrtAB are conserved in the 
cereus-group Bacilli and in the pathogenic and saprotrophic Listeriae.  Furthermore, B. 
anthracis, the causative agent of anthrax and a pathogen intimately associated with host 
blood and heme during infection, requires Hss and Hrt for resistance to heme toxicity.  In 
addition, members of the genus Bacilli may require elevated Hss/Hrt function due to the 
heightened heme sensitivity of such species lacking hss or hrt genes.  Finally, we 
present evidence indicating that B. anthracis may experience heme stress leading to 
HssRS activation during association with host tissues.  These studies demonstrate that 
heme sensing by HssRS and heme detoxification by HrtAB are not limited to S. aureus, 
and indeed may be conserved throughout the pathogenic or saprotrophic Firmicutes.  
Importantly, these studies also lay the foundation for investigation into Hss/Hrt function 
in other important bacterial species including S. epidermidis, B. cereus, B. thuringiensis, 
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and L. monocytogenes.  It is likely that a more complete understanding of the 
implications behind evolutionary conservation of Hss/Hrt function across the Firmicutes 
must await the emergence of insight into the activity of these systems in other species, 
as well as a mechanistic understanding for heme detoxification by HrtAB and heme 
sensing by HssRS. 
Finally, we provide initial insight into the mechanism whereby the histidine kinase 
HssS senses heme (Chapter VI).  By unlinking metalloporphyrin structure from HssS 
activation and identifying a non-metalloporphyrin small molecule HssS inducer, we 
present evidence that HssS senses heme through an indirect mechanism.  These results 
provide the foundation for future studies aimed at definitively identifying the HssS ligand, 
a step that will represent a significant advance in the understanding of Hss/Hrt function 
in Gram-positive bacteria and of histidine kinase activation in general. 
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Future Directions 
 
An assay for directly analyzing HssS activation  
 Although reporter-based assays have been the basis for most of the experiments 
described herein and have been of immense value, such assays are limited by the fact 
that they are an indirect measure of HssS activity.  So far, we have not been able to 
conclude whether a given HssS-activating compound merely perturbs the Gram-positive 
bacterial cell in a similar way as heme, leading to HssS activation, or whether the 
compound is similar enough to the HssS ligand to directly activate HssS.  As a means of 
directly assessing HssS activation, we have made significant progress toward the 
development of an in vitro assay for HssS activation.  We have been able to purify 
soluble epitope- and hexahistidine-tagged S. aureus HssS-Myc-his8 from the membrane 
fraction of E. coli overexpressing this histidine kinase.  We are in the process of 
attempting to incorporate this protein into proteoliposomes.  HssS-containing 
proteoliposomes could then be loaded with potential HssS-activating small molecules 
(including heme, C3, and hits from our small molecule library screen), incubated with 
γ32P-ATP, and activation of full-length HssS could be monitored by assessing its 
phosphorylation state.  As these proteoliposomes would lack any cellular machinery that 
likely contributes to the heme-induced accumulation of the HssS-activating ligand, they 
would represent an ideal platform for separating direct HssS activators from indirect 
activators.  Importantly, HssS sensing domain point mutants could be included in this 
assay as a negative control tying any in vitro data to the in vivo data presented here.  
Results from such an assay could significantly enhance our understanding of the mode 
of action of heme and non-metalloporphyrin HssS activators. 
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Identification of endogenous HssS ligands 
 If proteoliposome-based assays for direct HssS activation prove useful, they may 
represent a powerful platform for identification of the signal that activates HssS in S. 
aureus cells.  It may be possible to grow wild type S. aureus in the presence of heme, 
prepare crude fractions from cells, apply these fractions to proteoliposomes, and analyze 
HssS activation.  From here, it may be possible to further purify any HssS-inducing 
activity by HPLC and identify molecules responsible for HssS activation by high-
resolution mass spectrometry.  This has the potential of identify whether endogenous 
ligands increased in abundance or modified by heme are responsible for HssS 
activation.  The comparison of an HssS activator identified through this scheme with 
HssS activators identified through screening of small molecule libraries may clarify the 
mechanism by which HssS is activated in staphylococci. 
 
Identification of alternative hrtAB promoter-activating systems in B. anthracis 
 
 It is possible that in B. anthracis, hrtAB promoter expression is controlled by 
other gene regulatory systems in addition to HssRS (see Chapter V Discussion).  
Furthermore, newly identified small molecule activators of HssRS in S. aureus are able 
to induce significant hrtAB promoter activation in B. anthracis that occurs independent of 
HssRS (data not shown).  Remarkably, this HssRS-independent induction requires an 
intact HssR binding site within the hrtAB promoter, suggesting that B. anthracis 
expresses an additional HssRS-like TCS that can control expression of HrtAB.  As 
mentioned previously, a logical candidate for a system that could regulate the hrtAB 
promoter in a manner that requires the HssR binding site DR is the BAS1816/17 TCS, 
which contains a response regulator predicted to recognize the same DR as HssR (43).  
It is possible that these compounds (and possibly heme, see Figure 25) activate 
BAS1816/17, providing another layer of control for the heme detoxification response in 
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B. anthracis.  Accordingly, we plan to generate mutants lacking members of this novel 
TCS (BAS1816/17), as well as the ABC transporter it is predicted to regulate 
(BAS1814/15).  We will test whether BAS1814/15 plays a role in heme detoxification, 
whether HssRS-activating compounds induce expression of BAS1814/15 using 
BAS1814 reporter-based techniques, and which genes the BAS1816/17 TCS regulates 
in B. anthracis using microarray-based approaches.  This line of investigation has the 
potential to broaden our understanding of the heme detoxification response of Gram-
positive bacteria by elucidating whether HssRS signaling overlaps with that of other 
bacterial TCS. 
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